title,url,time_published,summary,ticker,relevance_score,ticker_sentiment_score,ticker_sentiment_label
"Hologic, Inc.  ( HOLX )  Hit a 52 Week High, Can the Run Continue?",https://www.zacks.com/stock/news/2037341/hologic-inc-holx-hit-a-52-week-high-can-the-run-continue,2023-01-10 14:15:05,"Hologic (HOLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",HOLX,0.752955,0.509454,Bullish
What's Going On With Hologic Shares Today? - Hologic  ( NASDAQ:HOLX ) ,https://www.benzinga.com/trading-ideas/movers/23/01/30336091/whats-going-on-with-hologic-shares-today,2023-01-09 17:38:16,"Hologic, Inc. HOLX shares are trading higher today after the company reported preliminary first-quarter revenue results. What happened: Hologic on Sunday announced that the company expects to report revenues of approximately $1.074 billion for the first quarter of 2023.",HOLX,0.910514,0.293037,Somewhat-Bullish
"Stocks making the biggest moves midday: Tesla, Nvidia, Lululemon and more",https://www.cnbc.com/2023/01/09/stocks-making-the-biggest-moves-midday-tesla-nvidia-lululemon-and-more.html,2023-01-09 17:36:10,These are the stocks posting the largest moves in midday trading.,HOLX,0.066414,0.181534,Somewhat-Bullish
"Stocks making the biggest moves premarket: Lululemon, Duck Creek, Mastercard, Uber and more",https://www.cnbc.com/2023/01/09/stocks-making-biggest-moves-premarket-lululemon-duck-creek-and-more.html,2023-01-09 13:09:23,These are the stocks posting the largest moves in the Monday ...,HOLX,0.084127,0.241821,Somewhat-Bullish
HOLX or EW: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2036343/holx-or-ew-which-is-the-better-value-stock-right-now,2023-01-06 16:40:13,HOLX vs. EW: Which Stock Is the Better Value Option?,HOLX,0.737428,0.619506,Bullish
Molecular Breast Imaging Market will worth USD 10.65 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30311368/molecular-breast-imaging-market-will-worth-usd-10-65-billion-by-2030-greyviews,2023-01-06 15:00:00,"Pune India, Jan. 06, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the molecular breast imaging market is operating ...",HOLX,0.028798,0.072858,Neutral
Hologic  ( HOLX )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2034827/hologic-holx-gains-as-market-dips-what-you-should-know,2023-01-03 22:45:21,"In the latest trading session, Hologic (HOLX) closed at $75.55, marking a +0.99% move from the previous day.",HOLX,0.554916,0.10506,Neutral
"Hologic, Inc.  ( HOLX )  Is a Trending Stock: Facts to Know Before Betting on It",https://www.zacks.com/stock/news/2034553/hologic-inc-holx-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-01-03 14:00:14,"Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.",HOLX,0.486627,0.095298,Neutral
Masimo  ( MASI )  Expands Partnership with Philips for W1 Watch,https://www.zacks.com/stock/news/2042178/masimo-masi-expands-partnership-with-philips-for-w1-watch,2023-01-20 18:15:00,Masimo (MASI) and Royal Philips to create an open ecosystem of medical information using Masimo W1 watch and the latter???s patient monitoring ecosystem to improve home-care.,HOLX,0.146025,0.063505,Neutral
Non-COVID Diagnostics Sales to Aid Hologic  ( HOLX )  Q1 Earnings,https://www.zacks.com/stock/news/2042136/non-covid-diagnostics-sales-to-aid-hologic-holx-q1-earnings,2023-01-20 17:09:00,The growing adoption of Panther instruments worldwide will likely drive Hologic's (HOLX) Q1 revenues.,HOLX,0.592978,0.496761,Bullish
Will Boston Scientific  ( BSX )  Beat Q4 Earnings Estimates?,https://www.zacks.com/stock/news/2041865/will-boston-scientific-bsx-beat-q4-earnings-estimates,2023-01-20 13:42:00,"Boston Scientific (BSX) is expected to have registered strong growth in EMEA within structural heart, including TAVR, WATCHMAN, and other interventional cardiology therapies.",HOLX,0.09989,0.0,Neutral
"For CEOs at Davos, efficient, profitable operations take center stage",https://www.foxbusiness.com/business-leaders/ceos-davos-efficient-profitable-operations-take-center-stage,2023-01-19 23:34:28,"Results. It is the outcome executives say they are seeking, demanding-and selling. Companies say they are giving priority to profitability and efficiency amid concerns about macroeconomic conditions, whether it is to reach their strategic goals, slim down their workforces or streamline operations.",HOLX,0.039811,0.070532,Neutral
Hologic  ( HOLX )  Stock Moves -0.2%: What You Should Know,https://www.zacks.com/stock/news/2041625/hologic-holx-stock-moves--02-what-you-should-know,2023-01-19 22:45:21,"In the latest trading session, Hologic (HOLX) closed at $78.76, marking a -0.2% move from the previous day.",HOLX,0.558244,0.122052,Neutral
Skin-Tightening Market will manage to achieve USD 1693.4 million by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30487202/skin-tightening-market-will-manage-to-achieve-usd-1693-4-million-by-2030-greyviews,2023-01-19 16:30:00,"Pune India, Jan. 19, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the skin-tightening market is operating and is ...",HOLX,0.026328,0.067318,Neutral
In Search of an Earnings Beat? Play These Top 5 Stocks,https://www.zacks.com/stock/news/2041143/in-search-of-an-earnings-beat-play-these-top-5-stocks,2023-01-19 12:25:00,"These top-ranked stocks are likely to beat on bottom line in their next releases. Tap Yum China (YUMC), Impinj (PI), Five Below (FIVE), Hologic (HOLX) and Progyny (PGNY).",HOLX,0.194868,0.03625,Neutral
"Hologic, Inc.  ( HOLX )  is Attracting Investor Attention: Here is What You Should Know",https://www.zacks.com/stock/news/2040651/hologic-inc-holx-is-attracting-investor-attention-here-is-what-you-should-know,2023-01-18 14:00:11,"Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",HOLX,0.486627,0.170861,Somewhat-Bullish
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings,https://www.zacks.com/stock/news/2040637/want-better-returns-dont-ignore-these-2-medical-stocks-set-to-beat-earnings,2023-01-18 13:50:07,Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.,HOLX,0.374312,0.388708,Bullish
What's in Store for Abbott Laboratories  ( ABT )  in Q4 Earnings?,https://www.zacks.com/stock/news/2040079/whats-in-store-for-abbott-laboratories-abt-in-q4-earnings,2023-01-17 13:43:00,"Within Abbott's (ABT) Established Pharmaceuticals Division (EPD), new product launches across key markets have been majorly boosting business in recent months.",HOLX,0.12023,0.0,Neutral
Hologic  ( HOLX )  to Report Q1 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2040015/hologic-holx-to-report-q1-earnings-whats-in-the-cards,2023-01-17 13:37:00,Growing adoption of Panther instruments and growth in the Surgical business will likely drive Hologic's (HOLX) Q1 revenues.,HOLX,0.402761,0.286849,Somewhat-Bullish
Should First Trust Capital Strength ETF  ( FTCS )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2039888/should-first-trust-capital-strength-etf-ftcs-be-on-your-investing-radar,2023-01-17 11:20:07,Style Box ETF report for ...,HOLX,0.124486,0.067704,Neutral
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises,https://www.zacks.com/stock/news/2039564/how-to-find-strong-medical-stocks-slated-for-positive-earnings-surprises,2023-01-16 13:50:06,Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.,HOLX,0.308504,0.288646,Somewhat-Bullish
"If You Invested $1000 in Hologic a Decade Ago, This is How Much It'd Be Worth Now",https://www.zacks.com/stock/news/2039540/if-you-invested-1000-in-hologic-a-decade-ago-this-is-how-much-itd-be-worth-now,2023-01-16 13:30:05,Holding on to popular or trending stocks for the long-term can make your portfolio a winner.,HOLX,0.600602,0.257234,Somewhat-Bullish
Hologic  ( HOLX )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2039290/hologic-holx-gains-but-lags-market-what-you-should-know,2023-01-13 22:45:22,"Hologic (HOLX) closed at $79.95 in the latest trading session, marking a +0.1% move from the prior day.",HOLX,0.634884,0.267533,Somewhat-Bullish
Market Rally Gains Steam As Inflation Cools,https://www.investors.com/news/stock-market-rally-gains-steam-as-inflation-tesla-price-cuts-big-earnings-in-focus/,2023-01-13 17:23:00,"The stock market rally, building on the Jan. 6 bounce, continued to advance in the latest week amid optimism over China's reopening and slowing inflation. The S&P 500 reclaimed its 50-day line and moved up to its 200-day line. Tesla ( TSLA ) slashed U.S. and European prices, hitting auto stocks.",HOLX,0.053212,-0.003,Neutral
Why Hologic  ( HOLX )  Could Beat Earnings Estimates Again,https://www.zacks.com/stock/news/2039207/why-hologic-holx-could-beat-earnings-estimates-again,2023-01-13 17:10:11,Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,HOLX,0.411848,0.505068,Bullish
What Makes Hologic  ( HOLX )  a Strong Momentum Stock: Buy Now?,https://www.zacks.com/stock/news/2039225/what-makes-hologic-holx-a-strong-momentum-stock-buy-now,2023-01-13 17:00:07,Does Hologic (HOLX) have what it takes to be a top stock pick for momentum investors? Let's find out.,HOLX,0.59928,0.449722,Bullish
5 Stocks With High ROE to Buy as Rate Hike Fears Subside,https://www.zacks.com/stock/news/2037758/5-stocks-with-high-roe-to-buy-as-rate-hike-fears-subside,2023-01-11 12:50:00,"Jabil (JBL), PepsiCo (PEP), DICK'S Sporting (DKS), Hologic (HOLX) and Suzano (SUZ) are some of the stocks with high ROE to profit from as rate hike fears subside.",HOLX,0.191675,0.160575,Somewhat-Bullish
BD  ( BDX )  Gears Up for Q1 Earnings: What's in the Offing?,https://www.zacks.com/stock/news/2046367/bd-bdx-gears-up-for-q1-earnings-whats-in-the-offing,2023-01-30 15:22:00,Continued strength in BD's (BDX) Life Sciences segment's base business is expected to have driven up Q1 sales.,HOLX,0.10863,0.089311,Neutral
Charles River  ( CRL )  to Report Q4 Earnings: What's in Store?,https://www.zacks.com/stock/news/2046152/charles-river-crl-to-report-q4-earnings-whats-in-store,2023-01-30 13:31:00,The broad-based demand and meaningful price increases in the RMS business particularly in North America are expected to have contributed to Charles River's (CRL) top line in Q4.,HOLX,0.122685,0.0,Neutral
Influenza Diagnostics Market will worth USD 2.58 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30606896/influenza-diagnostics-market-will-worth-usd-2-58-billion-by-2030-greyviews,2023-01-27 18:00:00,"Pune India, Jan. 27, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the influenza diagnostics market is operating and ...",HOLX,0.026562,0.125674,Neutral
"Hologic, Inc.  ( HOLX )  Hits Fresh High: Is There Still Room to Run?",https://www.zacks.com/stock/news/2045446/hologic-inc-holx-hits-fresh-high-is-there-still-room-to-run,2023-01-27 14:15:04,"Hologic (HOLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",HOLX,0.751437,0.446233,Bullish
"The Zacks Analyst Blog Highlights Juniper Networks, MSCI, IDEX, Hologic and Air Products and Chemicals",https://www.zacks.com/stock/news/2045319/the-zacks-analyst-blog-highlights-juniper-networks-msci-idex-hologic-and-air-products-and-chemicals,2023-01-27 12:34:00,"Juniper Networks, MSCI, IDEX, Hologic and Air Products and Chemicals are part of the Zacks top Analyst Blog.",HOLX,0.220522,0.1417,Neutral
"The Automated Breast Ultrasound Systems Market was estimated at US$ 1.71 Billion in 2022 which is expected to reach US$ 6.34 Billion by the end of 2032, with a CAGR of 14%: Market Decipher",https://www.benzinga.com/pressreleases/23/01/g30598816/the-automated-breast-ultrasound-systems-market-was-estimated-at-us-1-71-billion-in-2022-which-is-e,2023-01-27 07:55:40,"Pune, Jan. 26, 2023 ( GLOBE NEWSWIRE ) -- Market decipher has published its latest report - ""Automated Breast Ultrasound Systems Market"" Size, Statistics, Growth Trend Analysis and Forecast Report, 2022 - 2032.",HOLX,0.056407,0.025072,Neutral
"CVRx  ( CVRX )  Reports Q4 Loss, Tops Revenue Estimates",https://www.zacks.com/stock/news/2045137/cvrx-cvrx-reports-q4-loss-tops-revenue-estimates,2023-01-26 23:25:06,"CVRx (CVRX) delivered earnings and revenue surprises of 7.27% and 5.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",HOLX,0.140485,0.0,Neutral
STERIS  ( STE )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2044621/steris-ste-to-report-q3-earnings-whats-in-the-cards,2023-01-26 13:18:00,"STERIS' (STE) hospital capital spending is expected to have remained robust in Q3, as evident from the healthcare backlog's recent trend.",HOLX,0.126561,0.0,Neutral
5 S&P 500 Stocks to Buy Ahead of Earnings Next Week,https://www.zacks.com/stock/news/2044550/5-sp-500-stocks-to-buy-ahead-of-earnings-next-week,2023-01-26 11:31:00,"Five S&P 500 companies are set to beat earnings estimates next week. These are: JNPR, MSCI, IEX, APD and HOLX.",HOLX,0.197951,0.159489,Somewhat-Bullish
Hologic  ( HOLX )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2044354/hologic-holx-gains-as-market-dips-what-you-should-know,2023-01-25 22:45:21,"Hologic (HOLX) closed at $81.70 in the latest trading session, marking a +0.13% move from the prior day.",HOLX,0.677342,0.303358,Somewhat-Bullish
"NextGen  ( NXGN )  Q3 Earnings Fall Shy of Estimates, Revenues Top",https://www.zacks.com/stock/news/2044189/nextgen-nxgn-q3-earnings-fall-shy-of-estimates-revenues-top,2023-01-25 16:28:00,NextGen's (NXGN) third-quarter fiscal 2023 results reflect strength in its Recurring revenues.,HOLX,0.1331,0.097317,Neutral
Hologic  ( HOLX )  Expected to Beat Earnings Estimates: Should You Buy?,https://www.zacks.com/stock/news/2044112/hologic-holx-expected-to-beat-earnings-estimates-should-you-buy,2023-01-25 15:00:49,Hologic (HOLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,HOLX,0.3007,0.163875,Somewhat-Bullish
HOLX vs. EW: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2042769/holx-vs-ew-which-stock-is-the-better-value-option,2023-01-23 16:40:12,Investors interested in Medical - Instruments stocks are likely familiar with Hologic ( HOLX Quick QuoteHOLX - ) and Edwards Lifesciences ( EW Quick QuoteEW - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.,HOLX,0.703273,0.559964,Bullish
"Diagnostic imaging market: Driving factors, Industry challenges, Segmentation, Key vendor analysis, Leading countries, and Market size and forecast 2023-2027 - Technavio",https://www.prnewswire.com/news-releases/diagnostic-imaging-market-driving-factors-industry-challenges-segmentation-key-vendor-analysis-leading-countries-and-market-size-and-forecast-2023-2027---technavio-301726654.html,2023-01-23 16:30:00,"Diagnostic imaging market: Driving factors, Industry challenges ... PR ...",HOLX,0.032558,0.0,Neutral
What's in Store for Thermo Fisher  ( TMO )  in Q4 Earnings?,https://www.zacks.com/stock/news/2042730/whats-in-store-for-thermo-fisher-tmo-in-q4-earnings,2023-01-23 15:31:00,"The industrywide trend of record-level inflation, supply issues and staffing shortages are expected to have deterred growth in several areas of Thermo Fisher's (TMO) business in Q4.",HOLX,0.135347,0.0,Neutral
"Aesthetic Lasers Market to Reach USD 2.5 Billion, Globally, by 2031 at 9.3% CAGR: Allied Market Research",https://www.prnewswire.com/news-releases/aesthetic-lasers-market-to-reach-usd-2-5-billion-globally-by-2031-at-9-3-cagr-allied-market-research-301728087.html,2023-01-23 13:13:00,"Aesthetic Lasers Market to Reach USD 2.5 Billion, Globally, by 2031 ... PR ...",HOLX,0.033656,0.102026,Neutral
"Baxter  ( BAX )  Q4 Earnings Miss Estimates, FY23 Outlook Weak",https://www.zacks.com/stock/news/2052441/baxter-bax-q4-earnings-miss-estimates-fy23-outlook-weak,2023-02-09 16:22:00,Baxter's (BAX) fourth-quarter results reflect impact of additional sales from the legacy Hilrom's business acquired in 2021. Ongoing macroeconomic challenges hurt earnings significantly.,HOLX,0.159043,0.05216,Neutral
"STERIS  ( STE )  Q3 Earnings Miss Estimates, Margins Down Y/Y",https://www.zacks.com/stock/news/2052298/steris-ste-q3-earnings-miss-estimates-margins-down-yy,2023-02-09 14:43:00,Negative foreign currency and the impact of increased supply chain and inflationary costs hurt STERIS (STE) revenues in the fiscal third quarter.,HOLX,0.174903,0.055673,Neutral
"Haemonetics  ( HAE )  Q3 Earnings Beat Estimates, Margins Down",https://www.zacks.com/stock/news/2052278/haemonetics-hae-q3-earnings-beat-estimates-margins-down,2023-02-09 14:25:00,"In the fiscal third quarter, Haemonetics (HAE) incurs higher research and development costs, primarily due to increased investments in product innovation.",HOLX,0.17618,0.054486,Neutral
"2023 CALIFORNIA CONFERENCE FOR WOMEN TO FOCUS ON LEADERSHIP, CONNECTION, AND BEING A FORCE FOR CHANGE",https://www.benzinga.com/pressreleases/23/02/n30821811/2023-california-conference-for-women-to-focus-on-leadership-connection-and-being-a-force-for-chang,2023-02-08 20:29:00,"SANTA CLARA, Feb. 8, 2023 /PRNewswire/ -- Leaders from corporate America, the media, sports, arts, and Hollywood will come together this Women's History Month to discuss women leading together to be a force for positive change in 2023. They include the former CEO of IBM Ginny Rometty.",HOLX,0.051551,0.15847,Somewhat-Bullish
"Physicians' Education Resource Announces 40th Annual Miami Breast Cancer Conference Scheduled for March 2-5, 2023",https://www.benzinga.com/pressreleases/23/02/g30818618/physicians-education-resource-announces-40th-annual-miami-breast-cancer-conference-scheduled-for-m,2023-02-08 17:27:34,"CRANBURY, N.J., Feb. 08, 2023 ( GLOBE NEWSWIRE ) -- Physicians' Education Resource®, LLC ( PER® ) , a top educational resource for health care professionals across all specialties to advance patient care, today announced it will host its 40th Annual Miami Breast Cancer Conference® at the ...",HOLX,0.072876,0.155301,Somewhat-Bullish
"Illumina  ( ILMN )  Q4 Earnings Miss Estimates, Gross Margin Down",https://www.zacks.com/stock/news/2051750/illumina-ilmn-q4-earnings-miss-estimates-gross-margin-down,2023-02-08 15:57:00,"Delays in recruitment for some large research projects in the Americas and Europe, the impact of COVID disruptions in China and foreign exchange woes hurt Illumina's (ILMN) Q4 revenues.",HOLX,0.169975,0.055953,Neutral
"QIAGEN's  ( QGEN )  Q4 Earnings Top Estimates, Margins Down",https://www.zacks.com/stock/news/2051748/qiagens-qgen-q4-earnings-top-estimates-margins-down,2023-02-08 15:55:00,The ongoing double-digit sales growth in the non-COVID product portfolio contributed to QIAGEN's (QGEN) Q4 revenues.,HOLX,0.156715,0.032247,Neutral
"CVS Health  ( CVS )  Q4 Earnings Surpass Estimates, Margins Down",https://www.zacks.com/stock/news/2051657/cvs-health-cvs-q4-earnings-surpass-estimates-margins-down,2023-02-08 14:56:00,"CVS Health's (CVS) Retail/LTC segment revenues rise on increased prescription and front store volume, pharmacy drug mix and brand inflation.",HOLX,0.17179,0.054946,Neutral
"Inspire Medical  ( INSP )  Q4 Earnings, Revenues Top Estimates",https://www.zacks.com/stock/news/2051584/inspire-medical-insp-q4-earnings-revenues-top-estimates,2023-02-08 14:10:00,Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the fourth quarter.,HOLX,0.184246,0.057771,Neutral
4 Top Stocks to Buy on Earnings Beat Potential,https://www.zacks.com/stock/news/2051462/4-top-stocks-to-buy-on-earnings-beat-potential,2023-02-08 13:03:00,"These top-ranked stocks are likely to beat on the bottom line in their next releases. These stocks include Genmab (GMAB), Hologic (HOLX), ServiceNow (NOW) and Splunk (SPLK).",HOLX,0.246167,0.143803,Neutral
"Catalent  ( CTLT )  Q2 Earnings Lag Estimates, Revenues Top",https://www.zacks.com/stock/news/2051030/catalent-ctlt-q2-earnings-lag-estimates-revenues-top,2023-02-07 15:07:00,"Catalent (CTLT) records lower revenues in both segments in its second-quarter fiscal 2023, resulting in overall soft performance.",HOLX,0.190043,0.059112,Neutral
"Surmodics  ( SRDX )  Q1 Earnings Top Estimates, FY23 View Revised",https://www.zacks.com/stock/news/2050978/surmodics-srdx-q1-earnings-top-estimates-fy23-view-revised,2023-02-07 14:52:00,Surmodics (SRDX) reports a solid fiscal first quarter top line on the back of robust Medical Device revenues.,HOLX,0.148045,0.049871,Neutral
"IDEXX  ( IDXX )  Q4 Earnings Beat Estimates, Margins Increases",https://www.zacks.com/stock/news/2050444/idexx-idxx-q4-earnings-beat-estimates-margins-increases,2023-02-06 15:57:00,IDEXX's (IDXX) Q4 revenues are driven by continued benefits from expanding the global premium instrument installed base.,HOLX,0.17618,0.057378,Neutral
DexCom  ( DXCM )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2050380/dexcom-dxcm-to-report-q4-earnings-whats-in-the-cards,2023-02-06 14:42:00,DexCom's (DXCM) fourth-quarter results are likely to reflect rising global awareness of its real-time CGM.,HOLX,0.144275,0.117832,Neutral
"Avantor  ( AVTR )  Q4 Earnings Surpass Estimates, Margins Up",https://www.zacks.com/stock/news/2050333/avantor-avtr-q4-earnings-surpass-estimates-margins-up,2023-02-06 14:28:00,"Despite Avantor's (AVTR) robust core organic sales across its segments, it reports an overall soft Q4 performance.",HOLX,0.143843,0.049029,Neutral
"Investors Heavily Search Hologic, Inc.  ( HOLX ) : Here is What You Need to Know",https://www.zacks.com/stock/news/2050293/investors-heavily-search-hologic-inc-holx-here-is-what-you-need-to-know,2023-02-06 14:00:13,"Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.",HOLX,0.49219,0.207505,Somewhat-Bullish
"Zimmer Biomet  ( ZBH )  Q4 Earnings Beat Estimates, Margins Up",https://www.zacks.com/stock/news/2049754/zimmer-biomet-zbh-q4-earnings-beat-estimates-margins-up,2023-02-03 18:09:00,Each of Zimmer Biomet's (ZBH) geographic segments and product divisions record year-over-year sales growth at CER.,HOLX,0.215415,0.066787,Neutral
"CONMED  ( CNMD )  Down on Q4 Earnings Miss, New System Hurts Sales",https://www.zacks.com/stock/news/2049620/conmed-cnmd-down-on-q4-earnings-miss-new-system-hurts-sales,2023-02-03 15:11:00,CONMED's (CNMD) adjusted fourth-quarter sales and earnings reflect disruption due to implementation of a new warehouse management system.,HOLX,0.160099,0.052386,Neutral
"Cardinal Health  ( CAH )  Q2 Earnings Top, EPS Outlook Raised",https://www.zacks.com/stock/news/2049117/cardinal-health-cah-q2-earnings-top-eps-outlook-raised,2023-02-02 19:38:00,Cardinal Health's (CAH) fiscal second-quarter results benefit from the solid performance of the Pharmaceutical segment.,HOLX,0.214462,0.064911,Neutral
Accuray  ( ARAY )  Q2 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2049129/accuray-aray-q2-earnings-and-revenues-top-estimates,2023-02-02 19:30:00,"Despite solid product demand, Accuray (ARAY) reports an overall soft fiscal Q2 performance.",HOLX,0.169378,0.05441,Neutral
"BD  ( BDX )  Q1 Earnings and Revenues Beat Estimates, Margins Down",https://www.zacks.com/stock/news/2049130/bd-bdx-q1-earnings-and-revenues-beat-estimates-margins-down,2023-02-02 19:28:00,The majority of BD's (BDX) core units witness strong revenue growth in the fiscal first quarter.,HOLX,0.121959,0.045021,Neutral
"Quest Diagnostics  ( DGX )  Q4 Earnings Top Estimates, Margin Down",https://www.zacks.com/stock/news/2049156/quest-diagnostics-dgx-q4-earnings-top-estimates-margin-down,2023-02-02 18:58:00,Improvement within Quest Diagnostics' (DGX) legacy base business contributes to Q4 performance.,HOLX,0.1871,0.059941,Neutral
"Hologic  ( HOLX )  Q1 Earnings Beat Estimates, 2023 View Up",https://www.zacks.com/stock/news/2049161/hologic-holx-q1-earnings-beat-estimates-2023-view-up,2023-02-02 18:52:00,Lower COVID-19 assays sales and supply chain challenges related to semiconductor chips dent Hologic's (HOLX) top line in Q1.,HOLX,0.325208,0.116491,Neutral
"McKesson  ( MCK )  Q3 Earnings Surpass Estimates, EPS View Up",https://www.zacks.com/stock/news/2048522/mckesson-mck-q3-earnings-surpass-estimates-eps-view-up,2023-02-02 16:01:00,McKesson's (MCK) third-quarter fiscal 2023 results benefit from segmental growth.,HOLX,0.17179,0.054974,Neutral
Hologic CEO Sees Covid-Era Boom Translating Into Long-Term Growth,https://www.barrons.com/articles/hologic-earnings-ceo-interview-stock-price-51675297793,2023-02-02 13:37:00,Financial results announced late Wednesday by Hologic seem to vindicate the medical testing company's case that its Covid-era boom can translate to long-term growth. Hologic ( ticker: HOLX ) revenue is dropping swiftly as sales of its Covid-19 tests drop.,HOLX,0.949596,0.357937,Bullish
"As of 2027, the HPV Testing and Pap Test Market is expected to reach US$ 9.2 billion at a CAGR of 13.2% - Exclusive Report by MarketsandMarkets™",https://www.benzinga.com/pressreleases/23/02/g30687087/as-of-2027-the-hpv-testing-and-pap-test-market-is-expected-to-reach-us-9-2-billion-at-a-cagr-of-13,2023-02-02 13:20:00,"Chicago, Feb. 02, 2023 ( GLOBE NEWSWIRE ) -- According to the new market research report published by MarketsandMarkets, ""HPV Testing and Pap Test Market Size, Growth by Test Type ( HPV Testing ( Follow-Up HPV Testing, Co- Testing, Primary HPV Testing ) , PAP Test ) , End User ( Laboratories, ...",HOLX,0.087185,0.172524,Somewhat-Bullish
"Align Technology  ( ALGN )  Q4 Earnings Top Estimates, Margins Drop",https://www.zacks.com/stock/news/2048232/align-technology-algn-q4-earnings-top-estimates-margins-drop,2023-02-02 13:15:00,Align Technology's (ALGN) lower scanner volume and ASPs are partially offset by higher services revenues from the larger installed base of scanners and increased non-system revenues.,HOLX,0.182506,0.057401,Neutral
Hologic  ( HOLX )  Reports Q1 Earnings: What Key Metrics Have to Say,https://www.zacks.com/stock/news/2048120/hologic-holx-reports-q1-earnings-what-key-metrics-have-to-say,2023-02-02 09:12:00,"While the top- and bottom-line numbers for Hologic (HOLX) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",HOLX,0.36472,0.161445,Somewhat-Bullish
Hologic CEO Sees Covid-Era Boom Translating Into Long-Term Growth,https://www.barrons.com/articles/hologic-stock-earnings-ceo-51675297793,2023-02-02 00:32:00,Financial results announced late Wednesday by Hologic seem to vindicate the medical testing company's case that its Covid-era boom can translate to long-term growth. Hologic ( ticker: HOLX ) revenue is dropping swiftly as sales of its Covid-19 tests drop.,HOLX,0.949596,0.357937,Bullish
Hologic  ( HOLX )  Q1 Earnings and Revenues Beat Estimates,https://www.zacks.com/stock/news/2047942/hologic-holx-q1-earnings-and-revenues-beat-estimates,2023-02-01 22:15:02,"Hologic (HOLX) delivered earnings and revenue surprises of 18.89% and 9.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",HOLX,0.405651,0.279965,Somewhat-Bullish
"Stocks making the biggest moves after hours: Meta, Align Technology, e.l.f Beauty and more",https://www.cnbc.com/2023/02/01/stocks-moving-big-after-hours-meta-algn-elf.html,2023-02-01 21:54:45,These are the stocks posting the largest moves in after-hour trading.,HOLX,0.245339,0.322115,Somewhat-Bullish
"If You Invested $1000 in Hologic 10 Years Ago, This Is How Much You'd Have Now",https://www.zacks.com/stock/news/2047538/if-you-invested-1000-in-hologic-10-years-ago-this-is-how-much-youd-have-now,2023-02-01 13:30:06,Holding on to popular or trending stocks for the long-term can make your portfolio a winner.,HOLX,0.59928,0.279888,Somewhat-Bullish
5 Stocks With High ROE to Buy as Equity Markets Hold Promise,https://www.zacks.com/stock/news/2047480/5-stocks-with-high-roe-to-buy-as-equity-markets-hold-promise,2023-02-01 12:47:00,"Jabil (JBL), Delta Air (DAL), AGNC Investment (AGNC), Hologic (HOLX) and Suzano (SUZ) are some of the stocks with high ROE to profit from as equity markets start 2023 on a positive note.",HOLX,0.190167,0.170645,Somewhat-Bullish
"Philips'  ( PHG )  Q4 Earnings Down Y/Y, Supply Chain Issues Ease",https://www.zacks.com/stock/news/2047223/philips-phg-q4-earnings-down-yy-supply-chain-issues-ease,2023-01-31 18:44:00,Koninklijke Philips' (PHG) Q4 top and bottom-line results reflect easing supply chain constraints.,HOLX,0.249106,0.164196,Somewhat-Bullish
LabCorp  ( LH )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2047087/labcorp-lh-to-report-q4-earnings-whats-in-the-cards,2023-01-31 15:32:00,Ongoing sales rebound in the base business for the Diagnostics and Drug Development segments likely drive LabCorp (LH) Q4 revenues.,HOLX,0.124378,0.0,Neutral
"Medical Device Stocks' Earnings on Feb 1: BSX, TMO & More",https://www.zacks.com/stock/news/2046933/medical-device-stocks-earnings-on-feb-1-bsx-tmo-more,2023-01-31 14:04:00,"Medical device companies' results are likely to reflect a sequential decline. Let's see how BSX, TMO, HOLX and ALGN fare this time.",HOLX,0.230235,0.110064,Neutral
"PacBio  ( PACB )  Q4 Earnings Match Estimates, Revenues Top",https://www.zacks.com/stock/news/2055976/pacbio-pacb-q4-earnings-match-estimates-revenues-top,2023-02-17 16:17:00,"Despite robust Consumables revenues, PacBio (PACB) witnesses overall soft performance in the fourth quarter.",HOLX,0.14131,0.048532,Neutral
"Nevro  ( NVRO )  Q4 Earnings Lag Estimates, Revenues Beat",https://www.zacks.com/stock/news/2055965/nevro-nvro-q4-earnings-lag-estimates-revenues-beat,2023-02-17 16:06:00,"Nevro's (NVRO) worldwide revenues improve on a year-over-year basis in Q4, partly owing to robust domestic performance.",HOLX,0.163909,0.053209,Neutral
"Syneos Health  ( SYNH )  Q4 Earnings Beat Estimates, Margins Down",https://www.zacks.com/stock/news/2055949/syneos-health-synh-q4-earnings-beat-estimates-margins-down,2023-02-17 15:40:00,Higher reimbursable expenses and growth in Deployment Solutions contribute to Commercial Solutions revenue growth at Syneos Health (SYNH).,HOLX,0.198221,0.059449,Neutral
"Bio-Rad  ( BIO )  Q4 Earnings Miss Estimates, Operating Margin Up",https://www.zacks.com/stock/news/2055939/bio-rad-bio-q4-earnings-miss-estimates-operating-margin-up,2023-02-17 15:26:00,"Excluding COVID-related sales, Life Science revenues at Bio-Rad (BIO) increase 28.1%, primarily driven by Droplet Digital PCR, process chromatography, Western blotting and qPCR products.",HOLX,0.18602,0.056676,Neutral
"Hologic, Inc.  ( HOLX )  Is a Trending Stock: Facts to Know Before Betting on It",https://www.zacks.com/stock/news/2055839/hologic-inc-holx-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-02-17 14:00:10,"Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",HOLX,0.489394,0.177403,Somewhat-Bullish
"AMN Healthcare  ( AMN )  Q4 Earnings, Revenues Beat Estimates",https://www.zacks.com/stock/news/2055806/amn-healthcare-amn-q4-earnings-revenues-beat-estimates,2023-02-17 13:55:00,"Despite AMN Healthcare's (AMN) robust results in the majority of its segments, it records a soft overall Q4 performance.",HOLX,0.149656,0.050174,Neutral
"Amedisys  ( AMED )  Q4 Earnings Beat, Operating Margin Dips",https://www.zacks.com/stock/news/2055761/amedisys-amed-q4-earnings-beat-operating-margin-dips,2023-02-17 13:15:00,Amedisys (AMED) delivers strong Home Health performance in the fourth quarter amid cost pressure.,HOLX,0.171485,0.053459,Neutral
"Shockwave Medical's  ( SWAV )  Q4 Earnings Top, Revenues Surge Y/Y",https://www.zacks.com/stock/news/2055733/shockwave-medicals-swav-q4-earnings-top-revenues-surge-yy,2023-02-17 12:09:00,Shockwave Medical's (SWAV) fourth-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.,HOLX,0.190793,0.059287,Neutral
"QuidelOrtho  ( QDEL )  Q4 Earnings Top Estimates, Margins Down",https://www.zacks.com/stock/news/2055536/quidelortho-qdel-q4-earnings-top-estimates-margins-down,2023-02-16 17:07:00,"QuidelOrtho (QDEL) reports robust overall top-line results in fourth-quarter 2022, despite disappointing segmental and geographical performances on a reported basis.",HOLX,0.130571,0.046515,Neutral
"LabCorp  ( LH )  Q4 Earnings Surpass Estimates, Margins Fall",https://www.zacks.com/stock/news/2055469/labcorp-lh-q4-earnings-surpass-estimates-margins-fall,2023-02-16 16:00:00,"The severe foreign exchange headwind, inflationary pressure and the ongoing Ukraine/Russia crisis impact LabCorp's (LH) business performance in Q4.",HOLX,0.153961,0.051063,Neutral
"Henry Schein  ( HSIC )  Q4 Earnings In Line, Gross Margin Up",https://www.zacks.com/stock/news/2055417/henry-schein-hsic-q4-earnings-in-line-gross-margin-up,2023-02-16 15:09:00,Growth in Technology and Value-added Services and the Medical segment drove Henry Schein's (HSIC) Q4 revenues.,HOLX,0.160365,0.05247,Neutral
"West Pharmaceutical  ( WST )  Q4 Earnings Beat, Order Book Strong",https://www.zacks.com/stock/news/2055239/west-pharmaceutical-wst-q4-earnings-beat-order-book-strong,2023-02-16 14:09:00,West Pharmaceutical's (WST) fourth-quarter results reflect sustained growth in non-COVID-19 demand amid dismal overall performance.,HOLX,0.146692,0.049597,Neutral
5 Stocks With High ROE to Buy as Inflation Blows Hot Again,https://www.zacks.com/stock/news/2054484/5-stocks-with-high-roe-to-buy-as-inflation-blows-hot-again,2023-02-15 12:46:00,"THOR Industries (THO), CNH Industrial (CNHI), Valero Energy (VLO), Hologic (HOLX) and Suzano (SUZ) are some of the stocks with high ROE to profit from as inflation rises yet again.",HOLX,0.169437,0.132197,Neutral
"Ecolab  ( ECL )  Q4 Earnings & Revenues Beat, Margins Decline",https://www.zacks.com/stock/news/2054275/ecolab-ecl-q4-earnings-revenues-beat-margins-decline,2023-02-14 18:33:00,Ecolab's (ECL) robust performance across all segments drives its Q4 sales despite business challenges.,HOLX,0.144491,0.047887,Neutral
"PerkinElmer's  ( PKI )  Q4 Earnings Top, Revenues Decline Y/Y",https://www.zacks.com/stock/news/2054151/perkinelmers-pki-q4-earnings-top-revenues-decline-yy,2023-02-14 16:29:00,"PerkinElmer's (PKI) fourth-quarter results benefit from the solid performance of the Discover & Analytics Solutions business, more than offset by lower COVID-related sales.",HOLX,0.174272,0.055502,Neutral
"Bruker  ( BRKR )  Q4 Earnings Beat Estimates, Margins Increase",https://www.zacks.com/stock/news/2052945/bruker-brkr-q4-earnings-beat-estimates-margins-increase,2023-02-10 15:59:00,Robust performance across most of the geographies and operating segments drove Bruker's (BRKR) Q4 revenues.,HOLX,0.165883,0.053667,Neutral
"Phibro  ( PAHC )  Q2 Earnings Top Estimates, Gross Margin Up",https://www.zacks.com/stock/news/2052939/phibro-pahc-q2-earnings-top-estimates-gross-margin-up,2023-02-10 15:48:00,"Growing uptake of MFAs, dairy products and vaccines contributed to Phibro's (PAHC) Q2 revenues.",HOLX,0.193078,0.059851,Neutral
"Cardiovascular Systems  ( CSII )  Q2 Earnings, Revenues Miss",https://www.zacks.com/stock/news/2052865/cardiovascular-systems-csii-q2-earnings-revenues-miss,2023-02-10 14:14:00,"With the announcement of the merger agreement with Abbott, Cardiovascular Systems (CSII) refrains from providing any update on the 2023 guidance.",HOLX,0.249744,0.073304,Neutral
"DexCom  ( DXCM )  Q4 Earnings Beat Estimates, Volumes Remain Strong",https://www.zacks.com/stock/news/2052841/dexcom-dxcm-q4-earnings-beat-estimates-volumes-remain-strong,2023-02-10 13:52:00,DexCom's (DXCM) fourth-quarter results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.,HOLX,0.181137,0.057058,Neutral
Here's Why You Should Invest in Hologic  ( HOLX )  Stock Now,https://www.zacks.com/stock/news/2060508/heres-why-you-should-invest-in-hologic-holx-stock-now,2023-03-01 15:55:00,Investors are optimistic about Hologic (HOLX) on the continued strength of GYN Surgical and Breast Health businesses.,HOLX,0.362065,0.400845,Bullish
"Myriad Genetics  ( MYGN )  Q4 Earnings Top, Gross Margin Falls",https://www.zacks.com/stock/news/2060507/myriad-genetics-mygn-q4-earnings-top-gross-margin-falls,2023-03-01 15:53:00,Myriad Genetics (MYGN) hereditary cancer testing volume registered strong growth in the fourth quarter. GeneSight comes up with yet another strong performance.,HOLX,0.181137,0.093668,Neutral
"Hologic's  ( HOLX )  Strategic Buyouts Aid, Surgical Arm Grows",https://www.zacks.com/stock/news/2060399/hologics-holx-strategic-buyouts-aid-surgical-arm-grows,2023-03-01 14:18:00,Hologic's (HOLX) GYN Surgical results underscore a more diverse surgical business with more growth drivers than in the past.,HOLX,0.314151,0.261343,Somewhat-Bullish
"Masimo  ( MASI )  Q4 Earnings Surpass Estimates, Margins Down",https://www.zacks.com/stock/news/2060316/masimo-masi-q4-earnings-surpass-estimates-margins-down,2023-03-01 13:42:00,Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q4 sales.,HOLX,0.152499,0.083401,Neutral
"Inari Medical  ( NARI )  Q4 Earnings Beat, Revenues Rise Y/Y",https://www.zacks.com/stock/news/2060175/inari-medical-nari-q4-earnings-beat-revenues-rise-yy,2023-03-01 10:18:00,Inari Medical's (NARI) fourth-quarter results benefit from significant progress made across all its growth drivers.,HOLX,0.227538,0.068003,Neutral
DENTSPLY SIRONA  ( XRAY )  Q4 Earnings & Revenues Beat Estimates,https://www.zacks.com/stock/news/2059903/dentsply-sirona-xray-q4-earnings-revenues-beat-estimates,2023-02-28 16:27:00,DENTSPLY SIRONA's (XRAY) Q4 earnings and revenues decline year over year due to unfavorable foreign currency movement and soft demand across all geographical segments.,HOLX,0.191549,0.057926,Neutral
PerkinElmer's  ( PKI )  Latest Launch to Boost Research Workflows,https://www.zacks.com/stock/news/2059821/perkinelmers-pki-latest-launch-to-boost-research-workflows,2023-02-28 14:41:00,PerkinElmer's (PKI) latest launch is expected to provide increased assay flexibility to researchers.,HOLX,0.254307,0.101114,Neutral
Reasons to Add Quest Diagnostics  ( DGX )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2059812/reasons-to-add-quest-diagnostics-dgx-stock-to-your-portfolio,2023-02-28 14:35:00,Investors continue to be optimistic about Quest Diagnostics (DGX) on its accelerated growth strategy and improvements in base volumes.,HOLX,0.201944,0.080992,Neutral
"Hologic, Inc.  ( HOLX )  is Attracting Investor Attention: Here is What You Should Know",https://www.zacks.com/stock/news/2059750/hologic-inc-holx-is-attracting-investor-attention-here-is-what-you-should-know,2023-02-28 14:00:13,"Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.",HOLX,0.488469,0.153443,Somewhat-Bullish
BD's  ( BDX )  New FDA Approval to Improve Cervical Cancer Testing,https://www.zacks.com/stock/news/2059376/bds-bdx-new-fda-approval-to-improve-cervical-cancer-testing,2023-02-27 15:49:00,BD's (BDX) receipt of the latest FDA approval is likely to improve the detection and prevention of cervical cancer.,HOLX,0.220008,0.170158,Somewhat-Bullish
Electrosurgery Devices Market to be Worth $8.73 Billion by 2030 - Exclusive Report by Meticulous Research®,https://www.benzinga.com/pressreleases/23/02/g31070033/electrosurgery-devices-market-to-be-worth-8-73-billion-by-2030-exclusive-report-by-meticulous-rese,2023-02-27 15:00:00,"Redding, California, Feb. 27, 2023 ( GLOBE NEWSWIRE ) -- According to a new market research report titled, 'Electrosurgery Devices Market By Product ( Electrode, Smoke Evacuation System, Irrigation Device, Forcep, Generator ) , Surgery ( General, Gynecology, Oncology, Orthopedic, Cardiovascular, ...",HOLX,0.026503,0.070355,Neutral
Is First Trust Capital Strength ETF  ( FTCS )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2059106/is-first-trust-capital-strength-etf-ftcs-a-strong-etf-right-now,2023-02-27 11:20:07,Smart Beta ETF report for ...,HOLX,0.116067,0.061262,Neutral
"Insulet  ( PODD )  Q4 Earnings Beat Estimates, Margins Down",https://www.zacks.com/stock/news/2058923/insulet-podd-q4-earnings-beat-estimates-margins-down,2023-02-24 16:59:00,Insulet's (PODD) Q4 performance benefits from record quarterly U.S. and Total Omnipod new customer starts.,HOLX,0.184598,0.094966,Neutral
"Teleflex  ( TFX )  Q4 Earnings Top Estimates, Operating Margin Down",https://www.zacks.com/stock/news/2058829/teleflex-tfx-q4-earnings-top-estimates-operating-margin-down,2023-02-24 16:25:00,Teleflex (TFX) revenues in Asia rise backed by strong contributions from growth in all geographies.,HOLX,0.174587,0.055573,Neutral
"Inogen  ( INGN )  Q4 Earnings Beat Estimates, Revenues Lag",https://www.zacks.com/stock/news/2058822/inogen-ingn-q4-earnings-beat-estimates-revenues-lag,2023-02-24 16:03:00,Inogen's (INGN) fourth-quarter results benefit from higher revenues in its domestic business-to-business sales channel.,HOLX,0.145804,0.081166,Neutral
"OPKO Health  ( OPK )  Q4 Earnings Match Estimates, Revenues Top",https://www.zacks.com/stock/news/2058816/opko-health-opk-q4-earnings-match-estimates-revenues-top,2023-02-24 15:43:00,"Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in Pharmaceuticals segment, its overall fourth-quarter results reflect soft performances.",HOLX,0.148502,0.082057,Neutral
"Penumbra  ( PEN )  Q4 Earnings Top Estimates, Sales Remain Robust",https://www.zacks.com/stock/news/2058659/penumbra-pen-q4-earnings-top-estimates-sales-remain-robust,2023-02-24 13:42:00,Penumbra's (PEN) sales during the fourth quarter reflect continued demand for its products. The 2023 outlook is encouraging as EPS improves despite macro challenges.,HOLX,0.198628,0.059542,Neutral
"Chemed  ( CHE )  Q4 Earnings Beat Estimates, Margins Contract",https://www.zacks.com/stock/news/2058590/chemed-che-q4-earnings-beat-estimates-margins-contract,2023-02-24 12:41:00,Chemed (CHE) reports impressive sales growth in the Roto-Rooter subsidiary in the fourth quarter of 2022.,HOLX,0.17813,0.056373,Neutral
"Zacks Industry Outlook Highlights Edwards Lifesciences, IDEXX Laboratories and Hologic",https://www.zacks.com/stock/news/2058525/zacks-industry-outlook-highlights-edwards-lifesciences-idexx-laboratories-and-hologic,2023-02-24 08:13:00,"Edwards Lifesciences, IDEXX Laboratories and Hologic have been highlighted in this Industry Outlook article.",HOLX,0.180557,0.149489,Neutral
"DaVita  ( DVA )  Q4 Earnings Beat Estimates, Margins Down",https://www.zacks.com/stock/news/2058249/davita-dva-q4-earnings-beat-estimates-margins-down,2023-02-23 16:39:00,"Despite DaVita's (DVA) robust revenues in its Other segment, its overall Q4 performance was soft.",HOLX,0.177802,0.092427,Neutral
"NuVasive  ( NUVA )  Q4 Earnings Miss Estimates, Margins Down",https://www.zacks.com/stock/news/2058273/nuvasive-nuva-q4-earnings-miss-estimates-margins-down,2023-02-23 16:30:00,"Inflationary costs, supply chain disruptions, volatility in foreign exchange rates and the persistent COVID-led impact hurt NuVasive's (NUVA) Q4 revenues.",HOLX,0.191929,0.059551,Neutral
"Merit Medical  ( MMSI )  Q4 Earnings Top Estimates, Margins Down",https://www.zacks.com/stock/news/2058227/merit-medical-mmsi-q4-earnings-top-estimates-margins-down,2023-02-23 15:56:00,"Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in its Cardiovascular segment and the majority of product categories within its Cardiovascular unit.",HOLX,0.134027,0.074993,Neutral
"Tandem Diabetes  ( TNDM )  Q4 Earnings Beat, Gross Margin Dips",https://www.zacks.com/stock/news/2058221/tandem-diabetes-tndm-q4-earnings-beat-gross-margin-dips,2023-02-23 15:44:00,Tandem Diabetes (TNDM) Q4 GAAP sales reflect an accounting deferral related to the recent introduction of the company's Tandem Choice program in the United States.,HOLX,0.213517,0.064652,Neutral
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends,https://www.zacks.com/commentary/2058036/3-medical-instruments-stocks-to-buy-amid-improving-industry-trends,2023-02-23 15:27:00,"The Zacks Medical - Instruments industry is growing on rising demand for digital health. EW, IDXX and HOLX are set to gain the most. Yet, the ongoing inflation, in the form of rising freight, raw material costs, is disrupting the trend.",HOLX,0.160454,0.148596,Neutral
"Glaukos'  ( GKOS )  Q4 Earnings Beat Estimates, Sales Decline Y/Y",https://www.zacks.com/stock/news/2058203/glaukos-gkos-q4-earnings-beat-estimates-sales-decline-yy,2023-02-23 15:23:00,"Glaukos' (GKOS) Q4 revenues beat estimates but fall year over year. Lower revenues, along with higher expenses, hurt margins.",HOLX,0.204936,0.060994,Neutral
Fresenius Medical's  ( FMS )  Q4 Earnings and Revenues Beat,https://www.zacks.com/stock/news/2058159/fresenius-medicals-fms-q4-earnings-and-revenues-beat,2023-02-23 14:45:00,"Fresenius Medical's (FMS) fourth-quarter revenues benefit from strong performance across all segments, especially in the North America and Asia-Pacific regions. However, rising costs hurt margins.",HOLX,0.219312,0.06433,Neutral
"Integra Lifesciences  ( IART )  Q4 Earnings Top, Revenues Drop Y/Y",https://www.zacks.com/stock/news/2057968/integra-lifesciences-iart-q4-earnings-top-revenues-drop-yy,2023-02-23 13:05:00,Integra LifeSciences (IART) delivers strong earnings growth in the fourth quarter amid challenging macro environment issues.,HOLX,0.138464,0.049223,Neutral
5 Top Stocks Likely to Come Up With Earnings Beat,https://www.zacks.com/stock/news/2057919/5-top-stocks-likely-to-come-up-with-earnings-beat,2023-02-23 11:37:00,"These top-ranked stocks are likely to beat on the bottom line in their next releases. Tap Ulta Beauty (ULTA), Hologic (HOLX), Fortinet (FTNT), Splunk (SPLK) and ServiceNow (NOW).",HOLX,0.228431,0.039364,Neutral
"Charles River  ( CRL )  Q4 Earnings Top Estimates, Margins Dip",https://www.zacks.com/stock/news/2057630/charles-river-crl-q4-earnings-top-estimates-margins-dip,2023-02-22 18:19:00,Strength across the DSA and Research Models and Services RMS business segments drove Charles River's (CRL) Q4 revenues.,HOLX,0.180798,0.056981,Neutral
"Exact Sciences  ( EXAS )  Q4 Earnings Top Estimates, Margin Falls",https://www.zacks.com/stock/news/2057615/exact-sciences-exas-q4-earnings-top-estimates-margin-falls,2023-02-22 17:11:00,Robust revenues from the Screening and Precision Oncology segments contributed to the Exact Sciences (EXAS) Q4 top line.,HOLX,0.19117,0.059344,Neutral
"Globus Medical  ( GMED )  Q4 Earnings Beat, Operating Margin Rises",https://www.zacks.com/stock/news/2057351/globus-medical-gmed-q4-earnings-beat-operating-margin-rises,2023-02-22 13:44:00,Globus Medical (GMED) reports strong fourth-quarter sales growth amid currency headwinds and lingering COVID-19 impacts.,HOLX,0.157227,0.051774,Neutral
"Avanos  ( AVNS )  Q4 Earnings Surpass Estimates, Margins Up",https://www.zacks.com/stock/news/2057338/avanos-avns-q4-earnings-surpass-estimates-margins-up,2023-02-22 13:36:00,Avanos' (AVNS) fourth-quarter 2022 results reflect strength in both segments.,HOLX,0.150592,0.082757,Neutral
"Medtronic  ( MDT )  Q3 Earnings Beat Estimates, Margins Down",https://www.zacks.com/stock/news/2056945/medtronic-mdt-q3-earnings-beat-estimates-margins-down,2023-02-21 16:04:00,Medtronic's (MDT) CGM business banks on strong sales of the MiniMed 780G system and the associated increase in CGM attachment rates on the strength of the Guardian 4 sensor in Q3.,HOLX,0.142989,0.04886,Neutral
"Integer Holdings  ( ITGR )  Q4 Earnings Beat Estimates, Margins Up",https://www.zacks.com/stock/news/2056253/integer-holdings-itgr-q4-earnings-beat-estimates-margins-up,2023-02-20 13:28:00,"Integer Holdings' (ITGR) fourth-quarter results reflect robust Medical and Non-Medical Sales, besides strength in all the product lines.",HOLX,0.141726,0.048613,Neutral
PRESS RELEASE: #NACONCONNECT 2023: WHERE GAMEPLAY CAME FIRST!,https://www.globenewswire.com/news-release/2023/03/09/2624504/0/en/PRESS-RELEASE-NACONCONNECT-2023-WHERE-GAMEPLAY-CAME-FIRST.html,2023-03-09 18:45:00,#NACONCONNECT 2023: WHERE GAMEPLAY CAME FIRST!,HOLX,0.021718,0.122375,Neutral
Nevro's  ( NVRO )  Latest Launch to Customize Chronic Pain Treatment,https://www.zacks.com/stock/news/2063638/nevros-nvro-latest-launch-to-customize-chronic-pain-treatment,2023-03-09 15:24:00,Nevro's (NVRO) Senza HFX iQ SCS system is expected to treat individual patients per their particular treatment requirements.,HOLX,0.204936,0.041865,Neutral
Here's Why You Should Retain Catalent  ( CTLT )  Stock for Now,https://www.zacks.com/stock/news/2063629/heres-why-you-should-retain-catalent-ctlt-stock-for-now,2023-03-09 15:15:00,Catalent's (CTLT) product and service launches and a slew of strategic deals raise optimism about the stock.,HOLX,0.20537,0.041934,Neutral
"Women's Health Devices Market Size Expected to Hit USD 62.61 Billion by 2028, exhibiting 8.4% CAGR",https://www.benzinga.com/pressreleases/23/03/g31262045/womens-health-devices-market-size-expected-to-hit-usd-62-61-billion-by-2028-exhibiting-8-4-cagr,2023-03-08 17:14:50,"Pune, India, March 08, 2023 ( GLOBE NEWSWIRE ) -- The global Women's Health Devices Market size was valued at USD 34.23 billion in 2020. The market is projected to grow from USD 35.63 billion in 2021 to USD 62.61 billion in 2028, exhibiting a CAGR of 8.4% during the forecast period.",HOLX,0.035397,0.170773,Somewhat-Bullish
Cardinal Health's  ( CAH )  New Tie-Up to Boost Patient Outcomes,https://www.zacks.com/stock/news/2063122/cardinal-healths-cah-new-tie-up-to-boost-patient-outcomes,2023-03-08 17:06:00,Cardinal Health's (CAH) latest partnership is expected to improve patients' healthcare journey by offering a more integrated experience that connects all sites of care.,HOLX,0.221313,0.048016,Neutral
Three Reasons to Add BD  ( BDX )  Stock to Your Portfolio Now,https://www.zacks.com/stock/news/2063123/three-reasons-to-add-bd-bdx-stock-to-your-portfolio-now,2023-03-08 17:05:00,Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and product launches.,HOLX,0.215415,0.043553,Neutral
Women's Tennis Association partners with CVC to advance commercial growth of women's tennis,https://africa.businessinsider.com/sports/womens-tennis-association-partners-with-cvc-to-advance-commercial-growth-of-womens/l51tt61,2023-03-08 15:42:16,Women's Tennis Association partners with CVC to advance ... - Business Insider Africa ...,HOLX,0.083833,0.117569,Neutral
Women's Tennis Association partners with CVC to advance commercial growth of women's tennis,https://www.businessinsider.com/wta-partners-with-cvc-to-grow-womens-tennis-2023-3,2023-03-08 14:00:51,WTA Partners With CVC to Advance Growth of Women's Tennis - Business Insider ...,HOLX,0.067536,0.114631,Neutral
HOLX or EW: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2062627/holx-or-ew-which-is-the-better-value-stock-right-now,2023-03-07 16:40:12,HOLX vs. EW: Which Stock Is the Better Value Option?,HOLX,0.745397,0.635967,Bullish
BD  ( BDX )  Boosts Molecular Diagnostics Portfolio With New Tests,https://www.zacks.com/stock/news/2062601/bd-bdx-boosts-molecular-diagnostics-portfolio-with-new-tests,2023-03-07 15:15:00,Recent developments in the Molecular Diagnostics space have been aiding key MedTech players like BD (BDX) to boost their business.,HOLX,0.050572,0.133307,Neutral
Here's Why You Should Retain Surmodics  ( SRDX )  Stock for Now,https://www.zacks.com/stock/news/2062197/heres-why-you-should-retain-surmodics-srdx-stock-for-now,2023-03-06 15:13:00,Investors continue to be optimistic about Surmodics (SRDX) owing to its solid prospects in the thrombectomy business.,HOLX,0.200688,0.095206,Neutral
Walgreens Boots  ( WBA )  Benefits From New Launches Amid FX Woes,https://www.zacks.com/stock/news/2062192/walgreens-boots-wba-benefits-from-new-launches-amid-fx-woes,2023-03-06 15:05:00,"Walgreens Boots' (WBA) comparable pharmacy sales decline, reflecting lower demand for COVID-19 services.",HOLX,0.219312,0.089802,Neutral
Hologic  ( HOLX )  Down 5.2% Since Last Earnings Report: Can It Rebound?,https://www.zacks.com/stock/news/2061634/hologic-holx-down-52-since-last-earnings-report-can-it-rebound,2023-03-03 16:30:47,Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,HOLX,0.27432,0.107166,Neutral
Cooper Companies  ( COO )  Q1 Earnings and Revenues Beat Estimates,https://www.zacks.com/stock/news/2061604/cooper-companies-coo-q1-earnings-and-revenues-beat-estimates,2023-03-03 15:31:00,Cooper Companies' (COO) first-quarter fiscal 2023 revenues reflect a solid segmental performance despite a year-over-year decline in earnings.,HOLX,0.176825,0.056077,Neutral
Haemonetics  ( HAE )  Autotransfusion System Gets 510 ( k )  Clearance,https://www.zacks.com/stock/news/2061581/haemonetics-hae-autotransfusion-system-gets-510k-clearance,2023-03-03 14:53:00,The latest development is expected to upgrade Haemonetics' (HAE) Cell Salvage platform and broaden the company's scope in the growing autotransfusion space.,HOLX,0.269776,0.035853,Neutral
NextGen  ( NXGN )  Behavioral Health Suite Adopted by Compass Health,https://www.zacks.com/stock/news/2061481/nextgen-nxgn-behavioral-health-suite-adopted-by-compass-health,2023-03-03 13:48:00,NextGen's (NXGN) Behavioral Health Suite is expected to aid Compass Health in improving its workflow.,HOLX,0.270523,0.106279,Neutral
Hologic  ( HOLX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2061264/hologic-holx-outpaces-stock-market-gains-what-you-should-know,2023-03-02 22:45:20,"Hologic (HOLX) closed at $80.08 in the latest trading session, marking a +1.29% move from the prior day.",HOLX,0.5633,0.382844,Bullish
"Veeva Systems  ( VEEV )  Q4 Earnings Beat, Margins Decline",https://www.zacks.com/stock/news/2061193/veeva-systems-veev-q4-earnings-beat-margins-decline,2023-03-02 17:01:00,Veeva Systems' (VEEV) Q4 results reflect impressive performances by both segments.,HOLX,0.152499,0.083401,Neutral
"National Vision  ( EYE )  Q4 Revenues Miss Mark, Margins Down",https://www.zacks.com/stock/news/2061101/national-vision-eye-q4-revenues-miss-mark-margins-down,2023-03-02 16:28:00,"National Vision (EYE) is facing a challenging macroeconomic environment, which negatively impacted its performance in the fourth quarter of 2022.",HOLX,0.213988,0.104575,Neutral
"Patterson Companies  ( PDCO )  Q3 Earnings Beat, Sales Hurt by FX",https://www.zacks.com/stock/news/2061067/patterson-companies-pdco-q3-earnings-beat-sales-hurt-by-fx,2023-03-02 15:19:00,Patterson Companies' (PDCO) fiscal third-quarter 2023 results are negatively impacted by unfavorable currency movements.,HOLX,0.197816,0.060931,Neutral
Top 5 Stocks With High ROE as Equity Markets Flop in February,https://www.zacks.com/stock/news/2060886/top-5-stocks-with-high-roe-as-equity-markets-flop-in-february,2023-03-02 13:21:00,"AutoNation (AN), CNH Industrial (CNHI), Valero (VLO), Hologic (HOLX) and Ryder (R) are some of the stocks with high ROE to profit from as equity markets decline in February.",HOLX,0.167322,0.139309,Neutral
"Thousands of Women, Dozens of Top Employers Gather in Silicon Valley to Discuss Women in the Workplace",https://www.benzinga.com/pressreleases/23/03/n31151581/thousands-of-women-dozens-of-top-employers-gather-in-silicon-valley-to-discuss-women-in-the-workpl,2023-03-02 02:47:00,"SANTA CLARA,Calif., March 1, 2023 /PRNewswire/ -- Amid layoffs, economic headwinds, and backsliding on women's rights in many parts of the world, thousands of people from dozens of top employers gathered today to address women in the workplace at the 2023 California Conference for Women.",HOLX,0.076602,0.161138,Somewhat-Bullish
Syneos Health's  ( SYNH )  New Microsoft Deal to Expand AI Usage,https://www.zacks.com/stock/news/2068548/syneos-healths-synh-new-microsoft-deal-to-expand-ai-usage,2023-03-21 13:04:00,"With the multi-year deal, Syneos Health (SYNH) aims to deliver technology and data solutions with Microsoft.",HOLX,0.24847,0.170417,Somewhat-Bullish
Merit Medical's  ( MMSI )  New Launch to Boost its Product Suite,https://www.zacks.com/stock/news/2068530/merit-medicals-mmsi-new-launch-to-boost-its-product-suite,2023-03-21 12:45:00,Merit Medical's (MMSI) latest addition to its Vascular portfolio is expected to significantly enhance patient outcomes.,HOLX,0.22861,0.045646,Neutral
Hologic  ( HOLX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2068186/hologic-holx-outpaces-stock-market-gains-what-you-should-know,2023-03-20 21:45:19,"Hologic (HOLX) closed at $78.32 in the latest trading session, marking a +1.62% move from the prior day.",HOLX,0.684485,0.312793,Somewhat-Bullish
Buy 5 High ROE Stocks as Markets Brace for 25 Bps Rate Hike,https://www.zacks.com/stock/news/2068035/buy-5-high-roe-stocks-as-markets-brace-for-25-bps-rate-hike,2023-03-20 14:24:00,"AutoNation (AN), Atkore (ATKR), Valero (VLO), Hologic (HOLX) and Ryder (R) are some of the stocks with high ROE to profit from as markets brace for another rate hike.",HOLX,0.16709,0.148802,Neutral
Here's Why You Should Retain Accuray  ( ARAY )  Stock for Now,https://www.zacks.com/stock/news/2067941/heres-why-you-should-retain-accuray-aray-stock-for-now,2023-03-20 12:35:00,Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.,HOLX,0.213988,0.151405,Somewhat-Bullish
BD's  ( BDX )  New FDA Approval to Improve Vaginitis Testing,https://www.zacks.com/stock/news/2067345/bds-bdx-new-fda-approval-to-improve-vaginitis-testing,2023-03-17 14:40:00,BD's (BDX) receipt of the latest FDA approval is likely to improve the detection and prevention of vaginitis.,HOLX,0.210092,0.120546,Neutral
Catalent's  ( CTLT )  Tie-Up to Accelerate Clinical Trial Timelines,https://www.zacks.com/stock/news/2066808/catalents-ctlt-tie-up-to-accelerate-clinical-trial-timelines,2023-03-16 15:19:00,Catalent's (CTLT) latest collaboration is expected to leverage multiple services that reduce drug development timelines.,HOLX,0.230235,0.045907,Neutral
Shockwave Medical  ( SWAV )  Launches New IVL Catheter in U.S.,https://www.zacks.com/stock/news/2066548/shockwave-medical-swav-launches-new-ivl-catheter-in-us,2023-03-16 10:30:00,Shockwave Medical's (SWAV) latest U.S. launch is expected to serve a wider patient pool.,HOLX,0.212115,0.043008,Neutral
Here's Why You Should Retain Merit Medical  ( MMSI )  Stock for Now,https://www.zacks.com/stock/news/2066291/heres-why-you-should-retain-merit-medical-mmsi-stock-for-now,2023-03-15 16:18:00,Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.,HOLX,0.208464,0.042426,Neutral
OPKO Health  ( OPK )  to Develop EBV Vaccine With Latest Tie-Up,https://www.zacks.com/stock/news/2065588/opko-health-opk-to-develop-ebv-vaccine-with-latest-tie-up,2023-03-14 16:08:00,OPKO Health's (OPK) entry into a worldwide license and collaboration agreement with Merck is expected to aid in developing a vaccine against EBV.,HOLX,0.243498,0.048029,Neutral
Here's Why You Should Retain NextGen  ( NXGN )  Stock for Now,https://www.zacks.com/stock/news/2065575/heres-why-you-should-retain-nextgen-nxgn-stock-for-now,2023-03-14 15:55:00,NextGen's (NXGN) strong product portfolio and continued demand for its solutions raise optimism about the stock.,HOLX,0.216376,0.043688,Neutral
QuidelOrtho's  ( QDEL )  Rapid Antigen Test Gets De Novo FDA Approval,https://www.zacks.com/stock/news/2064941/quidelorthos-qdel-rapid-antigen-test-gets-de-novo-fda-approval,2023-03-13 17:00:00,QuidelOrtho's (QDEL) receipt of the FDA's De Novo approval is expected to enable it to provide the test as an aid in the diagnosis of SARS-CoV-2 infections in symptomatic individuals.,HOLX,0.195419,0.040363,Neutral
"Is Trending Stock Hologic, Inc.  ( HOLX )  a Buy Now?",https://www.zacks.com/stock/news/2064644/is-trending-stock-hologic-inc-holx-a-buy-now,2023-03-13 13:00:16,"Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",HOLX,0.486627,0.119747,Neutral
Abbott's  ( ABT )  Epic Max Tissue Valve Receives FDA Approval,https://www.zacks.com/stock/news/2073266/abbotts-abt-epic-max-tissue-valve-receives-fda-approval,2023-03-31 16:48:00,Abbott's (ABT) Epic Max design optimizes patient blood flow and has a low profile that makes future cardiac interventions simpler.,HOLX,0.223866,0.156854,Somewhat-Bullish
3 Reasons to Retain DaVita  ( DVA )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2073273/3-reasons-to-retain-davita-dva-stock-in-your-portfolio,2023-03-31 15:58:00,Investors remain optimistic about DaVita (DVA) due to the strength in its DaVita Kidney Care.,HOLX,0.219809,0.044237,Neutral
"Catalent  ( CTLT )  New Launch to Aid TPD Programs, Clinical Trials",https://www.zacks.com/stock/news/2072593/catalent-ctlt-new-launch-to-aid-tpd-programs-clinical-trials,2023-03-30 16:34:00,Catalent's (CTLT) latest launch will likely aid in advancing the rational selection of orally developable TPD candidates and their progress into clinical trials.,HOLX,0.232996,0.046349,Neutral
QIAGEN  ( QGEN )  QIAxcel Connect Gets Red Dot Design Award,https://www.zacks.com/stock/news/2072495/qiagen-qgen-qiaxcel-connect-gets-red-dot-design-award,2023-03-30 15:03:00,QIAGEN (QGEN) QIAxcel Connect automates the analysis of the size and quality of isolated DNA and RNA.,HOLX,0.235823,0.163458,Somewhat-Bullish
Is Biohaven Ltd.  ( BHVN )  Stock Outpacing Its Medical Peers This Year?,https://www.zacks.com/stock/news/2072427/is-biohaven-ltd-bhvn-stock-outpacing-its-medical-peers-this-year,2023-03-30 13:40:08,Here is how Biohaven Ltd. (BHVN) and Hologic (HOLX) have performed compared to their sector so far this year.,HOLX,0.412861,0.181323,Somewhat-Bullish
Here's Why Investors Should Retain Omnicell  ( OMCL )  Stock Now,https://www.zacks.com/stock/news/2072021/heres-why-investors-should-retain-omnicell-omcl-stock-now,2023-03-29 16:17:00,Investors are optimistic about Omnicell (OMCL) owing to its planned geographic expansion.,HOLX,0.195025,0.141038,Neutral
Illumina  ( ILMN )  to Enable Tertiary Analysis With New Launch,https://www.zacks.com/stock/news/2072012/illumina-ilmn-to-enable-tertiary-analysis-with-new-launch,2023-03-29 16:08:00,Illumina's (ILMN) Connected Software is an end-to-end software system that standardizes analysis tools and connects data across the genomics workflow.,HOLX,0.191549,0.139162,Neutral
Surmodics  ( SRDX )  Gets FDA's Formal Feedback About SurVeil DCB,https://www.zacks.com/stock/news/2071886/surmodics-srdx-gets-fdas-formal-feedback-about-surveil-dcb,2023-03-29 12:44:00,Surmodics' (SRDX) receipt of the FDA's positive formal feedback regarding its PMA application for the SurVeil DCB looks promising.,HOLX,0.241085,0.047643,Neutral
Here's Why You Should Retain Avantor  ( AVTR )  Stock for Now,https://www.zacks.com/stock/news/2071432/heres-why-you-should-retain-avantor-avtr-stock-for-now,2023-03-28 15:40:00,Investors continue to be optimistic about Avantor's (AVTR) strong product portfolio.,HOLX,0.213048,0.084412,Neutral
NextGen's  ( NXGN )  New Cloud-Based Solution to Improve Workflow,https://www.zacks.com/stock/news/2071408/nextgens-nxgn-new-cloud-based-solution-to-improve-workflow,2023-03-28 15:21:00,"NextGen's (NXGN) latest product is expected to simplify connectivity for healthcare providers, thereby solving clinical data exchange challenges.",HOLX,0.230235,0.08977,Neutral
Reasons to Retain Quest Diagnostics  ( DGX )  Stock for Now,https://www.zacks.com/stock/news/2071400/reasons-to-retain-quest-diagnostics-dgx-stock-for-now,2023-03-28 15:12:00,Investors are optimistic about Quest Diagnostics (DGX) on solid fourth-quarter 2022 performance and its strategies to accelerate growth.,HOLX,0.188193,0.137361,Neutral
"Walgreens Boots  ( WBA )  Q2 Earnings Top Estimates, Margins Down",https://www.zacks.com/stock/news/2071398/walgreens-boots-wba-q2-earnings-top-estimates-margins-down,2023-03-28 15:11:00,"The U.S. Healthcare segment of Walgreens Boots (WBA) grows on key contract wins, continued partnership growth and a strong focus on execution during fiscal Q2.",HOLX,0.169975,0.127811,Neutral
Hologic  ( HOLX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2070999/hologic-holx-outpaces-stock-market-gains-what-you-should-know,2023-03-27 21:45:24,"In the latest trading session, Hologic (HOLX) closed at $79.61, marking a +0.52% move from the previous day.",HOLX,0.571903,0.315312,Somewhat-Bullish
Quest Diagnostics  ( DGX )  Introduces New Post-COVID-19 Panels,https://www.zacks.com/stock/news/2070872/quest-diagnostics-dgx-introduces-new-post-covid-19-panels,2023-03-27 15:28:00,"Quest Diagnostics' (DGX) latest panels provide consumers a deeper look into their health, helping to prepare them for meaningful discussions with their healthcare providers ...",HOLX,0.217834,0.153525,Somewhat-Bullish
Here's Why You Should Retain Inogen  ( INGN )  Stock for Now,https://www.zacks.com/stock/news/2070832/heres-why-you-should-retain-inogen-ingn-stock-for-now,2023-03-27 14:22:00,Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.,HOLX,0.226477,0.045305,Neutral
Pneumonia testing market size is set to grow by USD 709 million from 2022 to 2027; The rising number of M and A and new product launches are a key trend - Technavio,https://www.prnewswire.com/news-releases/pneumonia-testing-market-size-is-set-to-grow-by-usd-709-million-from-2022-to-2027-the-rising-number-of-m-and-a-and-new-product-launches-are-a-key-trend---technavio-301781432.html,2023-03-27 10:56:00,Pneumonia testing market size is set to grow by USD 709 million ... PR ...,HOLX,0.029728,0.003889,Neutral
Catalent  ( CTLT )  Inks Deal for Nasal Spray for Opioid Overdoses,https://www.zacks.com/stock/news/2070302/catalent-ctlt-inks-deal-for-nasal-spray-for-opioid-overdoses,2023-03-24 15:16:00,Catalent's (CTLT) latest commercial supply agreement is expected to combat the opioid epidemic by making OTC naloxone more widely and easily accessible.,HOLX,0.231884,0.046171,Neutral
"Here is What to Know Beyond Why Hologic, Inc.  ( HOLX )  is a Trending Stock",https://www.zacks.com/stock/news/2070084/here-is-what-to-know-beyond-why-hologic-inc-holx-is-a-trending-stock,2023-03-24 13:00:12,"Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.",HOLX,0.49407,0.148488,Neutral
Medtronic  ( MDT )  to Enhance AI Innovation With New Platform,https://www.zacks.com/stock/news/2069781/medtronic-mdt-to-enhance-ai-innovation-with-new-platform,2023-03-23 16:48:00,"Medtronic's (MDT) GI Genius intelligent endoscopy module is the first FDA-cleared, AI-assisted colonoscopy tool to help physicians detect polyps that can lead to colorectal cancer.",HOLX,0.206245,0.167684,Somewhat-Bullish
3 Reasons to Retain QuidelOrtho  ( QDEL )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2069757/3-reasons-to-retain-quidelortho-qdel-stock-in-your-portfolio,2023-03-23 16:19:00,Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.,HOLX,0.214462,0.084851,Neutral
HOLX vs. EW: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2069731/holx-vs-ew-which-stock-is-the-better-value-option,2023-03-23 15:40:05,Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic ( HOLX Quick QuoteHOLX - ) and Edwards Lifesciences ( EW Quick QuoteEW - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.,HOLX,0.7414,0.625344,Bullish
Quest Diagnostics  ( DGX )  Advances Transplant Testing Service,https://www.zacks.com/stock/news/2069682/quest-diagnostics-dgx-advances-transplant-testing-service,2023-03-23 15:19:00,"These services by Quest Diagnostics (DGX) are available to recipients and living donors across the United States (excluding Alaska and Hawaii), broadening access for both donor and patient.",HOLX,0.230782,0.160675,Somewhat-Bullish
Should First Trust Capital Strength ETF  ( FTCS )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2069415/should-first-trust-capital-strength-etf-ftcs-be-on-your-investing-radar,2023-03-23 10:20:07,Style Box ETF report for ...,HOLX,0.126784,0.069436,Neutral
Here's Why You Should Retain Abbott  ( ABT )  Stock for Now,https://www.zacks.com/stock/news/2069241/heres-why-you-should-retain-abbott-abt-stock-for-now,2023-03-22 17:07:00,Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.,HOLX,0.193852,0.140404,Neutral
Neogen  ( NEOG )  Receives New Label Claims for Viroxide Super,https://www.zacks.com/stock/news/2069237/neogen-neog-receives-new-label-claims-for-viroxide-super,2023-03-22 16:53:00,"Neogen's (NEOG) Viroxide Super active constituents are potassium peroxymonosulfate and sodium chloride, which have been verified effective against multiple industry-relevant bacteria and viruses.",HOLX,0.20537,0.146671,Neutral
Three Reasons to Add Masimo  ( MASI )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2069183/three-reasons-to-add-masimo-masi-stock-to-your-portfolio,2023-03-22 15:58:00,Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.,HOLX,0.214937,0.036626,Neutral
"Chemed  ( CHE )  Up on Roto-Rooter Sales Growth, Strong Admissions",https://www.zacks.com/stock/news/2069207/chemed-che-up-on-roto-rooter-sales-growth-strong-admissions,2023-03-22 15:13:00,"Chemed (CHE) records increases in drain cleaning, plumbing, excavation and water restoration revenues within the Roto-Rooter branch commercial business.",HOLX,0.25168,0.174013,Somewhat-Bullish
"HealthEquity  ( HQY )  Beats on Q4 Earnings, Margins Rise",https://www.zacks.com/stock/news/2069107/healthequity-hqy-beats-on-q4-earnings-margins-rise,2023-03-22 14:38:00,"HealthEquity (HQY) witnesses solid growth in HSAs, alongside recording robust performances in all its segments, in the fourth quarter of fiscal 2023.",HOLX,0.158,0.085293,Neutral
Hologic  ( HOLX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2076542/hologic-holx-outpaces-stock-market-gains-what-you-should-know,2023-04-10 21:45:22,"Hologic (HOLX) closed the most recent trading day at $83.07, moving +0.25% from the previous trading session.",HOLX,0.549988,0.269696,Somewhat-Bullish
HOLX or EW: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2076390/holx-or-ew-which-is-the-better-value-stock-right-now,2023-04-10 15:40:16,HOLX vs. EW: Which Stock Is the Better Value Option?,HOLX,0.75957,0.637016,Bullish
Baxter's  ( BAX )  New Premix Drug Now Available in the U.S.,https://www.zacks.com/stock/news/2076367/baxters-bax-new-premix-drug-now-available-in-the-us,2023-04-10 15:13:00,"Baxter's (BAX) latest frozen premix formulation is expected to support patient safety, simplify medication preparation and boost operational efficiencies.",HOLX,0.249744,0.095839,Neutral
Here's Why You Should Invest in IDEXX  ( IDXX )  Stock Right Now,https://www.zacks.com/stock/news/2076359/heres-why-you-should-invest-in-idexx-idxx-stock-right-now,2023-04-10 15:00:00,Investors are optimistic about IDEXX's (IDXX) strength in the Companion Animal Group business.,HOLX,0.1871,0.139723,Neutral
CVS Health  ( CVS )  Team Up to Treat Digestive Disorder Virtually,https://www.zacks.com/stock/news/2076356/cvs-health-cvs-team-up-to-treat-digestive-disorder-virtually,2023-04-10 14:56:00,CVS Health's (CVS) recent partnership with Oshi makes it possible for its members to receive coordinated virtual digestive treatment.,HOLX,0.191549,0.010599,Neutral
Here's Why You Should Retain Intuitive Surgical  ( ISRG )  Stock Now,https://www.zacks.com/stock/news/2076345/heres-why-you-should-retain-intuitive-surgical-isrg-stock-now,2023-04-10 14:42:00,Investors continue to be optimistic about Intuitive Surgical (ISRG) owing to its strength in robotics.,HOLX,0.212115,0.084122,Neutral
Here's How Much You'd Have If You Invested $1000 in Hologic a Decade Ago,https://www.zacks.com/stock/news/2075910/heres-how-much-youd-have-if-you-invested-1000-in-hologic-a-decade-ago,2023-04-07 12:30:05,"Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",HOLX,0.59404,0.281935,Somewhat-Bullish
HealthEquity  ( HQY )  New Tie Up to Meet Clients' Healthcare Needs,https://www.zacks.com/stock/news/2075722/healthequity-hqy-new-tie-up-to-meet-clients-healthcare-needs,2023-04-06 16:17:00,HealthEquity's (HQY) latest collaboration is expected to enhance digital transformation with Microsoft Azure and build better experiences for customers and employees.,HOLX,0.306963,0.057886,Neutral
"QIAGEN's  ( QGEN )  Expanded Test Menu Aids, FX Woe Lingers",https://www.zacks.com/stock/news/2075684/qiagens-qgen-expanded-test-menu-aids-fx-woe-lingers,2023-04-06 16:15:00,"In terms of QIAstat-Dx, QIAGEN (QGEN) continues to witness increased demand for system placements and growing consumables usage around the world.",HOLX,0.222838,-0.008557,Neutral
National Vision  ( EYE )  Rides on Comps Growth Amid Macro Issues,https://www.zacks.com/stock/news/2075700/national-vision-eye-rides-on-comps-growth-amid-macro-issues,2023-04-06 16:08:00,"National Vision (EYE) continues to roll out its remote care capabilities, which provide doctors with additional levels of flexibility and expand exam capacity in many areas.",HOLX,0.235823,0.163458,Somewhat-Bullish
3 Reasons to Add Avanos  ( AVNS )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2075669/3-reasons-to-add-avanos-avns-stock-to-your-portfolio,2023-04-06 15:59:00,Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.,HOLX,0.214937,0.043477,Neutral
Illumina  ( ILMN )  to Expand Genomics Capacity With New Pact,https://www.zacks.com/stock/news/2075478/illumina-ilmn-to-expand-genomics-capacity-with-new-pact,2023-04-06 13:38:00,Illumina's (ILMN) recent collaboration is built on the shared goal of the organizations to expand sequencing capabilities and capacity for all people in Africa.,HOLX,0.240489,0.153591,Somewhat-Bullish
Here's Why Investors Should Invest in Zimmer Biomet  ( ZBH )  Now,https://www.zacks.com/stock/news/2075481/heres-why-investors-should-invest-in-zimmer-biomet-zbh-now,2023-04-06 13:37:00,Investors are optimistic about Zimmer Biomet (ZBH) on strong elective procedure recovery and commercial execution.,HOLX,0.195419,0.139731,Neutral
Hologic  ( NASDAQ:HOLX )  Downgraded by StockNews.com to Hold,https://www.defenseworld.net/2023/04/06/hologic-nasdaqholx-downgraded-by-stocknews-com-to-hold.html,2023-04-06 09:38:44,StockNews.com downgraded shares of Hologic ( NASDAQ:HOLX - Get Rating ) from a buy rating to a hold rating in a report released on Wednesday. Other equities research analysts have also issued research reports about the company.,HOLX,0.831658,0.440646,Bullish
Illumina's  ( ILMN )  NovaSeq X Exceeds 200 Order Milestone,https://www.zacks.com/stock/news/2075013/illuminas-ilmn-novaseq-x-exceeds-200-order-milestone,2023-04-05 15:55:00,Illumina's (ILMN) NovaSeq X records the strongest pre-launch demand ever witnessed for any instrument.,HOLX,0.216376,0.01165,Neutral
3 Reasons to Retain Integer Holdings  ( ITGR )  Stock for Now,https://www.zacks.com/stock/news/2074965/3-reasons-to-retain-integer-holdings-itgr-stock-for-now,2023-04-05 15:13:00,Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and a solid foothold in the broader MedTech space.,HOLX,0.206685,0.042143,Neutral
"CVS Health's  ( CVS )  New Initiatives Aid, Margin Woes Linger",https://www.zacks.com/stock/news/2074912/cvs-healths-cvs-new-initiatives-aid-margin-woes-linger,2023-04-05 14:07:00,CVS Health (CVS) launches functionality that gives patients more choices and convenience in filling prescriptions.,HOLX,0.208017,0.148122,Neutral
"Investors Heavily Search Hologic, Inc.  ( HOLX ) : Here is What You Need to Know",https://www.zacks.com/stock/news/2074793/investors-heavily-search-hologic-inc-holx-here-is-what-you-need-to-know,2023-04-05 13:00:12,"Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",HOLX,0.487546,0.159007,Somewhat-Bullish
Notice convening the Annual General Meeting in BioPorto A/S,https://www.globenewswire.com/news-release/2023/04/05/2641357/0/en/Notice-convening-the-Annual-General-Meeting-in-BioPorto-A-S.html,2023-04-05 06:35:00,"April 5, 2023Announcement no. ...",HOLX,0.018898,0.049052,Neutral
LabCorp  ( LH )  Expands Colon Cancer Test Access With New Pact,https://www.zacks.com/stock/news/2074448/labcorp-lh-expands-colon-cancer-test-access-with-new-pact,2023-04-04 16:35:00,LabCorp's (LH) at-home collection kit will offer patients an additional and easier option to get screened for colon cancer.,HOLX,0.232996,0.067259,Neutral
Here's Why You Should Invest in Haemonetics  ( HAE )  Right Now,https://www.zacks.com/stock/news/2074449/heres-why-you-should-invest-in-haemonetics-hae-right-now,2023-04-04 16:34:00,"Investors are upbeat about Haemonetics (HAE) owing to impressive Plasma and Hospital business performance, with continued strength in the Hemostasis Management product line.",HOLX,0.193852,0.058204,Neutral
3 Reasons to Retain AMN Healthcare  ( AMN )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2074475/3-reasons-to-retain-amn-healthcare-amn-stock-in-your-portfolio,2023-04-04 16:23:00,Investors are optimistic about AMN Healthcare's (AMN) broad array of services.,HOLX,0.210731,0.042787,Neutral
Masimo's  ( MASI )  New FDA Clearance to Boost Patient Monitoring,https://www.zacks.com/stock/news/2074471/masimos-masi-new-fda-clearance-to-boost-patient-monitoring,2023-04-04 16:10:00,Masimo's (MASI) receipt of the FDA's De Novo grant is expected to combat opioid overdoses by boosting patient monitoring.,HOLX,0.214462,0.041689,Neutral
Here's Why You Should Retain Amedisys  ( AMED )  Stock for Now,https://www.zacks.com/stock/news/2074160/heres-why-you-should-retain-amedisys-amed-stock-for-now,2023-04-04 12:43:00,Amedisys's (AMED) share price is likely to grow following an impressive fourth-quarter 2022 performance and new partnerships.,HOLX,0.179788,0.041172,Neutral
Bet on 5 High ROE Stocks as Markets Shrug Off Oil Output Cut,https://www.zacks.com/stock/news/2074128/bet-on-5-high-roe-stocks-as-markets-shrug-off-oil-output-cut,2023-04-04 10:59:00,"AutoNation (AN), Suzano (SUZ), Valero Energy (VLO), Hologic (HOLX) and Ryder (R) are some of the stocks with high ROE to profit from as markets rise despite lower oil production.",HOLX,0.163243,0.130325,Neutral
Hologic  ( HOLX )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2073977/hologic-holx-stock-sinks-as-market-gains-what-you-should-know,2023-04-03 21:45:19,"Hologic (HOLX) closed at $80.58 in the latest trading session, marking a -0.15% move from the prior day.",HOLX,0.548363,0.280317,Somewhat-Bullish
3 Reasons to Retain PacBio  ( PACB )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2073864/3-reasons-to-retain-pacbio-pacb-stock-in-your-portfolio,2023-04-03 16:07:00,PacBio's (PACB) product development activities raise optimism about the stock.,HOLX,0.215894,0.043611,Neutral
Medtronic  ( MDT )  Launches New Venture to Treat Kidney Failure,https://www.zacks.com/stock/news/2073827/medtronic-mdt-launches-new-venture-to-treat-kidney-failure,2023-04-03 15:34:00,Medtronic's (MDT) new venture is dedicated to reshaping kidney health and driving patient-centered technology solutions.,HOLX,0.245339,0.190281,Somewhat-Bullish
"Tandem Diabetes  ( TNDM )  Gains on Pump Sales, Margin Woe Stays",https://www.zacks.com/stock/news/2073790/tandem-diabetes-tndm-gains-on-pump-sales-margin-woe-stays,2023-04-03 15:13:00,Tandem Diabetes (TNDM) is now increasing its renewal numbers both in volume and rates.,HOLX,0.211191,0.17076,Somewhat-Bullish
Why You Should Add Hologic  ( HOLX )  to Your Portfolio Now,https://www.zacks.com/stock/news/2073785/why-you-should-add-hologic-holx-to-your-portfolio-now,2023-04-03 15:07:00,"Hologic (HOLX) is currently well-positioned to achieve its full-year guidance of low double-digit organic growth ex-COVID in all three franchises, well above the 5-7% long-term growth rate.",HOLX,0.37643,0.413297,Bullish
Nevro Names Kevin Thornal as New Chief Executive Officer and President,https://www.prnewswire.com/news-releases/nevro-names-kevin-thornal-as-new-chief-executive-officer-and-president-301801530.html,2023-04-19 21:05:00,Nevro Names Kevin Thornal as New Chief Executive Officer and ... PR ...,HOLX,0.065446,0.054236,Neutral
Here's Why You Should Buy Boston Scientific  ( BSX )  Stock,https://www.zacks.com/stock/news/2081423/heres-why-you-should-buy-boston-scientific-bsx-stock,2023-04-19 14:26:00,Investors are optimistic about Boston Scientific (BSX) owing to impressive growth in MedSurg market share.,HOLX,0.201944,0.147911,Neutral
"Medical Imaging Equipment Market to Cross USD 50.3 Bn Revenue by 2028 with CAGR of 5.4%, says Transparency Market Research",https://www.benzinga.com/pressreleases/23/04/g31872237/medical-imaging-equipment-market-to-cross-usd-50-3-bn-revenue-by-2028-with-cagr-of-5-4-says-transp,2023-04-18 21:30:00,"Wilmington, Delaware, United States, April 19, 2023 ( GLOBE NEWSWIRE ) -- According to the latest research study by Transparency Market Research, the global medical imaging equipment market stood at USD 30.7 Bn in 2020 and is projected to expand at a CAGR of 5.4% from 2021 to 2028.",HOLX,0.044222,0.063601,Neutral
"Insulet's  ( PODD )  New Omnipod, Strategic Moves Drive Growth",https://www.zacks.com/stock/news/2080596/insulets-podd-new-omnipod-strategic-moves-drive-growth,2023-04-18 16:28:00,"Insulet (PODD) has been progressing well with respect to its four-pillar strategy, where the first two pillars include expanding access and awareness and delivering consumer-focused innovation.",HOLX,0.231773,0.096571,Neutral
Hologic  ( HOLX )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2079928/hologic-holx-stock-sinks-as-market-gains-what-you-should-know,2023-04-17 21:45:21,"Hologic (HOLX) closed the most recent trading day at $83.64, moving -0.59% from the previous trading session.",HOLX,0.541943,0.258565,Somewhat-Bullish
QuidelOrtho  ( QDEL )  Reports Solid Preliminary Q1 Revenues,https://www.zacks.com/stock/news/2079737/quidelortho-qdel-reports-solid-preliminary-q1-revenues,2023-04-17 14:28:00,QuidelOrtho's (QDEL) revenue growth in the first quarter is likely to have been boosted by continued strength in its non-respiratory product sales.,HOLX,0.256989,0.148874,Neutral
3 Reasons to Retain Veeva Systems  ( VEEV )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2079728/3-reasons-to-retain-veeva-systems-veev-stock-in-your-portfolio,2023-04-17 14:19:00,Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.,HOLX,0.200273,0.080457,Neutral
Here's Why You Should Invest in Henry Schein  ( HSIC )  Now,https://www.zacks.com/stock/news/2079716/heres-why-you-should-invest-in-henry-schein-hsic-now,2023-04-17 14:00:00,"Investors are optimistic about Henry Schein (HSIC), led by the strong potential in the company's dental technology joint venture, Henry Schein One.",HOLX,0.184246,0.047067,Neutral
Is Hologic  ( HOLX )  Outperforming Other Medical Stocks This Year?,https://www.zacks.com/stock/news/2079602/is-hologic-holx-outperforming-other-medical-stocks-this-year,2023-04-17 13:40:14,Here is how Hologic (HOLX) and Ligand Pharmaceuticals (LGND) have performed compared to their sector so far this year.,HOLX,0.747404,0.444427,Bullish
"Hologic, Inc.  ( HOLX )  Is a Trending Stock: Facts to Know Before Betting on It",https://www.zacks.com/stock/news/2079555/hologic-inc-holx-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-04-17 13:00:12,"Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",HOLX,0.489394,0.159382,Somewhat-Bullish
Bio-Rad  ( BIO )  Rises 6.5% Since Q4 Earnings: What's Driving It?,https://www.zacks.com/stock/news/2078976/bio-rad-bio-rises-65-since-q4-earnings-whats-driving-it,2023-04-14 15:16:00,Investors are optimistic about Bio-Rad's (BIO) strong global presence and stable solvency position.,HOLX,0.238133,0.164732,Somewhat-Bullish
Merit Medical  ( MMSI )  Hits 52-Week High: What's Driving the Stock?,https://www.zacks.com/stock/news/2078970/merit-medical-mmsi-hits-52-week-high-whats-driving-the-stock,2023-04-14 15:10:00,Investors are optimistic about Merit Medical's (MMSI) strong product portfolio.,HOLX,0.209365,0.1191,Neutral
"Globus'  ( GMED )  NUVA Buyout Seems Strategic, Cost Woe Stays",https://www.zacks.com/stock/news/2078942/globus-gmed-nuva-buyout-seems-strategic-cost-woe-stays,2023-04-14 14:31:00,Globus Medical (GMED) and NuVasive (NUVA) are currently planning to combine in an all-stock transaction to create a global musculoskeletal company.,HOLX,0.250386,0.047025,Neutral
"Amedisys  ( AMED )  New Buyouts Aid Growth, CMS Ruling Unfavorable",https://www.zacks.com/stock/news/2078935/amedisys-amed-new-buyouts-aid-growth-cms-ruling-unfavorable,2023-04-14 14:26:00,"For Amedisys (AMED), dealing with the continuous shortage of clinical labo, in nursing in particular, has been challenging.",HOLX,0.209819,0.040809,Neutral
Myriad Genetics'  ( MYGN )  New Pact to Boost Precision Medicine,https://www.zacks.com/stock/news/2078461/myriad-genetics-mygn-new-pact-to-boost-precision-medicine,2023-04-13 16:20:00,Myriad Genetics' (MYGN) latest program will increase access to affordable genetic testing. It will also aid in identifying and elevating high-risk patient care.,HOLX,0.193852,0.054958,Neutral
Masimo  ( MASI )  Hits 52-Week High: What's Aiding the Stock?,https://www.zacks.com/stock/news/2078424/masimo-masi-hits-52-week-high-whats-aiding-the-stock,2023-04-13 16:05:00,Investors are optimistic about Masimo's (MASI) slew of product launches.,HOLX,0.213517,0.077856,Neutral
BD's  ( BDX )  New Launch to Result in Optimal IV Placement,https://www.zacks.com/stock/news/2077681/bds-bdx-new-launch-to-result-in-optimal-iv-placement,2023-04-12 15:57:00,BD's (BDX) latest launch is expected to advance its vision of a One-Stick Hospital Stay by improving the first-stick success in IV placements.,HOLX,0.198221,0.079846,Neutral
Digital X-ray Systems Market to be Worth $8.12 Billion by 2030 - Exclusive Report by Meticulous Research®,https://www.benzinga.com/pressreleases/23/04/g31769984/digital-x-ray-systems-market-to-be-worth-8-12-billion-by-2030-exclusive-report-by-meticulous-resea,2023-04-12 14:15:26,"Redding, California, April 12, 2023 ( GLOBE NEWSWIRE ) -- According to a new market research report, 'Digital X-ray Systems Market by Portability {Fixed ( Ceiling, Floor ) , Portable ( Mobile, Handheld ) }, Technology ( Computed, Direct ) , Application ( Orthopedic, Dental, Cardiovascular, ...",HOLX,0.024273,0.0,Neutral
Shockwave Medical  ( SWAV )  Moves 10.6% Higher: Will This Strength Last?,https://www.zacks.com/stock/news/2077447/shockwave-medical-swav-moves-106-higher-will-this-strength-last,2023-04-12 13:14:00,Shockwave Medical (SWAV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.,HOLX,0.411176,0.0,Neutral
Here's Why Investors Should Buy Bio-Rad  ( BIO )  Stock Now,https://www.zacks.com/stock/news/2077120/heres-why-investors-should-buy-bio-rad-bio-stock-now,2023-04-11 16:45:00,Investors are optimistic about Bio-Rad (BIO) on robust growth in Life Science and Clinical Diagnostics arms.,HOLX,0.218325,0.01173,Neutral
Thermo Fisher  ( TMO )  Expands to Boost Commercial Manufacturing,https://www.zacks.com/stock/news/2077119/thermo-fisher-tmo-expands-to-boost-commercial-manufacturing,2023-04-11 16:43:00,Thermo Fisher's expansion in Bourgoin is built on the company's investments in small molecule solutions.,HOLX,0.218817,0.011759,Neutral
3 Reasons to Retain Ecolab  ( ECL )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2077017/3-reasons-to-retain-ecolab-ecl-stock-in-your-portfolio,2023-04-11 15:20:00,Investors continue to be optimistic about Ecolab (ECL) owing to its strong business.,HOLX,0.203215,0.084608,Neutral
PacBio's  ( PACB )  New Offering to Enable High-Throughput Workflows,https://www.zacks.com/stock/news/2077016/pacbios-pacb-new-offering-to-enable-high-throughput-workflows,2023-04-11 15:14:00,PacBio's (PACB) latest launch is expected to combine the power of HiFi sequencing and Nanobind technology to optimize sample preparation workflows for its high-volume customers.,HOLX,0.217834,0.085923,Neutral
Here's Why You Should Retain Neogen  ( NEOG )  Stock for Now,https://www.zacks.com/stock/news/2087064/heres-why-you-should-retain-neogen-neog-stock-for-now,2023-04-28 15:25:00,Investors are optimistic about Neogen (NEOG) owing to strong performance across its Animal Safety and Food Safety segments.,HOLX,0.195814,0.141465,Neutral
Integra LifeSciences  ( IART )  Q1 Earnings Meet Estimates,https://www.zacks.com/stock/news/2084706/integra-lifesciences-iart-q1-earnings-meet-estimates,2023-04-26 11:15:10,"Integra (IART) delivered earnings and revenue surprises of 0% and 2%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",HOLX,0.142989,0.0,Neutral
Here's Why You Should Invest in Edwards Lifesciences  ( EW )  Now,https://www.zacks.com/stock/news/2084312/heres-why-you-should-invest-in-edwards-lifesciences-ew-now,2023-04-25 13:44:00,Investors are optimistic about Edwards Lifesciences (EW) on the increased adoption of its premium RESILIA technologies.,HOLX,0.214462,0.158174,Somewhat-Bullish
Hologic  ( HOLX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2083687/hologic-holx-outpaces-stock-market-gains-what-you-should-know,2023-04-24 21:45:19,"Hologic (HOLX) closed at $85.63 in the latest trading session, marking a +1.87% move from the prior day.",HOLX,0.537213,0.183666,Somewhat-Bullish
"Dow Jones Flat As Microsoft, Intel Slip; Fox Skids On Tucker Carlson Departure",https://www.investors.com/market-trend/stock-market-today/dow-jones-flat-as-microsoft-intel-slip-fox-stock-skids-on-tucker-carlson-departure/,2023-04-24 19:18:00,"Dow Jones Flat As Microsoft, Intel Slip. Fox Skids On Tucker Carlson ... Investor's Business Daily ...",HOLX,0.139534,0.228421,Somewhat-Bullish
GYN Surgical Sales to Aid Hologic  ( HOLX )  in Q2 Earnings,https://www.zacks.com/stock/news/2083512/gyn-surgical-sales-to-aid-hologic-holx-in-q2-earnings,2023-04-24 14:20:00,Strong performance led by MyoSure and NovaSure is expected to have driven Hologic' s (HOLX) Q2 performance.,HOLX,0.608634,0.509166,Bullish
Hologic  ( HOLX )  to Report Q2 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2082845/hologic-holx-to-report-q2-earnings-whats-in-the-cards,2023-04-21 14:01:00,Robust performance from MyoSure and NovaSure along with increasing contributions from the company's laparoscopic portfolio are expected to have contributed to the Hologic's (HOLX) Q2 reveneus.,HOLX,0.443626,0.308254,Somewhat-Bullish
"Abbott  ( ABT )  EPD Business Grows Strong, Macro Issues Stay",https://www.zacks.com/stock/news/2091614/abbott-abt-epd-business-grows-strong-macro-issues-stay,2023-05-08 14:45:00,"Abbott (ABT) continues to make good progress, increasing manufacturing production and recovering market share in the Nutrition business.",HOLX,0.213988,0.05527,Neutral
Here's Why Investors Should Retain Syneos Health  ( SYNH )  for Now,https://www.zacks.com/stock/news/2091382/heres-why-investors-should-retain-syneos-health-synh-for-now,2023-05-08 12:24:00,Syneos Health's (SYNH) share price movement is expected to be favorable due to the strength of the company's Syneos One portfolio and several value-added partnership deals.,HOLX,0.122269,0.037493,Neutral
Market Rally Finishes Strong As Banks Slash Losses: Weekly Review,https://www.investors.com/news/market-rally-finishes-strong-regional-banks-fed-rate-hike-jobs-report-apple-in-focus/,2023-05-05 17:16:00,"Market Rally Finishes Strong. Regional Banks, Fed Rate Hike, Jobs ... Investor's Business Daily ...",HOLX,0.049348,0.051001,Neutral
"Hologic, Inc.  ( HOLX )  is Attracting Investor Attention: Here is What You Should Know",https://www.zacks.com/stock/news/2090797/hologic-inc-holx-is-attracting-investor-attention-here-is-what-you-should-know,2023-05-05 13:00:12,"Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",HOLX,0.488469,0.14441,Neutral
"Cardinal Health  ( CAH )  Beats on Q3 Earnings, Ups '23 EPS View",https://www.zacks.com/stock/news/2090156/cardinal-health-cah-beats-on-q3-earnings-ups-23-eps-view,2023-05-04 14:47:00,Cardinal Health's (CAH) fiscal third-quarter results benefit from the Pharmaceutical segment's solid performance.,HOLX,0.222838,0.110944,Neutral
Is Arbutus Biopharma  ( ABUS )  Outperforming Other Medical Stocks This Year?,https://www.zacks.com/stock/news/2090034/is-arbutus-biopharma-abus-outperforming-other-medical-stocks-this-year,2023-05-04 13:40:13,Here is how Arbutus Biopharma (ABUS) and Hologic (HOLX) have performed compared to their sector so far this year.,HOLX,0.375722,0.26108,Somewhat-Bullish
"Inari Medical  ( NARI )  Q1 Earnings Top, Revenues Rise Y/Y",https://www.zacks.com/stock/news/2089832/inari-medical-nari-q1-earnings-top-revenues-rise-yy,2023-05-04 11:31:00,Inari Medical's (NARI) first-quarter results benefit from significant progress made across all its growth drivers.,HOLX,0.222838,0.109262,Neutral
"Glaukos'  ( GKOS )  Q1 Earnings Beat Estimates, Sales Rise Y/Y",https://www.zacks.com/stock/news/2089791/glaukos-gkos-q1-earnings-beat-estimates-sales-rise-yy,2023-05-04 11:13:00,"Glaukos' (GKOS) Q1 revenues beat estimates but fall year over year. Sales and gross margin improve, while higher operating expenses lead to wider operating loss.",HOLX,0.215415,0.106369,Neutral
BD Reports Second Quarter Fiscal 2023 Financial Results,https://www.prnewswire.com/news-releases/bd-reports-second-quarter-fiscal-2023-financial-results-301815241.html,2023-05-04 10:30:00,"Revenue of $4.8 billion increased 1.5% as reported and 4.1% on a currency-neutral basis Revenue from base business ( which excludes COVID-only diagnostic testing ) grew 6.0% as reported, 8.7% currency-neutral GAAP and adjusted diluted EPS from continuing operations of $1.53 and $2.86, ...",HOLX,0.008657,0.046558,Neutral
Here's Why You Should Retain Exact Sciences  ( EXAS )  Stock Now,https://www.zacks.com/stock/news/2089307/heres-why-you-should-retain-exact-sciences-exas-stock-now,2023-05-03 15:59:00,Investors are optimistic about Exact Sciences (EXAS) on continued strength across the Screening and Precision Oncology businesses.,HOLX,0.183546,0.134886,Neutral
HOLX vs. SONVY: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2089195/holx-vs-sonvy-which-stock-is-the-better-value-option,2023-05-03 15:40:11,Investors interested in Medical - Instruments stocks are likely familiar with Hologic ( HOLX Quick QuoteHOLX - ) and SONOVA HOLDING ( SONVY Quick QuoteSONVY - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.,HOLX,0.775472,0.598871,Bullish
"Hologic's  ( HOLX )  Q2 Earnings Beat Estimates, 2023 View Up",https://www.zacks.com/stock/news/2088415/hologics-holx-q2-earnings-beat-estimates-2023-view-up,2023-05-02 16:27:00,The year-over-year growth in Breast Health and GYN Surgical Businesses contributed to Hologic's (HOLX) Q2 revenues.,HOLX,0.295421,0.303319,Somewhat-Bullish
Hologic  ( HOLX )  Surpasses Q2 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2087669/hologic-holx-surpasses-q2-earnings-and-revenue-estimates,2023-05-01 21:35:11,"Hologic (HOLX) delivered earnings and revenue surprises of 20.45% and 6.15%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",HOLX,0.402403,0.208814,Somewhat-Bullish
Cognition Therapeutics Appoints John Doyle to the Role of Chief Financial Officer - Cognition Therapeutics  ( NASDAQ:CGTX ) ,https://www.benzinga.com/pressreleases/23/05/g32114772/cognition-therapeutics-appoints-john-doyle-to-the-role-of-chief-financial-officer,2023-05-01 11:30:44,"PURCHASE, N.Y. , May 01, 2023 ( GLOBE NEWSWIRE ) -- Cognition Therapeutics, Inc. CGTX, today announced the appointment of John Doyle to the role of chief financial officer.",HOLX,0.095138,0.0,Neutral
Cognition Therapeutics Appoints John Doyle to the Role of Chief Financial Officer,https://www.globenewswire.com/news-release/2023/05/01/2658207/0/en/Cognition-Therapeutics-Appoints-John-Doyle-to-the-Role-of-Chief-Financial-Officer.html,2023-05-01 11:30:00,"PURCHASE, N.Y. , May 01, 2023 ( GLOBE NEWSWIRE ) -- Cognition Therapeutics, Inc. ( Nasdaq: CGTX ) , today announced the appointment of John Doyle to the role of chief financial officer. Mr. Doyle has substantial experience leading and managing financial operations at development- and ...",HOLX,0.043186,0.0,Neutral
What's in the Cards for Medtronic  ( MDT )  in Q4 Earnings?,https://www.zacks.com/stock/news/2097444/whats-in-the-cards-for-medtronic-mdt-in-q4-earnings,2023-05-19 15:06:00,"Medtronic (MDT) is likely to have prioritized its R&D investments, which might get reflected in the fiscal Q4 results.",HOLX,0.149889,0.017916,Neutral
Veeva Systems'  ( VEEV )  New Launch to Improve Patient Outcomes,https://www.zacks.com/stock/news/2097357/veeva-systems-veev-new-launch-to-improve-patient-outcomes,2023-05-19 12:41:00,Veeva Systems' (VEEV) new offering is expected to facilitate effective engagement with customers and KOLs for improved patient journeys.,HOLX,0.26042,0.159941,Somewhat-Bullish
Here's Why You Should Retain QIAGEN  ( QGEN )  Stock for Now,https://www.zacks.com/stock/news/2097228/heres-why-you-should-retain-qiagen-qgen-stock-for-now,2023-05-19 12:05:00,"QIAGEN (QGEN) is likely to benefit from high organic growth across its non-COVID-19 product group and portfolio advancements, reflecting a positive share price movement.",HOLX,0.171181,0.095178,Neutral
BD's  ( BDX )  New FDA Approval to Improve MRSA Diagnostics,https://www.zacks.com/stock/news/2096939/bds-bdx-new-fda-approval-to-improve-mrsa-diagnostics,2023-05-18 15:15:00,BD's (BDX) receipt of the latest FDA approval is likely to improve laboratory workflow.,HOLX,0.188193,0.122563,Neutral
Here's Why You Should Retain Myriad Genetics  ( MYGN )  Stock Now,https://www.zacks.com/stock/news/2096913/heres-why-you-should-retain-myriad-genetics-mygn-stock-now,2023-05-18 14:21:00,"Myriad Genetics (MYGN) is likely to benefit from testing volumes across product segments and the latest partnerships, reflecting a positive share price movement.",HOLX,0.187827,0.101692,Neutral
"NextGen  ( NXGN )  Q4 Earnings Top Estimates, Revenues Surge Y/Y",https://www.zacks.com/stock/news/2096492/nextgen-nxgn-q4-earnings-top-estimates-revenues-surge-yy,2023-05-17 17:52:00,NextGen's (NXGN) fourth-quarter fiscal 2023 results reflect strength in both its revenue sources.,HOLX,0.172713,0.030967,Neutral
3 Reasons to Retain Masimo  ( MASI )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2096496/3-reasons-to-retain-masimo-masi-stock-in-your-portfolio,2023-05-17 17:25:00,Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.,HOLX,0.220308,0.138263,Neutral
Hologic  ( HOLX )  Announces Collaboration With NFL CB Kelee Ringo,https://www.zacks.com/stock/news/2096381/hologic-holx-announces-collaboration-with-nfl-cb-kelee-ringo,2023-05-17 15:09:00,"Hologic (HOLX) and Eagles' CB, Kelee Ringo, come together to highlight the importance of annual mammograms and other routine health screenings.",HOLX,0.40375,0.116228,Neutral
Here's Why You Should Retain Charles River  ( CRL )  Stock Now,https://www.zacks.com/stock/news/2096367/heres-why-you-should-retain-charles-river-crl-stock-now,2023-05-17 14:35:00,"Charles River's (CRL) share price is likely to grow, backed by strategic acquisitions and the DSA segment's strength.",HOLX,0.201944,0.107393,Neutral
"LabCorp  ( LH )  Base Business Growth Strong, Margin Pressure Stays",https://www.zacks.com/stock/news/2095882/labcorp-lh-base-business-growth-strong-margin-pressure-stays,2023-05-16 14:59:00,"LabCorp (LH) is progressing well with its planned spin-off of the Clinical Development business, which is expected to be completed in mid-2023.",HOLX,0.244109,0.057839,Neutral
Here's Why Investors Should Retain Henry Schein  ( HSIC )  for Now,https://www.zacks.com/stock/news/2095705/heres-why-investors-should-retain-henry-schein-hsic-for-now,2023-05-16 13:03:00,"Henry Schein (HSIC) is expected to witness a favorable share price movement, led by optimism surrounding the performance of the dental business and strategic buyouts.",HOLX,0.159305,0.090733,Neutral
"Hologic, Inc.  ( HOLX )  Is a Trending Stock: Facts to Know Before Betting on It",https://www.zacks.com/stock/news/2095710/hologic-inc-holx-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-05-16 13:00:12,"Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",HOLX,0.490323,0.156534,Somewhat-Bullish
Catalent  ( CTLT )  Expands Its Facility Capabilities in Shiga,https://www.zacks.com/stock/news/2101477/catalent-ctlt-expands-its-facility-capabilities-in-shiga,2023-05-30 15:29:00,Catalent's (CTLT) latest capability expansion is expected to boost its business in the global clinical trials space in its Clinical Supply Services network.,HOLX,0.251032,0.098161,Neutral
Here's Why You Should Retain Integra  ( IART )  Stock Now,https://www.zacks.com/stock/news/2101232/heres-why-you-should-retain-integra-iart-stock-now,2023-05-30 12:07:00,Investors continue to be optimistic about Integra Lifesciences (IART) based on the prospect of its CSS segment and ample liquidity to support M&A strategies.,HOLX,0.17813,0.004317,Neutral
Stocks This Week: Buy Hologic,https://www.forbes.com/sites/greatspeculations/2023/05/29/stocks-this-week-buy-hologic/,2023-05-29 17:32:00,June has been a strong month for this stock.,HOLX,0.174587,0.132568,Neutral
"Hologic, Inc.  ( HOLX )  is Attracting Investor Attention: Here is What You Should Know",https://www.zacks.com/stock/news/2100817/hologic-inc-holx-is-attracting-investor-attention-here-is-what-you-should-know,2023-05-29 13:00:11,"Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",HOLX,0.485711,0.13484,Neutral
Here's Why You Should Retain Tandem Diabetes  ( TNDM )  Now,https://www.zacks.com/stock/news/2100780/heres-why-you-should-retain-tandem-diabetes-tndm-now,2023-05-29 12:18:00,Investors continue to be optimistic about Tandem Diabetes (TNDM) based on the strong performance of the t:slim X2 insulin pump.,HOLX,0.200273,0.004713,Neutral
Veeva Systems  ( VEEV )  Offerings Adopted by Minaris Regenerative,https://www.zacks.com/stock/news/2100475/veeva-systems-veev-offerings-adopted-by-minaris-regenerative,2023-05-26 15:20:00,Veeva Systems' (VEEV) Vault Quality Suite applications are expected to aid the CDMO to modernize its operations and streamline its quality processes globally.,HOLX,0.210274,0.085225,Neutral
Here's Why You Should Retain Globus Medical  ( GMED )  Stock Now,https://www.zacks.com/stock/news/2100075/heres-why-you-should-retain-globus-medical-gmed-stock-now,2023-05-26 11:50:00,Investors continue to be optimistic about Globus Medical (GMED) based on the strong performances across geographies and the pending NuVasive acquisition.,HOLX,0.20537,0.108794,Neutral
"Zacks Industry Outlook Highlights Hologic, Masimo and Integer",https://www.zacks.com/stock/news/2100012/zacks-industry-outlook-highlights-hologic-masimo-and-integer,2023-05-26 09:00:00,"Hologic, Masimo and Integer have been highlighted in this Industry Outlook article.",HOLX,0.196953,0.168629,Somewhat-Bullish
"Medtronic  ( MDT )  Q4 Earnings Beat Estimates, Margins Down",https://www.zacks.com/stock/news/2099925/medtronic-mdt-q4-earnings-beat-estimates-margins-down,2023-05-25 18:29:00,"Strong growth in the Cardiovascular, Medical Surgical, and Neuroscience portfolios, and in Diabetes markets drove Medtronic (MDT) Q4 revenues.",HOLX,0.176825,0.111519,Neutral
Here's Why You Should Retain Bruker  ( BRKR )  Stock for Now,https://www.zacks.com/stock/news/2099733/heres-why-you-should-retain-bruker-brkr-stock-for-now,2023-05-25 15:21:00,Investors continue to be optimistic about Bruker Corporation (BRKR) based on the strong performances of CALID and BioSpin Group and its raised 2023 outlook.,HOLX,0.215894,0.113121,Neutral
Masimo's  ( MASI )  Platform Expansion to Boost Patient Monitoring,https://www.zacks.com/stock/news/2099731/masimos-masi-platform-expansion-to-boost-patient-monitoring,2023-05-25 14:17:00,Masimo's (MASI) latest expansion to its HEOS platform will likely revolutionize health and wellness tracking by allowing connected care as consumers become tetherless and smartphone-less.,HOLX,0.237551,0.148564,Neutral
3 Medical Instruments Stocks to Buy Amid Industry Challenges,https://www.zacks.com/commentary/2099462/3-medical-instruments-stocks-to-buy-amid-industry-challenges,2023-05-25 13:34:00,"The Zacks Medical - Instruments industry is growing on rising demand for digital health. HOLX, MASI and ITGR are set to gain the most. Yet, ongoing inflation, in the form of rising freight and raw material costs, is disrupting the trend.",HOLX,0.175646,0.168252,Somewhat-Bullish
"NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales",https://www.globenewswire.com/news-release/2023/05/24/2675668/0/en/NeuroPace-Announces-Addition-of-Kelley-Nicholas-as-Vice-President-Sales.html,2023-05-24 20:05:00,"To focus on commercial growth, including expanding adoption and driving higher utilization of NeuroPace's RNS System To focus on commercial growth, including expanding adoption and driving higher utilization of NeuroPace's RNS System ...",HOLX,0.151539,0.07775,Neutral
"Boston Scientific  ( BSX )  Gains From Acquisitions, New Launches",https://www.zacks.com/stock/news/2099237/boston-scientific-bsx-gains-from-acquisitions-new-launches,2023-05-24 16:38:00,Boston Scientific (BSX) remains excited about 2023 performance and expects to continue to outpace its peers within the EMEA market.,HOLX,0.221819,0.113893,Neutral
Abbott  ( ABT )  Unveils Late-Breaking Data on Leadless Pacemaker,https://www.zacks.com/stock/news/2099207/abbott-abt-unveils-late-breaking-data-on-leadless-pacemaker,2023-05-24 16:07:00,"Abbott (ABT) study analyzes primary safety and efficacy endpoints in the first 300 people enrolled across 55 centers in the United States, Canada and Europe.",HOLX,0.18856,0.101985,Neutral
Accuray  ( ARAY )  Hits 52-Week High: What's Aiding the Stock?,https://www.zacks.com/stock/news/2099116/accuray-aray-hits-52-week-high-whats-aiding-the-stock,2023-05-24 14:42:00,Investors are optimistic about Accuray's (ARAY) solid product portfolio.,HOLX,0.231884,0.143996,Neutral
Veeva Systems'  ( VEEV )  New Tie-Up to Improve Clinical Trials,https://www.zacks.com/stock/news/2099093/veeva-systems-veev-new-tie-up-to-improve-clinical-trials,2023-05-24 14:14:00,Veeva Systems' (VEEV) latest collaboration is expected to advance the patient experience in clinical trials.,HOLX,0.22595,0.142753,Neutral
Here's Why You Should Retain Chemed  ( CHE )  Stock for Now,https://www.zacks.com/stock/news/2098941/heres-why-you-should-retain-chemed-che-stock-for-now,2023-05-24 13:03:00,Investors continue to be optimistic about Chemed (CHE) on the strong performance of the VITAS Healthcare and Roto-Rooter segments.,HOLX,0.218325,0.114124,Neutral
Avantor's  ( AVTR )  New Tie-Up to Improve Lab Inventory Management,https://www.zacks.com/stock/news/2098649/avantors-avtr-new-tie-up-to-improve-lab-inventory-management,2023-05-23 16:17:00,Avantor's (AVTR) latest partnership is expected to significantly optimize labs' inventory management and the overall workflow.,HOLX,0.22861,0.142374,Neutral
3 Reasons to Add Merit Medical  ( MMSI )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2098586/3-reasons-to-add-merit-medical-mmsi-stock-to-your-portfolio,2023-05-23 15:04:00,Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.,HOLX,0.208017,0.133792,Neutral
Here's Why You Should Retain Insulet  ( PODD )  Stock for Now,https://www.zacks.com/stock/news/2098375/heres-why-you-should-retain-insulet-podd-stock-for-now,2023-05-23 12:25:00,Investors continue to be optimistic about Insulet (PODD) on the robust performance of Omnipod 5.,HOLX,0.184598,0.100408,Neutral
3 Reasons to Hold Inspire Medical  ( INSP )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2098052/3-reasons-to-hold-inspire-medical-insp-stock-in-your-portfolio,2023-05-22 15:10:00,Investors continue to be optimistic about Inspire Medical (INSP) on the back of its product innovations.,HOLX,0.213988,0.13514,Neutral
BD's  ( BDX )  Latest Product Launch to Boost Research Outcome,https://www.zacks.com/stock/news/2098046/bds-bdx-latest-product-launch-to-boost-research-outcome,2023-05-22 15:00:00,BD's (BDX) latest cell sorting technology is expected to speed up the process of cell sorting and allow researchers to answer complex biological questions.,HOLX,0.202366,0.129428,Neutral
Hologic  ( HOLX )  Gets FDA Nod for Multiplexed Respiratory Test,https://www.zacks.com/stock/news/2098094/hologic-holx-gets-fda-nod-for-multiplexed-respiratory-test,2023-05-22 14:48:00,"Hologic's (HOLX) Panther Fusion SARS-CoV-2/Flu A/B/RSV assay is done using the fully-automated, high-throughput Panther Fusion system.",HOLX,0.204072,0.134911,Neutral
Bruker  ( BRKR )  Launches ENRICH-iST Kits and Novel Workflow,https://www.zacks.com/stock/news/2106605/bruker-brkr-launches-enrich-ist-kits-and-novel-workflow,2023-06-09 17:39:00,Bruker's (BRKR) ENRICH-iST kit is ready to use right out of the box. The workflow is simple to understand and fully automatable.,HOLX,0.214937,0.045162,Neutral
Catalent  ( CTLT )  Launches Expanded OneBio Suite to Aid Customers,https://www.zacks.com/stock/news/2106532/catalent-ctlt-launches-expanded-onebio-suite-to-aid-customers,2023-06-09 15:53:00,Catalent's (CTLT) expansion of its OneBio Suite across multiple biologic therapies is expected to aid customers in leveraging its end-to-end capabilities in these areas.,HOLX,0.238133,0.147089,Neutral
"Here is What to Know Beyond Why Hologic, Inc.  ( HOLX )  is a Trending Stock",https://www.zacks.com/stock/news/2106295/here-is-what-to-know-beyond-why-hologic-inc-holx-is-a-trending-stock,2023-06-09 13:00:12,"Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.",HOLX,0.490323,0.132573,Neutral
Here's Why Investors Should Retain ResMed  ( RMD )  Stock for Now,https://www.zacks.com/stock/news/2106024/heres-why-investors-should-retain-resmed-rmd-stock-for-now,2023-06-08 17:25:00,Investors continue to be optimistic about ResMed (RMD) backed by the continued demand for digital health solutions.,HOLX,0.170576,0.096329,Neutral
Teleflex's  ( TFX )  Wattson Temporary Pacing Receives FDA Nod,https://www.zacks.com/stock/news/2106000/teleflexs-tfx-wattson-temporary-pacing-receives-fda-nod,2023-06-08 16:44:00,"Teleflex's (TFX) Wattson Temporary Pacing Guidewire offers dual functionality, allowing both valve delivery and ventricular bipolar pacing during TAVR or BAV treatments.",HOLX,0.245959,0.116467,Neutral
Inari Medical  ( NARI )  Launches New Catheters to Address VTE,https://www.zacks.com/stock/news/2105829/inari-medical-nari-launches-new-catheters-to-address-vte,2023-06-08 15:13:00,Inari Medical's (NARI) latest launches are expected to serve a wider patient pool by improving treatment options.,HOLX,0.20537,0.130899,Neutral
"Lateral Flow Assays Market Growth Report - Reach $12.18 Billion, Globally, by 2028 with 6.7% CAGR Lead by Multiplex Detection Assays Segment During 2023-2028 | The Insight Partners",https://www.benzinga.com/pressreleases/23/06/g32779525/lateral-flow-assays-market-growth-report-reach-12-18-billion-globally-by-2028-with-6-7-cagr-lead-b,2023-06-08 14:08:35,"Pune, India, June 08, 2023 ( GLOBE NEWSWIRE ) -- The Insight Partners published latest research study on ""Lateral Flow Assays Market Growth Report, Size, Share, Revenue, Strategy, Industry Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, Technology, ...",HOLX,0.058259,0.108986,Neutral
3 Reasons to Retain Intuitive Surgical  ( ISRG )  Stock for Now,https://www.zacks.com/stock/news/2105355/3-reasons-to-retain-intuitive-surgical-isrg-stock-for-now,2023-06-07 18:44:00,Investors continue to be optimistic about Intuitive Surgical (ISRG) owing to its strength in robotics.,HOLX,0.212115,0.134216,Neutral
Here's Why You Should Retain Exact Sciences  ( EXAS )  Stock Now,https://www.zacks.com/stock/news/2105333/heres-why-you-should-retain-exact-sciences-exas-stock-now,2023-06-07 17:53:00,Investors are optimistic about Exact Sciences (EXAS) led by continued strength across the Screening and Precision Oncology businesses.,HOLX,0.206685,0.101395,Neutral
Syneos Health  ( SYNH )  Sell-Off Appears Strategic Amid Margin Woes,https://www.zacks.com/stock/news/2105311/syneos-health-synh-sell-off-appears-strategic-amid-margin-woes,2023-06-07 17:25:00,Syneos Health's (SYNH) purchase price represents a 24% premium to its unaffected closing stock price prior to the announcement. Margin pressure continues to weigh on the stock.,HOLX,0.272029,0.144075,Neutral
LabCorp  ( LH )  Provides Update on Planned Spinoff of Fortrea,https://www.zacks.com/stock/news/2105305/labcorp-lh-provides-update-on-planned-spinoff-of-fortrea,2023-06-07 17:18:00,"After separation from LabCorp (LH), Fortrea is set to operate as a global contract research organization that offers comprehensive drug and medical device development services.",HOLX,0.199037,0.10621,Neutral
Neogen  ( NEOG )  Launches Genomic Test for Beef-on-Dairy Calves,https://www.zacks.com/stock/news/2105326/neogen-neog-launches-genomic-test-for-beef-on-dairy-calves,2023-06-07 16:52:00,"Neogen's (NEOG) new Igenity BeefXDairy test is an additional tool, enabling producers to gather crucial data they need to advance and grow their operations effectively and sustainably.",HOLX,0.229149,0.110007,Neutral
Masimo's  ( MASI )  New FDA Approval to Boost Patient Monitoring,https://www.zacks.com/stock/news/2105320/masimos-masi-new-fda-approval-to-boost-patient-monitoring,2023-06-07 16:36:00,Masimo's (MASI) Radius VSM is expected to equip any hospital bed with comprehensive monitoring and offer more personalized care without additional bedside equipment.,HOLX,0.202366,0.130989,Neutral
Here's Why Investors Should Retain Thermo Fisher  ( TMO )  Stock,https://www.zacks.com/stock/news/2105127/heres-why-investors-should-retain-thermo-fisher-tmo-stock,2023-06-07 14:32:00,Investors continue to be optimistic about Thermo Fisher's (TMO) continued strength across its end markets and the the execution of the growth strategy.,HOLX,0.17813,0.097864,Neutral
"Mammography Systems Market  ( Product, Technology )  - Reach $3.79 Billion by 2027 at 7.4% CAGR with 3D Mammograph Segment Driving Growth During 2020-2027 | The Insight Partners",https://www.benzinga.com/pressreleases/23/06/g32754965/mammography-systems-market-product-technology-reach-3-79-billion-by-2027-at-7-4-cagr-with-3d-mammo,2023-06-07 11:34:12,"Pune, India, June 07, 2023 ( GLOBE NEWSWIRE ) -- The Insight Partners published latest research study on ""Mammography Systems Market Share Report, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis By Product , Technology and End User"", ...",HOLX,0.03458,0.08643,Neutral
"HealthEquity  ( HQY )  Surpasses Q1 Earnings Estimates, FY24 View Up",https://www.zacks.com/stock/news/2104586/healthequity-hqy-surpasses-q1-earnings-estimates-fy24-view-up,2023-06-06 14:58:00,"HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in all its segments, in the first quarter of fiscal 2024.",HOLX,0.166169,0.030163,Neutral
Here's Why You Should Hold Integer Holdings  ( ITGR )  Stock for Now,https://www.zacks.com/stock/news/2104585/heres-why-you-should-hold-integer-holdings-itgr-stock-for-now,2023-06-06 14:56:00,Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and a solid foothold in the broader MedTech space.,HOLX,0.203643,0.167632,Somewhat-Bullish
Thermo Fisher's  ( TMO )  Unveils Orbitrap Astral Spectrometer,https://www.zacks.com/stock/news/2104533/thermo-fishers-tmo-unveils-orbitrap-astral-spectrometer,2023-06-06 14:20:00,Thermo Fisher's (TMO) OrbitrapTM AstralTM mass spectrometer enables accurate and exact quantification in proteomics laboratories.,HOLX,0.223866,0.107974,Neutral
Here's Why You Should Invest in IDEXX  ( IDXX )  Right Now,https://www.zacks.com/stock/news/2104295/heres-why-you-should-invest-in-idexx-idxx-right-now,2023-06-06 12:16:00,Investors continue to be optimistic about IDEXX (IDXX) on the strength of the Companion Animal Group business.,HOLX,0.165031,0.096906,Neutral
Hologic  ( HOLX )  Stock Up 5.6% YTD: Will the Rally Continue?,https://www.zacks.com/stock/news/2104045/hologic-holx-stock-up-56-ytd-will-the-rally-continue,2023-06-05 18:12:00,"The higher capital equipment revenues, procedural volumes return and an acceleration from the new business lines poise Hologic (HOLX) for future growth.",HOLX,0.388126,0.274312,Somewhat-Bullish
Here's Why You Should Retain AMN Healthcare  ( AMN )  Stock for Now,https://www.zacks.com/stock/news/2103929/heres-why-you-should-retain-amn-healthcare-amn-stock-for-now,2023-06-05 15:36:00,Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.,HOLX,0.200273,0.165528,Somewhat-Bullish
Here's Why You Should Invest in Edward Lifesciences  ( EW )  Now,https://www.zacks.com/stock/news/2103661/heres-why-you-should-invest-in-edward-lifesciences-ew-now,2023-06-05 11:26:00,Investors continue to be optimistic about Edward Lifesciences (EW) on the strength of the Surgical Structural Heart business and the Critical Care segment.,HOLX,0.172713,0.099946,Neutral
Illumina's  ( ILMN )  New AI Tool to Predict Genomics Disease,https://www.zacks.com/stock/news/2103423/illuminas-ilmn-new-ai-tool-to-predict-genomics-disease,2023-06-02 16:44:00,Illumina's (ILMN) PrimateAI-3D will be made broadly available to the genomics community integrated across Illumina Connected Software.,HOLX,0.200688,0.042808,Neutral
Here's Why You Should Retain PacBio  ( PACB )  Stock for Now,https://www.zacks.com/stock/news/2103412/heres-why-you-should-retain-pacbio-pacb-stock-for-now,2023-06-02 16:08:00,PacBio's (PACB) product development activities raise optimism about the stock.,HOLX,0.206685,0.169537,Somewhat-Bullish
"Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction - Edwards Lifesciences  ( NYSE:EW ) , Hologic  ( NASDAQ:HOLX ) , Illumina  ( NASDAQ:ILMN ) ",https://www.benzinga.com/general/biotech/23/06/32689141/illumina-takes-ai-to-genomics-launch-of-primateai-3d-for-accurate-disease-prediction,2023-06-02 12:54:21,"Illumina, Inc. ILMN launched PrimateAI-3D, an artificial intelligence ( AI ) algorithm that predicts disease-causing genetic mutations in patients. PrimateAI-3D utilizes deep neural network architectures similar to ChatGPT and AlphaFold, but is trained on genome sequences rather than human ...",HOLX,0.308891,0.238703,Somewhat-Bullish
Reasons to Retain Quest Diagnostics  ( DGX )  Stock for Now,https://www.zacks.com/stock/news/2103021/reasons-to-retain-quest-diagnostics-dgx-stock-for-now,2023-06-02 12:40:00,Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business performance and its strategies to accelerate growth.,HOLX,0.200688,0.004719,Neutral
Illumina board appoints Hologic CEO as non-exec chairman,https://www.reuters.com/business/healthcare-pharmaceuticals/illumina-board-appoints-hologic-ceo-non-exec-chairman-2023-06-02/,2023-06-02 11:45:00,"June 2 ( Reuters ) - Illumina Inc ( ILMN.O ) said on Friday it had elected two new independent board members, including Hologic Inc ( HOLX.O ) CEO Stephen MacMillan as the non-executive chairperson, with immediate effect.",HOLX,0.266828,0.0,Neutral
Illumina's Board of Directors elects two experienced Independent Directors to Board,https://www.prnewswire.com/news-releases/illuminas-board-of-directors-elects-two-experienced-independent-directors-to-board-301841153.html,2023-06-02 11:30:00,Illumina's Board of Directors elects two experienced Independent ... PR ...,HOLX,0.092569,0.061015,Neutral
Hologic  ( HOLX )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2102853/hologic-holx-gains-but-lags-market-what-you-should-know,2023-06-01 21:45:16,"In the latest trading session, Hologic (HOLX) closed at $79.15, marking a +0.33% move from the previous day.",HOLX,0.642977,0.253345,Somewhat-Bullish
"Haemonetics  ( HAE )  Hospital Arm Grows, Plasma Volume Improves",https://www.zacks.com/stock/news/2102627/haemonetics-hae-hospital-arm-grows-plasma-volume-improves,2023-06-01 15:28:00,"Within Haemonetics (HAE) Vascular Closure, growth is led by the opening of new accounts and increasing penetration to gain share in the top U.S. EP hospitals.",HOLX,0.263942,0.055283,Neutral
Charles River  ( CRL )  to Build RightSource Lab With New Pact,https://www.zacks.com/stock/news/2102756/charles-river-crl-to-build-rightsource-lab-with-new-pact,2023-06-01 15:17:00,Charles River (CRL) will establish a CGMP testing lab at Wheeler's factory through latest partnership.,HOLX,0.193852,0.04169,Neutral
"Veeva Systems  ( VEEV )  Beats on Q1 Earnings, Ups FY24 Outlook",https://www.zacks.com/stock/news/2102610/veeva-systems-veev-beats-on-q1-earnings-ups-fy24-outlook,2023-06-01 14:59:00,Veeva Systems' (VEEV) fiscal Q1 results reflect impressive performances by both segments.,HOLX,0.167032,0.03026,Neutral
Here's Why You Should Retain DaVita  ( DVA )  Stock for Now,https://www.zacks.com/stock/news/2102601/heres-why-you-should-retain-davita-dva-stock-for-now,2023-06-01 14:46:00,Investors remain optimistic about DaVita (DVA) due to the strength of its DaVita Kidney Care.,HOLX,0.217834,0.087623,Neutral
"Bio-Rad  ( BIO )  Faces Macroeconomic Headwinds, Rising Expenses",https://www.zacks.com/stock/news/2102582/bio-rad-bio-faces-macroeconomic-headwinds-rising-expenses,2023-06-01 14:14:00,Bio-Rad's (BIO) process chromatography business witnesses a slowdown in the quarter due to tough comparisons and some softness in the bioprocessing market.,HOLX,0.197816,0.043953,Neutral
Here's Why You Should Retain Medtronic  ( MDT )  Stock for Now,https://www.zacks.com/stock/news/2101873/heres-why-you-should-retain-medtronic-mdt-stock-for-now,2023-05-31 13:12:00,Investors continue to be optimistic about Medtronic (MDT) on the robust performances of the Neurosurgery and Cardiovascular portfolios.,HOLX,0.21686,0.052565,Neutral
3 Reasons to Retain Nevro  ( NVRO )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2110107/3-reasons-to-retain-nevro-nvro-stock-in-your-portfolio,2023-06-19 14:27:00,Investors continue to be optimistic about Nevro (NVRO) due to its R&D edge.,HOLX,0.205807,0.131113,Neutral
"Hologic  ( HOLX )  Gains From Core Businesses' Growth, Innovation",https://www.zacks.com/stock/news/2109972/hologic-holx-gains-from-core-businesses-growth-innovation,2023-06-19 12:57:00,Hologic's (HOLX) GYN Surgical business grows organically as the company registers procedural volumes return and acceleration from new business lines.,HOLX,0.467081,0.446869,Bullish
Here's Why Investors Should Retain Phibro  ( PAHC )  for Now,https://www.zacks.com/stock/news/2109966/heres-why-investors-should-retain-phibro-pahc-for-now,2023-06-19 12:55:00,Investors are optimistic about Phibro's (PAHC) diversified offerings and booming vaccine business.,HOLX,0.186738,0.101258,Neutral
Hologic  ( HOLX )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2109647/hologic-holx-gains-as-market-dips-what-you-should-know,2023-06-16 21:45:24,"Hologic (HOLX) closed the most recent trading day at $81.20, moving +0.2% from the previous trading session.",HOLX,0.672712,0.178482,Somewhat-Bullish
Surmodics'  ( SRDX )  Receipt of New FDA Nod to Boost Patient Care,https://www.zacks.com/stock/news/2109506/surmodics-srdx-receipt-of-new-fda-nod-to-boost-patient-care,2023-06-16 15:20:00,Surmodics' (SRDX) receipt of FDA's clearance is expected to expand the treatment range of the Pounce platform and serve a wider patient pool.,HOLX,0.207127,0.133349,Neutral
"Epigenetics Market size to grow by USD 1,148.2 million from 2022-2027 with 40% of the market growth originate from North America - Technavio",https://www.prnewswire.com/news-releases/epigenetics-market-size-to-grow-by-usd-1-148-2-million-from-2022-2027-with-40-of-the-market-growth-originate-from-north-america---technavio-301852330.html,2023-06-16 14:15:00,"Epigenetics Market size to grow by USD 1,148.2 million from 2022-2027 with 40% of the market growth originate from ... PR ...",HOLX,0.033098,0.02861,Neutral
IBD Rating Upgrades: Hologic Shows Improved Price Strength,https://www.investors.com/ibd-data-stories/ibd-rating-upgrades-hologic-shows-improved-price-strength/,2023-06-16 07:00:00,"The Relative Strength ( RS ) Rating for Hologic ( HOLX ) entered a higher percentile Friday, as it got a lift from 63 to 71. X When you're researching the best stocks to buy and watch, be sure to pay attention to relative price strength.",HOLX,0.640349,0.261878,Somewhat-Bullish
3 Reasons to Hold Patterson Companies  ( PDCO )  Stock for Now,https://www.zacks.com/stock/news/2108950/3-reasons-to-hold-patterson-companies-pdco-stock-for-now,2023-06-15 15:31:00,Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.,HOLX,0.22335,0.139769,Neutral
BD's  ( BDX )  Latest Product to Automate Clinical Flow Cytometry,https://www.zacks.com/stock/news/2108928/bds-bdx-latest-product-to-automate-clinical-flow-cytometry,2023-06-15 15:08:00,The latest worldwide commercial availability of BD's (BDX) product is expected to lead to increased automation in clinical lab workflow.,HOLX,0.206245,0.131328,Neutral
Here's Why Investors Should Retain SmileDirectClub  ( SDC )  Now,https://www.zacks.com/stock/news/2108687/heres-why-investors-should-retain-smiledirectclub-sdc-now,2023-06-15 12:27:00,Meaningful innovations and strategic alliances boost investors' confidence in SmileDirectClub (SDC).,HOLX,0.199037,0.10621,Neutral
Here's Why You Should Invest in Hologic  ( HOLX )  Stock Now,https://www.zacks.com/stock/news/2108776/heres-why-you-should-invest-in-hologic-holx-stock-now,2023-06-15 12:13:00,Investors are optimistic about Hologic (HOLX) on continued strength in GYN Surgical and Breast Health businesses.,HOLX,0.520601,0.391461,Bullish
QIAGEN's  ( QGEN )  QCI Is Used by Danish National Genome Center,https://www.zacks.com/stock/news/2108405/qiagens-qgen-qci-is-used-by-danish-national-genome-center,2023-06-14 15:48:00,"QIAGEN's (QGEN) QCI Interpret offers evidence-based variant interpretation and reporting, and upholds the highest standards for data security and privacy. It also provides testing sites flexibility.",HOLX,0.185306,0.154834,Somewhat-Bullish
Here's Why You Should Retain Illumina  ( ILMN )  Stock for Now,https://www.zacks.com/stock/news/2108381/heres-why-you-should-retain-illumina-ilmn-stock-for-now,2023-06-14 15:22:00,Investors are optimistic about Illumina (ILMN) on solid long-term growth potential in the oncology space.,HOLX,0.179121,0.11826,Neutral
Here's Why You Should Retain Alcon  ( ALC )  Stock for Now,https://www.zacks.com/stock/news/2108089/heres-why-you-should-retain-alcon-alc-stock-for-now,2023-06-14 12:55:00,Investors continue to be optimistic about Alcon (ALC) on the impressive performance of the Surgical and Vision Care segments.,HOLX,0.157227,0.092597,Neutral
CVS Heath  ( CVS )  MinuteClinic Earns 6th Health Care Approval,https://www.zacks.com/stock/news/2107822/cvs-heath-cvs-minuteclinic-earns-6th-health-care-approval,2023-06-13 17:59:00,"CVS Heath's (CVS) MinuteClinic has an in-clinic Net Promotor Score of more than 81, putting it in the top customer rankings.",HOLX,0.17813,0.117795,Neutral
"Merit Medical  ( MMSI )  Expands Suite via Buyouts, Revises FY23 View",https://www.zacks.com/stock/news/2107770/merit-medical-mmsi-expands-suite-via-buyouts-revises-fy23-view,2023-06-13 15:22:00,Merit Medical's (MMSI) latest addition to its portfolio is expected to significantly enhance patient outcomes.,HOLX,0.150122,0.112939,Neutral
Here's Why You Should Retain BD  ( BDX )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2107670/heres-why-you-should-retain-bd-bdx-stock-in-your-portfolio,2023-06-13 14:27:00,Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and product launches.,HOLX,0.208017,0.132198,Neutral
"Catalent  ( CTLT )  Tops Q3 Earnings Estimates, Cuts FY23 View",https://www.zacks.com/stock/news/2107090/catalent-ctlt-tops-q3-earnings-estimates-cuts-fy23-view,2023-06-12 14:43:00,"Catalent (CTLT) records lower revenues in both segments in third-quarter fiscal 2023, resulting in overall soft performance.",HOLX,0.190417,0.033242,Neutral
Teleflex's  ( TFX )  Arrow EZ-IO Needle Receives FDA Approval,https://www.zacks.com/stock/news/2107098/teleflexs-tfx-arrow-ez-io-needle-receives-fda-approval,2023-06-12 13:52:00,Teleflex's (TFX) Arrow EZ-IO Needle is the first and only intraosseous (IO) needle for MR Conditional labelling.,HOLX,0.197413,0.127013,Neutral
OPKO Health's  ( OPK )  NGENLA Approved by FDA for GHD Treatment,https://www.zacks.com/stock/news/2114869/opko-healths-opk-ngenla-approved-by-fda-for-ghd-treatment,2023-06-29 15:23:00,"The latest approval for OPKO Health's (OPK) NGENLA is expected to reduce the treatment frequency from daily injections, thereby better serving the GHD patient pool.",HOLX,0.211652,0.185502,Somewhat-Bullish
Walgreens  ( WBA )  to Advance Diabetes Care at FFL Conference,https://www.zacks.com/stock/news/2114837/walgreens-wba-to-advance-diabetes-care-at-ffl-conference,2023-06-29 13:30:00,Walgreens (WBA) will sponsor Children with Diabetes' FFL event to make a difference in the lives of the 122 million individuals afflicted by diabetes and pre-diabetes.,HOLX,0.213517,0.134907,Neutral
Hologic  ( HOLX )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2114448/hologic-holx-dips-more-than-broader-markets-what-you-should-know,2023-06-28 21:45:19,"Hologic (HOLX) closed the most recent trading day at $80.24, moving -0.72% from the previous trading session.",HOLX,0.664882,0.104162,Neutral
Three Reasons to Add Surmodics  ( SRDX )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2114312/three-reasons-to-add-surmodics-srdx-stock-to-your-portfolio,2023-06-28 15:31:00,Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.,HOLX,0.208914,0.134238,Neutral
Here's Why You Should Retain Myriad Genetics  ( MYGN )  Stock Now,https://www.zacks.com/stock/news/2114180/heres-why-you-should-retain-myriad-genetics-mygn-stock-now,2023-06-28 13:32:00,Investors are optimistic about Myriad Genetics (MYGN) due to the performance of its oncology business and product launches.,HOLX,0.195419,0.104743,Neutral
Amedisys  ( AMED )  to Advance Value-Based Care With Optum Merger,https://www.zacks.com/stock/news/2114256/amedisys-amed-to-advance-value-based-care-with-optum-merger,2023-06-28 13:21:00,"Amedisys' (AMED) combination with Optum brings together two organizations committed to offering patients and their families compassionate, value-based comprehensive care.",HOLX,0.197413,0.127013,Neutral
Here's Why You Should Retain CVS Health  ( CVS )  Stock for Now,https://www.zacks.com/stock/news/2113789/heres-why-you-should-retain-cvs-health-cvs-stock-for-now,2023-06-27 16:34:00,"Investors are optimistic about CVS Health (CVS) backed by the acquisition of Oak Street Health, which broadens its value-based primary care platform.",HOLX,0.183546,0.120348,Neutral
Here's Why You Should Invest in DENTSPLY SIRONA  ( XRAY )  Stock,https://www.zacks.com/stock/news/2113703/heres-why-you-should-invest-in-dentsply-sirona-xray-stock,2023-06-27 15:38:00,"DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.",HOLX,0.162802,0.116144,Neutral
McKesson's  ( MCK )  Latest Launch to Give Access to OTC Products,https://www.zacks.com/stock/news/2113766/mckessons-mck-latest-launch-to-give-access-to-otc-products,2023-06-27 15:22:00,McKesson's (MCK) latest launch is expected to meet the evolving needs and growing demand for quality OTC private-label health and wellness products.,HOLX,0.261818,0.158731,Somewhat-Bullish
Three Reasons to Add Masimo  ( MASI )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2113659/three-reasons-to-add-masimo-masi-stock-to-your-portfolio,2023-06-27 14:25:00,Masimo's (MASI) solid product suite raises optimism about the stock.,HOLX,0.218817,0.139181,Neutral
"Dexcom  ( DXCM )  to Launch New Product in 2024, Ups Long-Term View",https://www.zacks.com/stock/news/2113582/dexcom-dxcm-to-launch-new-product-in-2024-ups-long-term-view,2023-06-27 12:35:00,"Dexcom (DXCM) announces encouraging developments in 2024, including faster coverage for its products by private payers and new product launch for diabetic patients not on insulin.",HOLX,0.175859,0.119558,Neutral
NATIONAL BANK OPEN PRESENTED BY ROGERS TO OFFER EQUAL PRIZE MONEY TO WOMEN AND MEN STARTING IN 2027,https://www.newswire.ca/news-releases/national-bank-open-presented-by-rogers-to-offer-equal-prize-money-to-women-and-men-starting-in-2027-817373309.html,2023-06-27 11:15:00,NATIONAL BANK OPEN PRESENTED BY ROGERS TO OFFER EQUAL PRIZE MONEY TO WOMEN AND MEN ... Canada ...,HOLX,0.112929,0.168865,Somewhat-Bullish
Here's Why Investors Should Retain Abbott  ( ABT )  Stock Now,https://www.zacks.com/stock/news/2113211/heres-why-investors-should-retain-abbott-abt-stock-now,2023-06-26 16:30:00,Investors are optimistic about Abbott (ABT) on continued growth in Diabetes business and upbeat guidance.,HOLX,0.200273,0.129954,Neutral
Inspire Medical  ( INSP )  Hits 52-Week High: What's Aiding It?,https://www.zacks.com/stock/news/2113103/inspire-medical-insp-hits-52-week-high-whats-aiding-it,2023-06-26 14:50:00,Investors are optimistic about Inspire Medical's (INSP) global presence.,HOLX,0.208017,0.132198,Neutral
Masimo's  ( MASI )  W1 to Boost Virtual Care in Preoperative Patients,https://www.zacks.com/stock/news/2113098/masimos-masi-w1-to-boost-virtual-care-in-preoperative-patients,2023-06-26 14:44:00,Masimo's (MASI) W1 advanced health-tracking watch is expected to provide better insights into pre-operative patients' heart rate variability data and improve pre-habilitation.,HOLX,0.240489,0.150033,Somewhat-Bullish
Envista  ( NVST )  Gains From New Acquisitions Amid FX Woes,https://www.zacks.com/stock/news/2113065/envista-nvst-gains-from-new-acquisitions-amid-fx-woes,2023-06-26 13:52:00,Envista's (NVST) implant businesses in Europe perform well on the back of disciplined commercial execution.,HOLX,0.215415,0.165246,Somewhat-Bullish
Here's Why You Should Retain Henry Schein  ( HSIC )  Stock for Now,https://www.zacks.com/stock/news/2112905/heres-why-you-should-retain-henry-schein-hsic-stock-for-now,2023-06-26 12:41:00,Investors are optimistic about Henry Schein (HSIC) due to the performance of its dental business.,HOLX,0.188193,0.101838,Neutral
Abbott  ( ABT )  FreeStyle Libre 2 Gets Reimbursement in France,https://www.zacks.com/stock/news/2112562/abbott-abt-freestyle-libre-2-gets-reimbursement-in-france,2023-06-23 16:28:00,Abbott's (ABT) FreeStyle Libre increased reimbursement makes it possible for more people in France with diabetes to use the recent CGM technology.,HOLX,0.1437,0.071599,Neutral
Reasons to Retain QuidelOrtho  ( QDEL )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2112525/reasons-to-retain-quidelortho-qdel-stock-in-your-portfolio,2023-06-23 16:13:00,Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its product innovation aiding growth.,HOLX,0.209365,0.132862,Neutral
Boston Scientific's  ( BSX )  New Launches Aid Amid Cost Pressure,https://www.zacks.com/stock/news/2112440/boston-scientifics-bsx-new-launches-aid-amid-cost-pressure,2023-06-23 14:52:00,Boston Scientific (BSX) remains excited about the rest of 2023 and expects to continue to outpace its peers within the EMEA market.,HOLX,0.208914,0.13264,Neutral
Hologic  ( HOLX )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2112032/hologic-holx-gains-but-lags-market-what-you-should-know,2023-06-22 21:45:22,"Hologic (HOLX) closed at $81.49 in the latest trading session, marking a +0.07% move from the prior day.",HOLX,0.628473,0.141,Neutral
Quest Diagnostics'  ( DGX )  New Buyout Expands Cancer Portfolio,https://www.zacks.com/stock/news/2111989/quest-diagnostics-dgx-new-buyout-expands-cancer-portfolio,2023-06-22 16:35:00,Quest Diagnostics (DGX) will use MRD technology to create new blood-based clinical lab services for solid tumour cancers that will be available starting in 2024.,HOLX,0.195814,0.12776,Neutral
Masimo's  ( MASI )  Launch to Serve the Personalized Hearables Market,https://www.zacks.com/stock/news/2111973/masimos-masi-launch-to-serve-the-personalized-hearables-market,2023-06-22 15:33:00,Masimo's (MASI) new product offerings are expected to enable it to expand its footprint in the personalized hearables market.,HOLX,0.203215,0.131409,Neutral
QIAGEN's  ( QGEN )  ForenSeq MainstAY Workflow Gets FBI Nod,https://www.zacks.com/stock/news/2111418/qiagens-qgen-forenseq-mainstay-workflow-gets-fbi-nod,2023-06-21 16:50:00,QIAGEN's (QGEN) ForenSeq MainstAY workflow is a cost-effective substitute for analyzing short tandem repeats with capillary electrophoresis and facilitates volume casework for sexual assault cases.,HOLX,0.201105,0.128812,Neutral
Cardinal Health  ( CAH )  Hits 52-Week High: What's Aiding It?,https://www.zacks.com/stock/news/2111341/cardinal-health-cah-hits-52-week-high-whats-aiding-it,2023-06-21 15:35:00,Investors are optimistic about Cardinal Health's (CAH) diversified product portfolio.,HOLX,0.207571,0.131979,Neutral
Avanos'  ( AVNS )  Latest Buyout to Boost Its RF Product Offering,https://www.zacks.com/stock/news/2111282/avanos-avns-latest-buyout-to-boost-its-rf-product-offering,2023-06-21 15:10:00,Avanos' (AVNS) latest acquisition is expected to strengthen its foothold with a comprehensive suite of RF offerings.,HOLX,0.232996,0.144547,Neutral
Here's Why You Should Retain National Vision  ( EYE )  Stock Now,https://www.zacks.com/stock/news/2111192/heres-why-you-should-retain-national-vision-eye-stock-now,2023-06-21 13:42:00,Investors continue to remain optimistic about National Vision (EYE) due to the expansion of stores and new investments for the improved optometric experience.,HOLX,0.203643,0.108087,Neutral
"Investors Heavily Search Hologic, Inc.  ( HOLX ) : Here is What You Need to Know",https://www.zacks.com/stock/news/2111118/investors-heavily-search-hologic-inc-holx-here-is-what-you-need-to-know,2023-06-21 13:00:14,"Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",HOLX,0.489394,0.153677,Somewhat-Bullish
3 Reasons to Add HealthEquity  ( HQY )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2110761/3-reasons-to-add-healthequity-hqy-stock-in-your-portfolio,2023-06-20 15:43:00,Investors continue to be optimistic about HealthEquity's (HQY) strength in HSA.,HOLX,0.213517,0.136532,Neutral
PacBio's  ( PACB )  New Tie-Up to Boost Rare Disease Research,https://www.zacks.com/stock/news/2110759/pacbios-pacb-new-tie-up-to-boost-rare-disease-research,2023-06-20 15:41:00,PacBio's (PACB) latest collaboration is expected to highlight the feasibility and cost-effectiveness of using its HiFi sequencing technology.,HOLX,0.223866,0.140024,Neutral
Why You Should Retain Walgreens Boots  ( WBA )  Stock for Now,https://www.zacks.com/stock/news/2110652/why-you-should-retain-walgreens-boots-wba-stock-for-now,2023-06-20 15:19:00,Investors are optimistic about Walgreens Boots (WBA) on a strong focus on strategic priorities.,HOLX,0.204072,0.163204,Somewhat-Bullish
Kontaveit Forced To Retire At 27 Due To Chronic Back Injury,https://www.forbes.com/sites/manasipathak-1/2023/06/20/kontaveit-forced-to-retire-at-27-due-to-chronic-back-injury/,2023-06-20 08:27:49,"Former world number two Anett Kontaveit has been forced to retire from tennis at 27 due to a degenerative back injury, with this year's Wimbledon to be her final outing.",HOLX,0.10607,0.226147,Somewhat-Bullish
3 Reasons to Retain PacBio  ( PACB )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2118221/3-reasons-to-retain-pacbio-pacb-stock-in-your-portfolio,2023-07-07 16:04:00,PacBio's (PACB) product development activities raise optimism about the stock.,HOLX,0.213988,0.133512,Neutral
Reasons to Retain ShockWave Medical  ( SWAV )  in Your Portfolio,https://www.zacks.com/stock/news/2117958/reasons-to-retain-shockwave-medical-swav-in-your-portfolio,2023-07-07 11:40:00,ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.,HOLX,0.172507,0.117968,Neutral
Reasons to Retain AMN Healthcare  ( AMN )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2117601/reasons-to-retain-amn-healthcare-amn-stock-in-your-portfolio,2023-07-06 15:21:00,Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.,HOLX,0.211191,0.132149,Neutral
Here's Why You Should Add Stryker  ( SYK )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2117461/heres-why-you-should-add-stryker-syk-stock-to-your-portfolio,2023-07-06 12:22:00,"Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.",HOLX,0.158173,0.114004,Neutral
Hologic  ( HOLX )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2117182/hologic-holx-dips-more-than-broader-markets-what-you-should-know,2023-07-05 21:45:24,"In the latest trading session, Hologic (HOLX) closed at $78.83, marking a -1.29% move from the previous day.",HOLX,0.692877,0.143547,Neutral
Myomo's  ( MYO )  MyoPro Seeks CMS Classification for Medicare Cover,https://www.zacks.com/stock/news/2117032/myomos-myo-myopro-seeks-cms-classification-for-medicare-cover,2023-07-05 14:50:00,"If this rule is finalized without any changes to reimbursement practices, Myomo's (MYO) MyoPro could be reimbursed in a lump-sum manner by CMS.",HOLX,0.209365,0.108829,Neutral
DexCom's  ( DXCM )  G7 CGM System Gets Nod From Health Canada,https://www.zacks.com/stock/news/2117001/dexcoms-dxcm-g7-cgm-system-gets-nod-from-health-canada,2023-07-05 14:01:00,"DexCom's (DXCM) G7 CGM System's latest approval by Health Canada is expected to combine simplicity and power, thereby providing a better way to manage diabetes.",HOLX,0.21258,0.136065,Neutral
LabCorp  ( LH )  Partners With Forge Biologics for Gene Therapies,https://www.zacks.com/stock/news/2117036/labcorp-lh-partners-with-forge-biologics-for-gene-therapies,2023-07-05 13:54:00,"LabCorp's (LH) latest partnership will significantly assist patients gain access to cutting-edge, potentially life-saving medication.",HOLX,0.208017,0.127418,Neutral
Here's Why You Should Retain Teleflex  ( TFX )  Stock for Now,https://www.zacks.com/stock/news/2116885/heres-why-you-should-retain-teleflex-tfx-stock-for-now,2023-07-05 13:07:00,Revenue growth across global product categories and a broad geographic footprint bode well for Teleflex (TFX).,HOLX,0.192694,0.103643,Neutral
"Hologic, Inc.  ( HOLX )  Is a Trending Stock: Facts to Know Before Betting on It",https://www.zacks.com/stock/news/2116863/hologic-inc-holx-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-07-05 13:00:13,"Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.",HOLX,0.487546,0.15901,Somewhat-Bullish
Reasons to Retain AmerisourceBergen  ( ABC )  in Your Portfolio,https://www.zacks.com/stock/news/2116933/reasons-to-retain-amerisourcebergen-abc-in-your-portfolio,2023-07-05 12:43:00,"AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.",HOLX,0.148121,0.105718,Neutral
3 Reasons to Retain NextGen  ( NXGN )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2116525/3-reasons-to-retain-nextgen-nxgn-stock-in-your-portfolio,2023-07-04 14:52:00,NextGen's (NXGN) strong product portfolio and continued demand for its solutions raise optimism about the stock.,HOLX,0.210274,0.133309,Neutral
Here's Why You Should Buy Exact Sciences  ( EXAS )  Stock Now,https://www.zacks.com/stock/news/2116561/heres-why-you-should-buy-exact-sciences-exas-stock-now,2023-07-04 14:40:00,Investors are optimistic about Exact Sciences (EXAS) on strong Cologuard growth and raised guidance.,HOLX,0.211191,0.132149,Neutral
Reasons to Add Inari Medical  ( NARI )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2116395/reasons-to-add-inari-medical-nari-stock-to-your-portfolio,2023-07-04 11:19:00,"Inari Medical (NARI) continues to benefit from its commitment to understand the venous system. However, its dependency on adoption of products is a concern.",HOLX,0.135347,0.064508,Neutral
McKesson  ( MCK )  Hits 52-Week High: What's Driving the Stock?,https://www.zacks.com/stock/news/2116077/mckesson-mck-hits-52-week-high-whats-driving-the-stock,2023-07-03 15:38:00,Investors are optimistic about McKesson's (MCK) strength in its Biologics business.,HOLX,0.218325,0.137282,Neutral
Integer Holdings  ( ITGR )  Hits 52-Week High: What's Aiding It?,https://www.zacks.com/stock/news/2116078/integer-holdings-itgr-hits-52-week-high-whats-aiding-it,2023-07-03 15:36:00,Investors are optimistic about Integer Holdings' (ITGR) solid foothold in the broader MedTech space.,HOLX,0.213517,0.134907,Neutral
Molecular Diagnostics Market worth $28.6 billion | MarketsandMarkets,https://www.prnewswire.com/news-releases/molecular-diagnostics-market-worth-28-6-billion--marketsandmarkets-301868746.html,2023-07-03 15:15:00,"CHICAGO, July 3, 2023 /PRNewswire/ -- The molecular diagnostics industry is poised to undergo significant advancements in the near future, fueled by rapid technological innovation and increasing demand for personalized healthcare.",HOLX,0.040246,-0.001925,Neutral
Canopy Growth  ( CGC )  Improves Liquidity With Another Selloff,https://www.zacks.com/stock/news/2116040/canopy-growth-cgc-improves-liquidity-with-another-selloff,2023-07-03 14:55:00,Canopy Growth's (CGC) decision to divest facilities aligns with its organizational transformation plan.,HOLX,0.276648,0.140068,Neutral
Quest Diagnostics  ( DGX )  Presents New Data on Disease Testing,https://www.zacks.com/stock/news/2116092/quest-diagnostics-dgx-presents-new-data-on-disease-testing,2023-07-03 14:55:00,Quest Diagnostics (DGX) is dedicated to create cutting-edge laboratory tests to help assess patient risk for dementia and other degenerative diseases.,HOLX,0.18856,0.128667,Neutral
Here's Why You Should Invest in Neogen  ( NEOG )  Stock Now,https://www.zacks.com/stock/news/2116022/heres-why-you-should-invest-in-neogen-neog-stock-now,2023-07-03 13:35:00,Investors are upbeat about Neogen (NEOG) owing to strong performance across its Animal Safety and Food Safety segments.,HOLX,0.194242,0.123961,Neutral
Stryker  ( SYK )  Stock Hits 52-Week High: More Room to Grow?,https://www.zacks.com/stock/news/2115994/stryker-syk-stock-hits-52-week-high-more-room-to-grow,2023-07-03 13:04:00,"Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.",HOLX,0.137671,0.102681,Neutral
West Pharmaceutical  ( WST )  Hits 52-Week High: More Room to Grow?,https://www.zacks.com/stock/news/2115975/west-pharmaceutical-wst-hits-52-week-high-more-room-to-grow,2023-07-03 12:35:00,"West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.",HOLX,0.141726,0.106783,Neutral
Here's Why You Should Retain Zimmer Biomet  ( ZBH )  for Now,https://www.zacks.com/stock/news/2115866/heres-why-you-should-retain-zimmer-biomet-zbh-for-now,2023-07-03 12:20:00,Investors are optimistic about Zimmer Biomet (ZBH) due to the continued procedure recovery and the strength of emerging markets.,HOLX,0.190793,0.101384,Neutral
Baxter's  ( BAX )  New Launch to Support Complex Critical Care Needs,https://www.zacks.com/stock/news/2115409/baxters-bax-new-launch-to-support-complex-critical-care-needs,2023-06-30 14:45:00,Baxter's (BAX) Progressa+ bed for the ICU is expected to enhance workflow and reduce strain on nursing resources.,HOLX,0.244723,0.150344,Somewhat-Bullish
PacBio  ( PACB )  Gets New Order for Revio System From Bioscientia,https://www.zacks.com/stock/news/2115395/pacbio-pacb-gets-new-order-for-revio-system-from-bioscientia,2023-06-30 13:14:00,PacBio (PACB) receives new order for its Revio system from Bioscientia that will boost the latter's services. Here's how Revio can help Bioscientia improve diagnosis and treatment for monogenic disorders.,HOLX,0.146618,0.106346,Neutral
Thermo Fisher's  ( TMO )  New Launch to Advance Cancer Therapies,https://www.zacks.com/stock/news/2115391/thermo-fishers-tmo-new-launch-to-advance-cancer-therapies,2023-06-30 13:06:00,Thermo Fisher's (TMO) Gibco OncoPro Tumoroid Culture Medium Kit is intended to increase researchers' access to sophisticated cancer models.,HOLX,0.189298,0.123093,Neutral
Exosome Diagnostics and Therapeutics Market size to grow by USD 483.18 million from 2022 to 2027|Increasing research on exosomes for new therapeutics driving the market - Technavio,https://www.prnewswire.com/news-releases/exosome-diagnostics-and-therapeutics-market-size-to-grow-by-usd-483-18-million-from-2022-to-2027increasing-research-on-exosomes-for-new-therapeutics-driving-the-market---technavio-301867242.html,2023-06-30 05:15:00,Exosome Diagnostics and Therapeutics Market size to grow by USD 483.18 million from 2022 to 2027|Increasing ... PR ...,HOLX,0.03072,0.044269,Neutral
NextGen  ( NXGN )  Settles Misrepresentation Allegations for $31M,https://www.zacks.com/stock/news/2123885/nextgen-nxgn-settles-misrepresentation-allegations-for-31m,2023-07-19 14:18:00,"NextGen (NXGN) settles accusations of software fraud and anti-kickback violations for $31M. However, the company denies any wrongdoing.",HOLX,0.185781,0.12581,Neutral
Here's Why You Should Invest in Edward Lifesciences  ( EW )  Now,https://www.zacks.com/stock/news/2123563/heres-why-you-should-invest-in-edward-lifesciences-ew-now,2023-07-19 13:09:00,Investors continue to be optimistic about Edward Lifesciences (EW) on the strength of the Surgical Structural Heart business.,HOLX,0.190793,0.10886,Neutral
Reasons to Retain Quest Diagnostics  ( DGX )  Stock for Now,https://www.zacks.com/stock/news/2123159/reasons-to-retain-quest-diagnostics-dgx-stock-for-now,2023-07-18 15:20:00,Investors are optimistic about Quest Diagnostics (DGX) on stronger base volume recovery and growth from strategic acquisitions.,HOLX,0.144853,0.108105,Neutral
Reasons to Add West Pharmaceutical  ( WST )  to Your Portfolio Now,https://www.zacks.com/stock/news/2123042/reasons-to-add-west-pharmaceutical-wst-to-your-portfolio-now,2023-07-18 14:14:00,"West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.",HOLX,0.213517,0.079585,Neutral
Hologic  ( HOLX )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2122404/hologic-holx-stock-sinks-as-market-gains-what-you-should-know,2023-07-17 21:45:18,"Hologic (HOLX) closed at $78.96 in the latest trading session, marking a -1.69% move from the prior day.",HOLX,0.572194,0.335359,Somewhat-Bullish
Boston Scientific  ( BSX )  Gets FDA Nod for Vercise Software,https://www.zacks.com/stock/news/2122168/boston-scientific-bsx-gets-fda-nod-for-vercise-software,2023-07-17 14:35:00,Boston Scientific's (BSX) Vercise Neural Navigator 5 Software has an improved user interface that presents patient data in an easier-to-understand style and enables better therapy delivery.,HOLX,0.155451,0.112766,Neutral
Here's Why You Should Retain Charles River  ( CRL )  Stock Now,https://www.zacks.com/stock/news/2122163/heres-why-you-should-retain-charles-river-crl-stock-now,2023-07-17 14:27:00,Investors are optimistic about Charles River (CRL) on strategic acquisitions and robust performance of the DSA and RMS arms.,HOLX,0.142847,0.104775,Neutral
Is AmerisourceBergen  ( ABC )  Stock Outpacing Its Medical Peers This Year?,https://www.zacks.com/stock/news/2122062/is-amerisourcebergen-abc-stock-outpacing-its-medical-peers-this-year,2023-07-17 13:40:12,Here is how AmerisourceBergen (ABC) and Hologic (HOLX) have performed compared to their sector so far this year.,HOLX,0.506613,0.160974,Somewhat-Bullish
Hyperfine  ( HYPR )  ACTION PMR Study Targets Better Stroke Care,https://www.zacks.com/stock/news/2122034/hyperfine-hypr-action-pmr-study-targets-better-stroke-care,2023-07-17 13:23:00,Hyperfine's (HYPR) ACTION PMR study focuses on utilizing point-of-care brain imaging to identify strokes and salvageable brain tissue.,HOLX,0.194763,0.128762,Neutral
Here's Why You Should Retain Globus Medical  ( GMED )  Stock Now,https://www.zacks.com/stock/news/2122013/heres-why-you-should-retain-globus-medical-gmed-stock-now,2023-07-17 13:06:00,New product developments and the pending NuVasive acquisition raise optimism about the Globus Medical (GMED) stock.,HOLX,0.19661,0.112869,Neutral
"Hologic, Inc.  ( HOLX )  is Attracting Investor Attention: Here is What You Should Know",https://www.zacks.com/stock/news/2121993/hologic-inc-holx-is-attracting-investor-attention-here-is-what-you-should-know,2023-07-17 13:00:12,"Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",HOLX,0.484798,0.143716,Neutral
Thermo Fisher  ( TMO )  Launches Diomni Enterprise Software,https://www.zacks.com/stock/news/2121468/thermo-fisher-tmo-launches-diomni-enterprise-software,2023-07-14 14:40:00,"Thermo Fisher's (TMO) Diomni Enterprise Software effortlessly connects each individual processing stage to a single, integrated platform.",HOLX,0.233556,0.143084,Neutral
Glaukos  ( GKOS )  Stock Hits 52-Week High: More Room to Grow?,https://www.zacks.com/stock/news/2121294/glaukos-gkos-stock-hits-52-week-high-more-room-to-grow,2023-07-14 12:38:00,Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.,HOLX,0.170878,0.117202,Neutral
DexCom  ( DXCM )  Stock Hits 52-Week High: More Room to Grow?,https://www.zacks.com/stock/news/2121295/dexcom-dxcm-stock-hits-52-week-high-more-room-to-grow,2023-07-14 12:36:00,"DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.",HOLX,0.127231,0.099872,Neutral
Here's Why You Should Retain Merit Medical  ( MMSI )  Stock for Now,https://www.zacks.com/stock/news/2120777/heres-why-you-should-retain-merit-medical-mmsi-stock-for-now,2023-07-13 15:56:00,Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.,HOLX,0.20279,0.128072,Neutral
CVS Health  ( CVS )  Launches Caremark Cost Saver With a New Pact,https://www.zacks.com/stock/news/2120858/cvs-health-cvs-launches-caremark-cost-saver-with-a-new-pact,2023-07-13 15:42:00,CVS Health (CVS) is able to dynamically shop for the lowest price on its clients' behalf with the help of Caremark Cost Saver solution.,HOLX,0.204936,0.12911,Neutral
3 Reasons to Add Intuitive Surgical  ( ISRG )  to Your Portfolio,https://www.zacks.com/stock/news/2120724/3-reasons-to-add-intuitive-surgical-isrg-to-your-portfolio,2023-07-13 14:01:00,"Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.",HOLX,0.159218,0.113162,Neutral
Here's Why You Should Retain QIAGEN  ( QGEN )  Stock for Now,https://www.zacks.com/stock/news/2120112/heres-why-you-should-retain-qiagen-qgen-stock-for-now,2023-07-12 16:23:00,Investors remain optimistic about QIAGEN (QGEN) backed by the performance of the NGS portfolio and diagnostic solutions.,HOLX,0.185662,0.157976,Somewhat-Bullish
Illumina's  ( ILMN )  Latest Launch to Boost Genomics Analysis,https://www.zacks.com/stock/news/2120109/illuminas-ilmn-latest-launch-to-boost-genomics-analysis,2023-07-12 16:18:00,"Illumina's (ILMN) DRAGEN v4.2 is expected to improve the identification of genetic disease causes, drug discovery and population genomics.",HOLX,0.261818,0.158731,Somewhat-Bullish
Alcon  ( ALC )  Hits 52-Week High: What's Driving the Stock?,https://www.zacks.com/stock/news/2120134/alcon-alc-hits-52-week-high-whats-driving-the-stock,2023-07-12 15:41:00,"Investors are bullish about Alcon (ALC) owing to solid demand, strong commercial execution and pricing improvements across the Surgical and Vision Care franchises.",HOLX,0.213048,0.133053,Neutral
Here's Why You Should Retain CONMED  ( CNMD )  Stock for Now,https://www.zacks.com/stock/news/2120006/heres-why-you-should-retain-conmed-cnmd-stock-for-now,2023-07-12 13:57:00,"CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.",HOLX,0.143987,0.136391,Neutral
HISTORY BECKONS IN TORONTO AS STAR-STUDDED PLAYER FIELD FOR NATIONAL BANK OPEN PRESENTED BY ROGERS IS CONFIRMED,https://www.benzinga.com/pressreleases/23/07/n33198141/history-beckons-in-toronto-as-star-studded-player-field-for-national-bank-open-presented-by-rogers,2023-07-12 13:06:00,"Entry list headlined by World No. 1 Carlos Alcaraz, who will play his opening match during the night session of Wednesday, August 9 Milos Raonic, who receives a main draw wild card, joins fellow Canadians Félix Auger-Aliassime and Denis Shapovalov",HOLX,0.044222,0.091221,Neutral
HISTORY BECKONS IN TORONTO AS STAR-STUDDED PLAYER FIELD FOR NATIONAL BANK OPEN PRESENTED BY ROGERS IS CONFIRMED,https://www.newswire.ca/news-releases/history-beckons-in-toronto-as-star-studded-player-field-for-national-bank-open-presented-by-rogers-is-confirmed-847874976.html,2023-07-12 13:02:00,HISTORY BECKONS IN TORONTO AS STAR-STUDDED PLAYER FIELD FOR NATIONAL BANK OPEN PRESENTED ... Canada ...,HOLX,0.046452,0.091693,Neutral
Stryker  ( SYK )  Launches Q Guidance System for Cranial Surgeries,https://www.zacks.com/stock/news/2119937/stryker-syk-launches-q-guidance-system-for-cranial-surgeries,2023-07-12 13:01:00,"Stryker (SYK) launches its Q Guidance system with Cranial Guidance software, offering surgeons a comprehensive planning and guidance solution for complex cranial procedures.",HOLX,0.170878,0.118586,Neutral
Hologic  ( HOLX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2119494/hologic-holx-outpaces-stock-market-gains-what-you-should-know,2023-07-11 21:45:22,"Hologic (HOLX) closed at $79.10 in the latest trading session, marking a +0.7% move from the prior day.",HOLX,0.550532,0.321928,Somewhat-Bullish
DaVita  ( DVA )  Hits 52-Week High: What's Driving the Stock?,https://www.zacks.com/stock/news/2119343/davita-dva-hits-52-week-high-whats-driving-the-stock,2023-07-11 15:54:00,Investors are optimistic about DaVita's (DVA) strength in its kidney care.,HOLX,0.223866,0.140024,Neutral
Integra's  ( IART )  Codman EVD Catheter Study Data Favorable,https://www.zacks.com/stock/news/2119337/integras-iart-codman-evd-catheter-study-data-favorable,2023-07-11 14:50:00,Integra's (IART) Codman Bactiseal EVD lowers financial burdens and guarantees a safe clinical outcome in patients with aSAH-related hydrocephalus.,HOLX,0.157827,0.121735,Neutral
Here's Why You Should Add McKesson  ( MCK )  to Your Portfolio,https://www.zacks.com/stock/news/2119040/heres-why-you-should-add-mckesson-mck-to-your-portfolio,2023-07-11 12:03:00,McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.,HOLX,0.167709,0.118456,Neutral
"Alcon  ( ALC )  Surgical End Market Grows, Vision Care Sales Rise",https://www.zacks.com/stock/news/2118730/alcon-alc-surgical-end-market-grows-vision-care-sales-rise,2023-07-10 15:17:00,"In Equipment, Alcon (ALC) continues to upgrade and expand its installed base with the CENTURION and LEGION devices.",HOLX,0.229149,0.140926,Neutral
Here's Why Investors Should Hold Align Technology  ( ALGN )  Now,https://www.zacks.com/stock/news/2118775/heres-why-investors-should-hold-align-technology-algn-now,2023-07-10 15:07:00,Investors are optimistic about Align Technology's (ALGN) Invisalign portfolio expansion and strategic alliances.,HOLX,0.198221,0.144307,Neutral
Quest Diagnostics'  ( DGX )  New Pact to Get Home Fertility Test,https://www.zacks.com/stock/news/2118729/quest-diagnostics-dgx-new-pact-to-get-home-fertility-test,2023-07-10 14:15:00,The Proov Confirm home collection kit can be purchased now on Quest Diagnostics' questhealth.com for $29.,HOLX,0.201105,0.131919,Neutral
Here's Why You Should Retain Chemed  ( CHE )  Stock for Now,https://www.zacks.com/stock/news/2118588/heres-why-you-should-retain-chemed-che-stock-for-now,2023-07-10 12:25:00,Investors continue to be optimistic about Chemed (CHE) on the strength of the VITAS Healthcare and Roto-Rooter segments.,HOLX,0.201523,0.11345,Neutral
Stryker  ( SYK )  Launches Autonomous Guidance System for Surgeries,https://www.zacks.com/stock/news/2118541/stryker-syk-launches-autonomous-guidance-system-for-surgeries,2023-07-10 10:24:00,"Stryker's (SYK) fully autonomous Ortho Q Guidance system offers smart and streamlined workflow, leading to enhanced procedural speed and efficiency.",HOLX,0.172507,0.119361,Neutral
Breast Imaging Market is Expected to Reach $6.6 Billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/07/g33442720/breast-imaging-market-is-expected-to-reach-6-6-billion-marketsandmarkets,2023-07-28 13:30:00,"Chicago, July 28, 2023 ( GLOBE NEWSWIRE ) -- In the near future, the breast imaging industry is poised to witness significant advancements that will revolutionize breast cancer detection, diagnosis, and patient care.",HOLX,0.088799,0.129367,Neutral
"Zacks Industry Outlook Highlights Alcon, Hologic and Penumbra",https://www.zacks.com/stock/news/2126601/zacks-industry-outlook-highlights-alcon-hologic-and-penumbra,2023-07-25 08:46:00,"Alcon, Hologic and Penumbra have been highlighted in this Industry Outlook article.",HOLX,0.188823,0.160511,Somewhat-Bullish
Hologic  ( HOLX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2126454/hologic-holx-outpaces-stock-market-gains-what-you-should-know,2023-07-24 21:45:19,"In the latest trading session, Hologic (HOLX) closed at $81.32, marking a +0.54% move from the previous day.",HOLX,0.612521,0.33108,Somewhat-Bullish
Analysts Estimate Hologic  ( HOLX )  to Report a Decline in Earnings: What to Look Out for,https://www.zacks.com/stock/news/2126157/analysts-estimate-hologic-holx-to-report-a-decline-in-earnings-what-to-look-out-for,2023-07-24 14:00:36,Hologic (HOLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,HOLX,0.260189,-0.021961,Neutral
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends,https://www.zacks.com/commentary/2125940/3-medical-instruments-stocks-to-buy-amid-improving-industry-trends,2023-07-24 13:43:00,"The Zacks Medical - Instruments industry is growing on rising demand for digital health. ALC, HOLX and PEN are set to gain the most. Yet, ongoing inflation, in the form of rising freight and raw material costs, is disrupting the trend.",HOLX,0.166935,0.125799,Neutral
Breast Health Arm to Boost Hologic  ( HOLX )  in Q3 Earnings,https://www.zacks.com/stock/news/2126208/breast-health-arm-to-boost-hologic-holx-in-q3-earnings,2023-07-24 13:37:00,"Hologic's (HOLX) Breast Health is likely to have driven Q3 performance, owing to strong performance from improved semiconductor chip availability and strong backlog.",HOLX,0.454174,0.317049,Somewhat-Bullish
Hologic  ( HOLX )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2125604/hologic-holx-to-report-q3-earnings-whats-in-the-cards,2023-07-21 16:30:00,The growing adoption of Panther instruments and an expanded Panther installed base as well as strength in Breast Health is expected to have driven Hologic's (HOLX) Q3 revenues.,HOLX,0.364275,0.293274,Somewhat-Bullish
QIAGEN  ( QGEN )  Expands Digital PCR Offering With New Pact,https://www.zacks.com/stock/news/2124720/qiagen-qgen-expands-digital-pcr-offering-with-new-pact,2023-07-20 13:16:00,QIAGEN (QGEN) and Niba Labs can assist companies developing cell and gene therapies to overcome significant resource limitations and adhere to stringent project deadlines.,HOLX,0.147216,0.105338,Neutral
Here's Why You Should Retain Glaukos  ( GKOS )  in Your Portfolio,https://www.zacks.com/stock/news/2124342/heres-why-you-should-retain-glaukos-gkos-in-your-portfolio,2023-07-20 11:19:00,Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.,HOLX,0.171688,0.117583,Neutral
OraSure Technologies Elects Robert McMahon to the Board of Directors,https://www.globenewswire.com/news-release/2023/07/20/2708070/11732/en/OraSure-Technologies-Elects-Robert-McMahon-to-the-Board-of-Directors.html,2023-07-20 11:05:00,"BETHLEHEM, Pa., July 20, 2023 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. ( NASDAQ: OSUR ) , a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced today the election of Robert W.",HOLX,0.028868,0.175451,Somewhat-Bullish
OraSure Technologies Elects Robert McMahon to the Board of Directors - OraSure Technologies  ( NASDAQ:OSUR ) ,https://www.benzinga.com/pressreleases/23/07/g33299862/orasure-technologies-elects-robert-mcmahon-to-the-board-of-directors,2023-07-20 11:05:00,"BETHLEHEM, Pa., July 20, 2023 ( GLOBE NEWSWIRE ) -- OraSure Technologies, Inc. OSUR, a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced today the election of Robert W.",HOLX,0.028456,0.175152,Somewhat-Bullish
The MRI Systems Market to grow at a CAGR of 6.32% from 2022 to 20227|The technological advances in MRI to boost ... - PR Newswire,https://www.prnewswire.com/news-releases/the-mri-systems-market-to-grow-at-a-cagr-of-6-32-from-2022-to-20227the-technological-advances-in-mri-to-boost-market-growth--technavio-301894273.html,2023-08-08 02:30:00,The MRI Systems Market to grow at a CAGR of 6.32% from 2022 to 20227|The technological advances in MRI to boost ... PR ...,HOLX,0.042571,0.033,Neutral
Medical imaging market size to grow by USD 12.87 billion from 2022 to 2027 | Increasing prevalence of chronic ... - PR Newswire,https://www.prnewswire.com/news-releases/medical-imaging-market-size-to-grow-by-usd-12-87-billion-from-2022-to-2027--increasing-prevalence-of-chronic-conditions-drives-growth---technavio-301893116.html,2023-08-04 16:00:00,Medical imaging market size to grow by USD 12.87 billion from 2022 to 2027 | Increasing prevalence of chronic ... PR ...,HOLX,0.033562,0.145207,Neutral
Hologic  ( NASDAQ:HOLX )  Rating Increased to Strong-Buy at StockNews.com,https://www.defenseworld.net/2023/08/04/hologic-nasdaqholx-rating-increased-to-strong-buy-at-stocknews-com.html,2023-08-04 06:24:42,"Hologic ( NASDAQ:HOLX - Get Free Report ) was upgraded by investment analysts at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a report issued on Wednesday. A number of other equities research analysts also recently issued reports on the company.",HOLX,0.7877,0.433221,Bullish
"Hologic Stock Falls After Q3 Revenue Dip, But It Lifts Revenue and Profit Outlook - Hologic  ( NASDAQ:HOLX ) ",https://www.benzinga.com/news/earnings/23/08/33487982/hologic-stock-falls-after-q3-revenue-dip-but-it-lifts-revenue-and-profit-outlook,2023-08-01 19:49:38,"Hologic Inc HOLX posted Q3 adjusted EPS of $0.93, down from $0.95 a year ago and beating the consensus of $0.88.",HOLX,0.705799,0.158418,Somewhat-Bullish
"Hologic's  ( HOLX )  Q3 Earnings Beat Estimates, 2023 View Up",https://www.zacks.com/stock/news/2130597/hologics-holx-q3-earnings-beat-estimates-2023-view-up,2023-08-01 15:27:00,Strength in Breast Health and GYN Surgical drives Hologic's (HOLX) Q3 performance.,HOLX,0.302708,0.302844,Somewhat-Bullish
Hologic  ( HOLX )  Tops Q3 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2130087/hologic-holx-tops-q3-earnings-and-revenue-estimates,2023-07-31 21:25:08,"Hologic (HOLX) delivered earnings and revenue surprises of 5.68% and 2.85%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",HOLX,0.406745,0.249588,Somewhat-Bullish
"Global Clinical Laboratory Molecular Diagnostic for Infectious Disease Research 2023-2027: Focus on Respiratory, Blood Borne Virus, Transplant, HAIs, Reproductive Health, & C19 Singleplex",https://www.prnewswire.com/news-releases/global-clinical-laboratory-molecular-diagnostic-for-infectious-disease-research-2023-2027-focus-on-respiratory-blood-borne-virus-transplant-hais-reproductive-health--c19-singleplex-301889056.html,2023-07-31 09:45:00,Global Clinical Laboratory Molecular Diagnostic for Infectious Disease Research 2023-2027: Focus on Respiratory ... PR ...,HOLX,0.057079,-0.231,Somewhat-Bearish
3 Best Empower Mutual Funds to Buy for Solid Returns,https://www.zacks.com/stock/news/2136418/3-best-empower-mutual-funds-to-buy-for-solid-returns,2023-08-15 11:52:00,"Considering the prevailing market conditions, it would be wise for investors to explore the prospects offered by well-established Empower mutual funds such as MXLSX, MXMGX and MXSHX.",HOLX,0.058759,0.0,Neutral
The Medical Aesthetics Market to grow at a CAGR of 8.6% from 2022 to 2027; Increasing global awareness about ... - PR Newswire,https://www.prnewswire.com/news-releases/the-medical-aesthetics-market-to-grow-at-a-cagr-of-8-6-from-2022-to-2027-increasing-global-awareness-about-medical-aesthetics-to-boost-market-growth---technavio-301898792.html,2023-08-14 09:00:00,The Medical Aesthetics Market to grow at a CAGR of 8.6% from 2022 to 2027. Increasing global awareness about ... PR ...,HOLX,0.056674,0.0,Neutral
"Investors Heavily Search Hologic, Inc.  ( HOLX ) : Here is What You Need to Know",https://www.zacks.com/stock/news/2135590/investors-heavily-search-hologic-inc-holx-here-is-what-you-need-to-know,2023-08-11 13:00:10,"Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",HOLX,0.488469,0.098606,Neutral
Hologic  ( NASDAQ:HOLX )  Rating Lowered to Buy at StockNews.com,https://www.defenseworld.net/2023/08/10/hologic-nasdaqholx-rating-lowered-to-buy-at-stocknews-com.html,2023-08-10 08:50:42,"Hologic ( NASDAQ:HOLX - Get Free Report ) was downgraded by research analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued on Thursday. HOLX has been the topic of several other research reports.",HOLX,0.821469,0.484464,Bullish
Here's Why You Should Retain Hologic  ( HOLX )  Stock for Now,https://www.zacks.com/stock/news/2140464/heres-why-you-should-retain-hologic-holx-stock-for-now,2023-08-24 15:35:00,"Investors are optimistic about Hologic (HOLX) on the expanded global installed base of more than 3,250 Panthers instruments, representing the catalyst for sustained growth.",HOLX,0.264515,0.259488,Somewhat-Bullish
"Hologic, Inc.  ( HOLX )  Is a Trending Stock: Facts to Know Before Betting on It",https://www.zacks.com/stock/news/2139374/hologic-inc-holx-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-08-22 21:53:17,"Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",HOLX,0.482982,0.094844,Neutral
Cutting-Edge Biopsy Technologies Expected To Drive Biopsy Devices Market In The Forecast Period 2023-2027 As Per The Business Research Company's Biopsy Devices Global Market Report 2023,https://www.benzinga.com/pressreleases/23/08/g33966109/cutting-edge-biopsy-technologies-expected-to-drive-biopsy-devices-market-in-the-forecast-period-20,2023-08-21 15:30:00,"LONDON, Aug. 21, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company, the global biopsy devices market continues to thrive, displaying remarkable resilience and growth amidst a complex global landscape.",HOLX,0.059049,0.098996,Neutral
Sense Arena's Partnership With ATP Tour Brings Optimism On Use Of Virtual Reality For Cognitive Training,https://www.forbes.com/sites/mattrybaltowski/2023/09/07/sense-arenas-partnership-with-atp-tour-brings-optimism-on-use-of-virtual-reality-for-cognitive-training/,2023-09-07 18:57:23,"New partnership with ATP raises questions on if top players will use virtual reality to optimize visualization, mental conditioning, and reaction time in tennis.",HOLX,0.027958,0.056671,Neutral
Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer,https://www.globenewswire.com/news-release/2023/09/07/2739181/0/en/Renalytix-Appoints-Senior-Executive-Howard-Doran-as-Chief-Business-Officer.html,2023-09-07 11:00:00,Doran Brings Significant Diagnostics Sector Experience to Lead the KidneyIntelX Global Sales Effort Doran Brings Significant Diagnostics Sector Experience to Lead the KidneyIntelX Global Sales Effort ...,HOLX,0.055881,0.051963,Neutral
Hologic  ( HOLX )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2145059/hologic-holx-dips-more-than-broader-markets-what-you-should-know,2023-09-05 21:45:21,"Hologic (HOLX) closed the most recent trading day at $74.06, moving -1.41% from the previous trading session.",HOLX,0.614479,0.096539,Neutral
Breast Imaging Devices Market Is Expected To Grow At A Rate Of More Than 5% With Rising Prevalence Of Breast Cancer As Per The Business Research Company's Breast Imaging Devices Global Market Report 2023,https://www.benzinga.com/pressreleases/23/09/g34211679/breast-imaging-devices-market-is-expected-to-grow-at-a-rate-of-more-than-5-with-rising-prevalence-,2023-09-04 15:30:00,"LONDON, Sept. 04, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company, the breast imaging devices market size increased from $4.31 billion in 2022 to $4.53 billion in 2023, marking a notable compound annual growth rate ( CAGR ) of 5.2%.",HOLX,0.063763,0.062027,Neutral
"Hologic, Inc.  ( HOLX )  is Attracting Investor Attention: Here is What You Should Know",https://www.zacks.com/stock/news/2144203/hologic-inc-holx-is-attracting-investor-attention-here-is-what-you-should-know,2023-09-04 13:00:10,"Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",HOLX,0.49219,0.083826,Neutral
Why Is Penumbra  ( PEN )  Down 2.1% Since Last Earnings Report?,https://www.zacks.com/stock/news/2143134/why-is-penumbra-pen-down-21-since-last-earnings-report,2023-08-31 15:31:23,Penumbra (PEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,HOLX,0.215415,0.060477,Neutral
"Is Trending Stock Hologic, Inc.  ( HOLX )  a Buy Now?",https://www.zacks.com/stock/news/2149391/is-trending-stock-hologic-inc-holx-a-buy-now,2023-09-15 13:00:12,"Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",HOLX,0.482982,0.085913,Neutral
Hologic  ( HOLX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2147435/hologic-holx-outpaces-stock-market-gains-what-you-should-know,2023-09-11 21:45:17,"Hologic (HOLX) closed at $72.79 in the latest trading session, marking a +0.78% move from the prior day.",HOLX,0.620415,0.270995,Somewhat-Bullish
Kazakhstan Tennis Federation Anna Danilina claims US Open Championship,https://www.benzinga.com/pressreleases/23/09/n34436724/kazakhstan-tennis-federation-anna-danilina-claims-us-open-championship,2023-09-11 12:01:00,"ASTANA, Kazakhstan, Sept. 11, 2023 /PRNewswire/ -- Anna Danilina together with Finnish player Harri Heliovaara won the US Open 2023 mixed doubles title. In the finals, the Kazakh-Finnish duo defeated top seeds Americans Jessica Pegula and Austin Krajicek 6:3, 6:4.",HOLX,0.124809,0.157304,Somewhat-Bullish
"Here is What to Know Beyond Why Hologic, Inc.  ( HOLX )  is a Trending Stock",https://www.zacks.com/stock/news/2156085/here-is-what-to-know-beyond-why-hologic-inc-holx-is-a-trending-stock,2023-09-27 13:00:10,"Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",HOLX,0.486627,0.09245,Neutral
Hologic  ( HOLX )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2155095/hologic-holx-stock-sinks-as-market-gains-what-you-should-know,2023-09-25 21:45:18,"Hologic (HOLX) closed the most recent trading day at $70.13, moving -0.11% from the previous trading session.",HOLX,0.552443,0.250222,Somewhat-Bullish
"Global COVID-19 Testing Strategic Business Report 2023: Market to Reach $5.8 Billion by 2030, Declining by 16.3% - US and Europe Dominate, Asia-Pacific to Witness Fastest Growth",https://www.prnewswire.com/news-releases/global-covid-19-testing-strategic-business-report-2023-market-to-reach-5-8-billion-by-2030--declining-by-16-3---us-and-europe-dominate-asia-pacific-to-witness-fastest-growth-301936075.html,2023-09-22 18:45:00,"Global COVID-19 Testing Strategic Business Report 2023: Market to Reach $5.8 Billion by 2030, Declining by 16.3 ... PR ...",HOLX,0.048919,0.121643,Neutral
Hologic  ( HOLX )  to Boost Breast Imaging Modality With New Pact,https://www.zacks.com/stock/news/2154388/hologic-holx-to-boost-breast-imaging-modality-with-new-pact,2023-09-22 15:50:00,Hologic's (HOLX) collaboration with Bayer will enable physicians everywhere to include CEM in their breast cancer diagnosis workflows.,HOLX,0.431371,0.213255,Somewhat-Bullish
Biopsy Market to grow at a CAGR of 11.14% during the forecast period reaching USD 61.03 Bn. by 2029 - says Maximize Market Research,https://www.benzinga.com/pressreleases/23/09/g34788934/biopsy-market-to-grow-at-a-cagr-of-11-14-during-the-forecast-period-reaching-usd-61-03-bn-by-2029-,2023-09-21 11:41:19,"Pune, Sept. 21, 2023 ( GLOBE NEWSWIRE ) -- A global healthcare business-consulting firm, Maximize Market Research, has published a market intelligence and competitive landscape report on the ""Biopsy Market"".",HOLX,0.029618,0.028382,Neutral
Hologic  ( HOLX )  Gains From New Launches as Macro Concerns Rise,https://www.zacks.com/stock/news/2153170/hologic-holx-gains-from-new-launches-as-macro-concerns-rise,2023-09-20 15:10:00,"Hologic (HOLX) has been making impressive progress in its Breast Health arm, leveraging its strategic expansion efforts to diversify business across the patient continuum of care.",HOLX,0.300088,0.141307,Neutral
Hologic  ( HOLX )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2152130/hologic-holx-outpaces-stock-market-gains-what-you-should-know,2023-09-18 21:45:19,"Hologic (HOLX) closed the most recent trading day at $72, moving +0.26% from the previous trading session.",HOLX,0.624423,0.366037,Bullish
"Molecular Diagnostic for Infectious Diseases Market Size Worth $17.61 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35063825/molecular-diagnostic-for-infectious-diseases-market-size-worth-17-61-billion-globally-by-2030-excl,2023-10-03 13:29:52,"Pune, India, Oct. 03, 2023 ( GLOBE NEWSWIRE ) -- Molecular diagnostics is referred to as the detection of genomic variants, aiming to facilitate detection, diagnosis, subclassification, prognosis, and monitoring response to therapy.",HOLX,0.022643,0.082167,Neutral
Hologic  ( HOLX )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2158854/hologic-holx-stock-sinks-as-market-gains-what-you-should-know,2023-10-02 21:45:18,"Hologic (HOLX) closed the most recent trading day at $68.87, moving -0.76% from the previous trading session.",HOLX,0.705377,0.242873,Somewhat-Bullish
Here's Why You Should Retain Hologic  ( HOLX )  Stock for Now,https://www.zacks.com/stock/news/2157011/heres-why-you-should-retain-hologic-holx-stock-for-now,2023-09-28 13:16:00,"Investors continue to remain optimistic about Hologic (HOLX), backed by the Breast Health business' performance and international execution.",HOLX,0.342093,0.355507,Bullish
Hologic  ( HOLX )  Ascends But Remains Behind Market: Some Facts to Note,https://www.zacks.com/stock/news/2166733/hologic-holx-ascends-but-remains-behind-market-some-facts-to-note,2023-10-16 21:45:19,"In the latest trading session, Hologic (HOLX) closed at $69.22, marking a +0.35% move from the previous day.",HOLX,0.560201,0.277414,Somewhat-Bullish
Breast Cancer Awareness Month: Tennis great Martina Navratilova shares journey of her dual cancer battle,https://www.foxbusiness.com/sports/breast-cancer-awareness-month-tennis-great-martina-navratilova-shares-journey-her-dual-cancer-battle,2023-10-15 19:47:14,Breast Cancer Awareness Month: Tennis great Martina Navratilova ... Fox Business ...,HOLX,0.067347,0.063164,Neutral
Hologic  ( HOLX )  to Elevate OB-GYN Training With New Partnerships,https://www.zacks.com/stock/news/2164736/hologic-holx-to-elevate-ob-gyn-training-with-new-partnerships,2023-10-12 12:33:00,Hologic's (HOLX) collaboration with AAGL and Inovus Medical is likely to optimize OB-GYN training for minimally invasive surgeries.,HOLX,0.351273,0.304354,Somewhat-Bullish
Hologic  ( HOLX )  Rises Yet Lags Behind Market: Some Facts Worth Knowing,https://www.zacks.com/stock/news/2162946/hologic-holx-rises-yet-lags-behind-market-some-facts-worth-knowing,2023-10-09 21:45:20,"The latest trading day saw Hologic (HOLX) settling at $70.25, representing a +0.59% change from its previous close.",HOLX,0.602879,0.287156,Somewhat-Bullish
"Investors Heavily Search Hologic, Inc.  ( HOLX ) : Here is What You Need to Know",https://www.zacks.com/stock/news/2162518/investors-heavily-search-hologic-inc-holx-here-is-what-you-need-to-know,2023-10-09 13:00:10,"Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",HOLX,0.484798,0.11909,Neutral
Hologic  ( HOLX )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2173798/hologic-holx-to-report-q4-earnings-whats-in-the-cards,2023-10-27 13:03:00,Strength in Breast Health and GYN Surgical businesses will likely drive Hologic's (HOLX) Q4 revenues.,HOLX,0.306484,0.274841,Somewhat-Bullish
"Test Strip Market Growth Worth $12.5 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35410612/test-strip-market-growth-worth-12-5-billion-globally-by-2030-exclusive-report-by-the-insight-partn,2023-10-25 09:40:48,"Pune, India, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- A test strip is crucial for the medical diagnostics industry, especially for blood sugar testing and urinalysis. Test strips consist of multiple layers, including hydrophilic inner, adhesive, and electrode layers and an outer layer that provides ...",HOLX,0.041039,0.179466,Somewhat-Bullish
"Rapid Influenza Diagnostic Tests Market Worth Nearly $2 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35410282/rapid-influenza-diagnostic-tests-market-worth-nearly-2-billion-globally-by-2030-exclusive-report-b,2023-10-25 09:06:59,"Pune, India, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- According to our new research study on ""Rapid Influenza Diagnostic Tests Market covers analysis By Test Type ( Influenza A Tests, Influenza B Test, and Influenza A+B Test ). Sample Type ( Nasal Swab, Throat Swab, Nasopharyngeal Swab, and Others ).",HOLX,0.040348,0.10201,Neutral
Here's Why Hologic  ( HOLX )  Fell More Than Broader Market,https://www.zacks.com/stock/news/2170456/heres-why-hologic-holx-fell-more-than-broader-market,2023-10-23 21:45:17,"In the most recent trading session, Hologic (HOLX) closed at $67.56, indicating a -0.37% shift from the previous trading day.",HOLX,0.541149,0.164875,Somewhat-Bullish
"Hologic, Inc.  ( HOLX )  Is a Trending Stock: Facts to Know Before Betting on It",https://www.zacks.com/stock/news/2169503/hologic-inc-holx-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-10-20 13:00:10,"Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",HOLX,0.489394,0.107843,Neutral
Unveiling Hologic  ( HOLX )  Q4 Outlook: Wall Street Estimates for Key Metrics,https://www.zacks.com/stock/news/2179271/unveiling-hologic-holx-q4-outlook-wall-street-estimates-for-key-metrics,2023-11-06 14:57:00,"Besides Wall Street's top -and-bottom-line estimates for Hologic (HOLX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2023.",HOLX,0.379435,0.121911,Neutral
3D Ultrasound Market is to grow by USD 1.33 billion from 2023 to 2028- Technavio - PR Newswire,https://www.prnewswire.com/news-releases/3d-ultrasound-market-is-to-grow-by-usd-1-33-billion-from-2023-to-2028--technavio-301976695.html,2023-11-03 21:15:00,3D Ultrasound Market is to grow by USD 1.33 billion from 2023 to 2028- Technavio PR ...,HOLX,0.069495,0.034099,Neutral
Hologic  ( HOLX )  Earnings Expected to Grow: Should You Buy?,https://www.zacks.com/stock/news/2177354/hologic-holx-earnings-expected-to-grow-should-you-buy,2023-11-02 14:00:42,Hologic (HOLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,HOLX,0.262994,0.128355,Neutral
"Hologic, Inc.  ( HOLX )  is Attracting Investor Attention: Here is What You Should Know",https://www.zacks.com/stock/news/2176175/hologic-inc-holx-is-attracting-investor-attention-here-is-what-you-should-know,2023-11-01 13:00:10,"Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",HOLX,0.49407,0.108499,Neutral
"Medical Digital Imaging System Market Size is Projected to Reach $31.45 Billion by 2030, Driven by Rising Demand for Growing Public Recognition of The Significance of Early Disease Detection",https://www.benzinga.com/pressreleases/23/10/g35522998/medical-digital-imaging-system-market-size-is-projected-to-reach-31-45-billion-by-2030-driven-by-r,2023-10-31 19:00:00,"New York, United States, Oct. 31, 2023 ( GLOBE NEWSWIRE ) -- A medical digital imaging system refers to the use of a variety of imaging techniques to obtain visual representations of the interior of the human body for therapeutic and diagnostic purposes.",HOLX,0.130926,0.2449,Somewhat-Bullish
Hologic  ( HOLX )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2174827/hologic-holx-gains-but-lags-market-what-you-should-know,2023-10-30 21:45:20,"Hologic (HOLX) reachead $65.37 at the closing of the latest trading day, reflecting a +0.4% change compared to its last close.",HOLX,0.568148,0.246082,Somewhat-Bullish
"Hysteroscopy Procedures Market to Exceed USD 9 billion by 2032, Expanding at a CAGR of 8.4%: TMR Report",https://www.benzinga.com/pressreleases/23/10/g35496749/hysteroscopy-procedures-market-to-exceed-usd-9-billion-by-2032-expanding-at-a-cagr-of-8-4-tmr-repo,2023-10-30 17:30:00,"Wilmington, Delaware, United States, Oct. 30, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global hysteroscopy procedures market is projected to flourish at a CAGR of 8.4% from 2022 to 2032. As per the report published by TMR, a valuation of US$ billion is anticipated for ...",HOLX,0.047654,0.049956,Neutral
Hologic  ( HOLX )  Q4 Earnings Might Rise on 7.7% Breast Health Growth,https://www.zacks.com/stock/news/2174620/hologic-holx-q4-earnings-might-rise-on-77-breast-health-growth,2023-10-30 14:03:00,Strength in Breast Health and growing Panther instrument installed base will likely benefit Hologic's (HOLX) Q4 performance.,HOLX,0.344987,0.338837,Somewhat-Bullish
"10 'better values' in the stock market, selected for the next two years",https://www.marketwatch.com/story/10-better-values-in-the-stock-market-selected-for-the-next-two-years-5b9bc809,2023-11-16 17:49:00,"William Blair's list of favored stocks for the next 24 months includes Five Below, Chewy and Allstate.",HOLX,0.06471,0.090227,Neutral
"Hologic, Inc.  ( HOLX )  Is a Trending Stock: Facts to Know Before Betting on It",https://www.zacks.com/stock/news/2183208/hologic-inc-holx-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-11-13 14:00:10,"Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.",HOLX,0.491255,0.138415,Neutral
Stock market today: Asian shares are mostly lower in quiet trading ahead of Biden-Xi meeting,https://apnews.com/article/stock-market-oil-china-biden-6fc2d65e49b4912e57f4a8df87ac795d,2023-11-13 03:18:00,"HONG KONG ( AP ) - Shares edged lower Monday in quiet trading in Asia ahead of a meeting this week between U.S. President Joe Biden and Chinese leader Xi Jinping. Tokyo advanced but other markets were little changed, edging lower. Oil prices fell.",HOLX,0.061315,0.296399,Somewhat-Bullish
"Big Stocks Moving Higher On Friday: Synaptics Reports Q1 Beat; Joins Lyft, Hologic, Blink Charging - AvePoint  ( NASDAQ:AVPT ) , Alarm.com Holdings  ( NASDAQ:ALRM ) ",https://www.benzinga.com/news/23/11/35727609/big-stocks-moving-higher-on-friday-synaptics-reports-q1-beat-joins-lyft-hologic-blink-charging,2023-11-10 16:51:36,"U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Friday. Shares of Synaptics Incorporated SYNA rose sharply on Friday after the company reported better-than-expected quarterly financial results. Synaptics posted adjusted earnings of 52 cents per share, beating market ...",HOLX,0.171485,0.37426,Bullish
"Hologic's  ( HOLX )  Q4 Earnings Beat Estimates, Gross Margin Down",https://www.zacks.com/stock/news/2182249/hologics-holx-q4-earnings-beat-estimates-gross-margin-down,2023-11-10 14:02:00,Solid year-over-year growth in the Breast Health segment drives Hologic's (HOLX) Q4 performance.,HOLX,0.303644,0.326171,Somewhat-Bullish
"US Stocks Could Wobble As Powell's Inflation Obsession Intensifies Rate Uncertainty: Will Nasdaq Wipe Off Week's Gains? - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/11/35722783/us-stocks-could-wobble-as-powells-inflation-obsession-intensifies-rate-uncertainty-will-nasdaq-wipe,2023-11-10 12:08:17,"U.S. stocks are priming for a lackluster open on Friday, with the index futures trading on a narrowly mixed note. Interest rate worries have likely perked up, as reflected by the upward move in bond yields. Traders are also left to digest some disappointing earnings reports.",HOLX,0.098255,-0.028445,Neutral
"The Influenza Diagnostics Market size to grow at a CAGR of 6.95% from 2022 to 2027|Abbott Laboratories, Becton ... - PR Newswire",https://www.prnewswire.com/news-releases/the-influenza-diagnostics-market-size-to-grow-at-a-cagr-of-6-95-from-2022-to-2027abbott-laboratories-becton-dickinson-and-co-bico-group-ab-and-more-among-the-key-companies-in-the-market--technavio-301983746.html,2023-11-10 02:30:00,"The Influenza Diagnostics Market size to grow at a CAGR of 6.95% from 2022 to 2027|Abbott Laboratories, Becton ... PR ...",HOLX,0.042723,0.105666,Neutral
"S&P 500, Nasdaq Futures Mixed: Wall Street To Snap Longest Rally Since 2021? - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/11/35697040/wall-streets-longest-winning-streak-since-2021-to-snap-today-earnings-bond-yields-in-focus-ahead-of,2023-11-09 12:25:02,"The stock market's momentum appears to be waning, and futures suggest a mixed opening for Thursday. Earnings reports have generally been positive, with companies like Walt Disney Co. DIS posting encouraging quarterly results.",HOLX,0.082535,-0.051986,Neutral
"Hologic, Inc.  ( HOLX )  is Attracting Investor Attention: Here is What You Should Know",https://www.zacks.com/stock/news/2188951/hologic-inc-holx-is-attracting-investor-attention-here-is-what-you-should-know,2023-11-24 14:00:12,"Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",HOLX,0.483888,0.154749,Somewhat-Bullish
Isothermal Nucleic Acid Amplification Technology Market worth $8.83 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.,https://www.prnewswire.com/news-releases/isothermal-nucleic-acid-amplification-technology-market-worth-8-83-bn-by-2031---exclusive-report-by-insightace-analytic-pvt-ltd-301997023.html,2023-11-24 08:09:00,Isothermal Nucleic Acid Amplification Technology Market worth $8.83 Bn by 2031 - Exclusive Report by InsightAce ... PR ...,HOLX,0.039878,0.100881,Neutral
Human immunodeficiency virus (HIV) rapid test kits market to grow by USD 294.96 million from 2023 to 2028; North ... - PR Newswire,https://www.prnewswire.com/news-releases/human-immunodeficiency-virus-hiv-rapid-test-kits-market-to-grow-by-usd-294-96-million-from-2023-to-2028-north-america-to-account-for-40-of-market-growth--technavio-301991616.html,2023-11-17 19:00:00,Human immunodeficiency virus ( HIV ) rapid test kits market to grow by USD 294.96 million from 2023 to 2028. North ... PR ...,HOLX,0.070105,0.062237,Neutral
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities,https://www.prnewswire.com/news-releases/novavax-makes-changes-to-executive-leadership-team-to-enhance-focus-on-delivery-of-strategic-priorities-301991645.html,2023-11-17 12:15:00,• New organizational structure for executive leadership team designed to facilitate a leaner and more focused approach to annual execution of business plans • to join as Chief Legal Officer and Corporate Secretary,HOLX,0.03468,0.079721,Neutral
"Syphilis Testing Market size to grow by USD 2.22 billion from 2023-2028 | Abbott Laboratories, AdvaCare Pharma ... - PR Newswire",https://www.prnewswire.com/news-releases/syphilis-testing-market-size-to-grow-by-usd-2-22-billion-from-2023-2028--abbott-laboratories-advacare-pharma-beckman-coulter-inc-and-more-among-the-key-companies-in-the-market---technavio-302006630.html,2023-12-05 23:45:00,"Syphilis Testing Market size to grow by USD 2.22 billion from 2023-2028 | Abbott Laboratories, AdvaCare Pharma ... PR ...",HOLX,0.032871,0.032638,Neutral
"Investors Heavily Search Hologic, Inc.  ( HOLX ) : Here is What You Need to Know",https://www.zacks.com/stock/news/2193502/investors-heavily-search-hologic-inc-holx-here-is-what-you-need-to-know,2023-12-05 14:00:10,"Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",HOLX,0.491255,0.1683,Somewhat-Bullish
"Hologic  ( NASDAQ:HOLX )  Upgraded to ""Buy"" at StockNews.com",https://www.defenseworld.net/2023/12/05/hologic-nasdaqholx-upgraded-to-buy-at-stocknews-com.html,2023-12-05 06:14:44,"Hologic ( NASDAQ:HOLX - Get Free Report ) was upgraded by equities research analysts at StockNews.com from a ""hold"" rating to a ""buy"" rating in a research note issued to investors on Tuesday.",HOLX,0.800782,0.378608,Bullish
"Diagnostic imaging market size to grow by USD 8.69 billion from 2022 -2027 | Agfa Gevaert NV, Allengers Medical ... - PR Newswire",https://www.prnewswire.com/news-releases/diagnostic-imaging-market-size-to-grow-by-usd-8-69-billion-from-2022--2027--agfa-gevaert-nv-allengers-medical-systems-ltd-and-more-among-the-key-companies-in-the-market--technavio-302003985.html,2023-12-04 09:15:00,"Diagnostic imaging market size to grow by USD 8.69 billion from 2022 -2027 | Agfa Gevaert NV, Allengers Medical ... PR ...",HOLX,0.055492,0.045887,Neutral
"Hologic  ( NASDAQ:HOLX )  Downgraded by StockNews.com to ""Hold""",https://www.defenseworld.net/2023/11/28/hologic-nasdaqholx-downgraded-by-stocknews-com-to-hold.html,2023-11-28 07:56:43,StockNews.com cut shares of Hologic ( NASDAQ:HOLX - Free Report ) from a buy rating to a hold rating in a report issued on Monday. Other research analysts also recently issued reports about the stock.,HOLX,0.822186,0.340958,Somewhat-Bullish
Here's Why Hologic  ( HOLX )  Gained But Lagged the Market Today,https://www.zacks.com/stock/news/2198298/heres-why-hologic-holx-gained-but-lagged-the-market-today,2023-12-14 22:45:16,"Hologic (HOLX) reachead $71.09 at the closing of the latest trading day, reflecting a +0.08% change compared to its last close.",HOLX,0.600271,0.183977,Somewhat-Bullish
Hologic  ( NASDAQ:HOLX )  Lowered to Hold at StockNews.com,https://www.defenseworld.net/2023/12/14/hologic-nasdaqholx-lowered-to-hold-at-stocknews-com.html,2023-12-14 09:31:31,StockNews.com downgraded shares of Hologic ( NASDAQ:HOLX - Free Report ) from a buy rating to a hold rating in a research report report published on Wednesday.,HOLX,0.756655,0.314538,Somewhat-Bullish
3 MedTech Stocks With Potential to Benefit From AI Boom in 2024,https://www.zacks.com/stock/news/2200918/3-medtech-stocks-with-potential-to-benefit-from-ai-boom-in-2024,2023-12-21 12:37:00,"Investors looking to tap the budding prospects in the lucrative AI market in 2024 can count on Medtronic (MDT), GE HealthCare Technologies (GEHC) and Hologic (HOLX).",HOLX,0.165258,0.27633,Somewhat-Bullish
Hologic  ( HOLX )  Stock Moves -1.17%: What You Should Know,https://www.zacks.com/stock/news/2200753/hologic-holx-stock-moves--117-what-you-should-know,2023-12-20 22:45:21,"In the most recent trading session, Hologic (HOLX) closed at $70.32, indicating a -1.17% shift from the previous trading day.",HOLX,0.635085,0.186807,Somewhat-Bullish
Here's Why You Should Retain Hologic  ( HOLX )  Stock for Now,https://www.zacks.com/stock/news/2199227/heres-why-you-should-retain-hologic-holx-stock-for-now,2023-12-18 12:39:00,"Investors are optimistic about Hologic (HOLX), which is led by growth with recovery in procedural volumes and acceleration from new business lines.",HOLX,0.272788,0.210232,Somewhat-Bullish
Generative AI Reshapes Healthcare: 3 Stocks in Limelight,https://www.zacks.com/stock/news/2206515/generative-ai-reshapes-healthcare-3-stocks-in-limelight,2024-01-05 17:53:00,"Stocks like Medtronic (MDT), Stryker (SYK) and NVIDIA (NVDA) are likely to benefit from the rising prospects of Generative AI in healthcare.",HOLX,0.070725,0.14788,Neutral
"Ultrasound Equipment Market is to grow by USD 2.98 billion from 2023 to 2028, North America to account for 36% of ... - PR Newswire",https://www.prnewswire.com/news-releases/ultrasound-equipment-market-is-to-grow-by-usd-2-98-billion-from-2023-to-2028--north-america-to-account-for-36-of-market-growth--technavio-302026161.html,2024-01-05 01:00:00,"Ultrasound Equipment Market is to grow by USD 2.98 billion from 2023 to 2028, North America to account for 36% of ... PR ...",HOLX,0.062761,0.0,Neutral
Hologic  ( HOLX )  Increases Despite Market Slip: Here's What You Need to Know,https://www.zacks.com/stock/news/2204642/hologic-holx-increases-despite-market-slip-heres-what-you-need-to-know,2024-01-02 22:45:19,"Hologic (HOLX) concluded the recent trading session at $72.46, signifying a +1.41% move from its prior day's close.",HOLX,0.610329,0.145215,Neutral
"Bone Densitometer Market Analysis 2024-2033: Expected Market Size, Major Drivers And Key Trends As Per The Business Research Company's Bone Densitometer Global Market Report 2024",https://www.benzinga.com/pressreleases/24/01/g36454828/bone-densitometer-market-analysis-2024-2033-expected-market-size-major-drivers-and-key-trends-as-p,2024-01-02 16:30:00,"LONDON, Jan. 02, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Bone Densitometer Global Market Report 2024, the bone densitometer market has exhibited a robust trajectory in recent years, poised to continue its upward trend.",HOLX,0.062597,0.160116,Somewhat-Bullish
"The Zacks Analyst Blog Highlights DaVita, GE HealthCare Technologies and Hologic",https://www.zacks.com/stock/news/2203126/the-zacks-analyst-blog-highlights-davita-ge-healthcare-technologies-and-hologic,2023-12-28 14:16:00,"DaVita, GE HealthCare Technologies and Hologic are part of the Zacks top Analyst Blog.",HOLX,0.200355,0.110602,Neutral
Hologic  ( HOLX )  Stock Falls Amid Market Uptick: What Investors Need to Know,https://www.zacks.com/stock/news/2202854/hologic-holx-stock-falls-amid-market-uptick-what-investors-need-to-know,2023-12-27 22:45:19,"Hologic (HOLX) closed the most recent trading day at $70.94, moving -0.24% from the previous trading session.",HOLX,0.618922,0.290582,Somewhat-Bullish
3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2024,https://www.zacks.com/stock/news/2202667/3-beaten-down-medtech-stocks-poised-for-a-turnaround-in-2024,2023-12-27 15:17:00,"Here are some dirt-cheap MedTech value stocks - DVA, GEHC, HOLX - which are expected to provide long-term gains.",HOLX,0.158781,0.120011,Neutral
"Hologic, Inc.  ( HOLX )  Is a Trending Stock: Facts to Know Before Betting on It",https://www.zacks.com/stock/news/2202548/hologic-inc-holx-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-12-27 14:00:13,"Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.",HOLX,0.486627,0.122774,Neutral
"Mammography Market Worth US$ 6.9 Billion by 2033, By Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36625595/mammography-market-worth-us-6-9-billion-by-2033-by-persistence-market-research,2024-01-14 19:15:00,"New York, Jan. 15, 2024 ( GLOBE NEWSWIRE ) -- Mammography Market: A Snapshot and Growth Projections Mammography is a diagnostic imaging technique specifically designed for breast examination, playing a pivotal role in the early detection of breast cancer.",HOLX,0.035424,0.201306,Somewhat-Bullish
X-Ray Equipment Market to grow by USD 14.97 billion by 2027 with a CAGR of 6.2% between 2022 to 2027; Market ... - PR Newswire,https://www.prnewswire.com/news-releases/x-ray-equipment-market-to-grow-by-usd-14-97-billion-by-2027-with-a-cagr-of-6-2-between-2022-to-2027-market-size-share--trends-analysis-report--technavio-302032924.html,2024-01-12 01:30:00,X-Ray Equipment Market to grow by USD 14.97 billion by 2027 with a CAGR of 6.2% between 2022 to 2027. Market ... PR ...,HOLX,0.049732,0.0,Neutral
"Strength Seen in Intuitive Surgical, Inc.  ( ISRG ) : Can Its 10.3% Jump Turn into More Strength?",https://www.zacks.com/stock/news/2208841/strength-seen-in-intuitive-surgical-inc-isrg-can-its-103-jump-turn-into-more-strength,2024-01-11 14:19:00,"Intuitive Surgical, Inc. (ISRG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.",HOLX,0.572601,-0.087397,Neutral
"Influenza Diagnostics Market Expected to Exceed USD 2.0 billion by 2031, at a CAGR 5.6%| Analysis by Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36575512/influenza-diagnostics-market-expected-to-exceed-usd-2-0-billion-by-2031-at-a-cagr-5-6-analysis-by-,2024-01-10 13:40:49,"Wilmington, Delaware, United States, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global influenza diagnostics market is estimated to flourish at a CAGR of 5.6% from 2023 to 2031.",HOLX,0.032781,0.315643,Somewhat-Bullish
"Mammography Systems Market to be Worth USD 3.7 billion by 2031: Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36571411/mammography-systems-market-to-be-worth-usd-3-7-billion-by-2031-transparency-market-research-inc,2024-01-10 08:16:34,"Wilmington, Delaware, United States, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The mammography systems market was valued at US$ 2.1 billion in 2022. The market is expected to expand at a CAGR of 6.3% from 2023 to 2031, reaching US$ 3.7 billion by 2031.",HOLX,0.036037,-0.107337,Neutral
Hologic  ( HOLX )  Advances While Market Declines: Some Information for Investors,https://www.zacks.com/stock/news/2207772/hologic-holx-advances-while-market-declines-some-information-for-investors,2024-01-09 22:45:20,"Hologic (HOLX) closed at $72.12 in the latest trading session, marking a +1.11% move from the prior day.",HOLX,0.606946,0.248638,Somewhat-Bullish
"Breast Biopsy Market Set to Achieve US$ 3.8 Billion in Revenue by 2033, Report by Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36561357/breast-biopsy-market-set-to-achieve-us-3-8-billion-in-revenue-by-2033-report-by-persistence-market,2024-01-09 17:10:00,"New York, Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- Breast biopsy is a medical procedure involving the removal of a sample of breast tissue for diagnostic examination. It is a crucial step in the early detection and diagnosis of breast cancer, enabling healthcare professionals to determine the presence ...",HOLX,0.020491,0.205118,Somewhat-Bullish
"Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - CyberArk Software  ( NASDAQ:CYBR ) , Grifols  ( NASDAQ:GRFS ) ",https://www.benzinga.com/news/24/01/36552256/hewlett-packard-enterprise-hologic-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session,2024-01-09 11:36:38,"U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise Company HPE shares fell sharply in pre-market trading on Tuesday. HP might be on the verge of acquiring Juniper Networks JNPR, in a deal possibly ...",HOLX,0.313484,-0.067454,Neutral
Hologic  ( NASDAQ:HOLX )  Upgraded to Buy at StockNews.com,https://www.defenseworld.net/2024/01/09/hologic-nasdaqholx-upgraded-to-buy-at-stocknews-com.html,2024-01-09 08:16:44,StockNews.com upgraded shares of Hologic ( NASDAQ:HOLX - Free Report ) from a hold rating to a buy rating in a research report report published on Monday morning.,HOLX,0.766478,0.391509,Bullish
"Hologic, Inc.  ( HOLX )  is Attracting Investor Attention: Here is What You Should Know",https://www.zacks.com/stock/news/2206876/hologic-inc-holx-is-attracting-investor-attention-here-is-what-you-should-know,2024-01-08 14:00:12,"Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",HOLX,0.490323,0.171114,Somewhat-Bullish
Hologic  ( HOLX )  Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release,https://www.zacks.com/stock/news/2215861/hologic-holx-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q1-release,2024-01-25 15:00:54,Hologic (HOLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,HOLX,0.301933,0.153628,Somewhat-Bullish
Here's How Much a $1000 Investment in Hologic Made 10 Years Ago Would Be Worth Today,https://www.zacks.com/stock/news/2214806/heres-how-much-a-1000-investment-in-hologic-made-10-years-ago-would-be-worth-today,2024-01-24 13:30:03,"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",HOLX,0.591449,0.287433,Somewhat-Bullish
HOLX or SONVY: Which Is the Better Value Stock Right Now?,https://www.zacks.com/stock/news/2214370/holx-or-sonvy-which-is-the-better-value-stock-right-now,2024-01-23 16:40:07,HOLX vs. SONVY: Which Stock Is the Better Value Option?,HOLX,0.781119,0.554852,Bullish
3 Medical Instruments Stocks to Buy as Industry Trends Improve,https://www.zacks.com/commentary/2214112/3-medical-instruments-stocks-to-buy-as-industry-trends-improve,2024-01-23 15:13:00,"The Zacks Medical - Instruments industry is gaining from the rising demand for digital health offers. However, inflation and staffing shortages continue to disrupt growth. HOLX, MASI and VCYT appear well-poised to brave the challenges.",HOLX,0.083251,0.091447,Neutral
Hologic  ( HOLX )  Beats Stock Market Upswing: What Investors Need to Know,https://www.zacks.com/stock/news/2213766/hologic-holx-beats-stock-market-upswing-what-investors-need-to-know,2024-01-22 22:45:18,"In the most recent trading session, Hologic (HOLX) closed at $74.04, indicating a +0.71% shift from the previous trading day.",HOLX,0.541943,0.318296,Somewhat-Bullish
Breast Biopsy Devices Market size to grow by USD 721.64 million from 2022 to 2027; North America accounts for 39 ... - PR Newswire,https://www.prnewswire.com/news-releases/breast-biopsy-devices-market-size-to-grow-by-usd-721-64-million-from-2022-to-2027-north-america-accounts-for-39-of-market-growth--technavio-302039676.html,2024-01-22 10:35:00,Breast Biopsy Devices Market size to grow by USD 721.64 million from 2022 to 2027. North America accounts for 39 ... PR ...,HOLX,0.056674,0.124941,Neutral
Liquid Biopsy in Cancer Diagnostics Global Market is Likely to Increase at a Massive Growth Rate of ~17% by 2028 | DelveInsight,https://www.prnewswire.com/news-releases/liquid-biopsy-in-cancer-diagnostics-global-market-is-likely-to-increase-at-a-massive-growth-rate-of-17-by-2028--delveinsight-302039144.html,2024-01-19 22:01:00,Liquid Biopsy in Cancer Diagnostics Global Market is Likely to Increase at a Massive Growth Rate of ~17% by 2028 ... PR ...,HOLX,0.021143,0.024956,Neutral
3 Discounted MedTech Stocks Poised for Sturdy Growth in 2024,https://www.zacks.com/stock/news/2212910/3-discounted-medtech-stocks-poised-for-sturdy-growth-in-2024,2024-01-19 16:21:00,"Prestige Consumer Health (PBH), Quest Diagnostics (DGX) and Hologic (HOLX) are currently at discounted zone that are expected to provide long-term gains.",HOLX,0.174335,0.245492,Somewhat-Bullish
"Investors Heavily Search Hologic, Inc.  ( HOLX ) : Here is What You Need to Know",https://www.zacks.com/stock/news/2212717/investors-heavily-search-hologic-inc-holx-here-is-what-you-need-to-know,2024-01-19 14:00:11,"Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",HOLX,0.490323,0.156404,Somewhat-Bullish
"Hepatitis C Virus Testing Market Poised to Expand at a 5.8% CAGR, Surpassing US$1,185.2 Million by 2030 | Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36691001/hepatitis-c-virus-testing-market-poised-to-expand-at-a-5-8-cagr-surpassing-us-1-185-2-million-by-2,2024-01-19 08:30:00,"New York, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The Hepatitis C Virus ( HCV ) Testing Market is a dynamic and evolving sector within the healthcare industry, driven by the persistent threat posed by the Hepatitis C Virus.",HOLX,0.025775,0.244618,Somewhat-Bullish
Hologic  ( HOLX )  Q1 Earnings Might Rise on Breast Health Growth,https://www.zacks.com/stock/news/2212288/hologic-holx-q1-earnings-might-rise-on-breast-health-growth,2024-01-18 16:30:00,Strong performance in the Breast Health segment is likely to boost Hologic's (HOLX) Q1 result.,HOLX,0.485711,0.397288,Bullish
Why Hologic  ( HOLX )  is Poised to Beat Earnings Estimates Again,https://www.zacks.com/stock/news/2211646/why-hologic-holx-is-poised-to-beat-earnings-estimates-again,2024-01-17 17:10:10,Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,HOLX,0.409171,0.390306,Bullish
Hologic  ( HOLX )  to Report Q1 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2211619/hologic-holx-to-report-q1-earnings-whats-in-the-cards,2024-01-17 17:07:00,Strength in Breast Health and GYN Surgical businesses are likely to contribute to Hologic's (HOLX) Q1 2024 revenues.,HOLX,0.416614,0.255298,Somewhat-Bullish
Hologic  ( HOLX )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2211062/hologic-holx-gains-as-market-dips-what-you-should-know,2024-01-16 22:45:20,"In the most recent trading session, Hologic (HOLX) closed at $72.89, indicating a +0.19% shift from the previous trading day.",HOLX,0.592095,0.132153,Neutral
"Molecular Diagnostics Market Hits US$ 39.5 Billion in 2022, Expected to Reach US$ 59.4 Billion by 2033 with a 4.2% CAGR, Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36643857/molecular-diagnostics-market-hits-us-39-5-billion-in-2022-expected-to-reach-us-59-4-billion-by-203,2024-01-16 15:30:00,"New York, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- The Molecular Diagnostics Market is experiencing robust growth due to technological advancements and increasing demand for personalized medicine. Key applications include oncology, infectious diseases, genetic testing, and cardiovascular diseases.",HOLX,0.019797,-0.14516,Neutral
"U.S. women's health ranks on par with Kazakhstan, research finds",https://www.marketwatch.com/story/u-s-womens-health-ranks-on-par-with-kazakhstan-research-finds-ca53d3f7,2024-01-16 15:16:00,"The U.S. fell seven places in an annual global ranking of women's health, landing at 30th place alongside Kazakhstan and Mauritius.",HOLX,0.393462,0.03038,Neutral
"Hologic's  ( HOLX )  Q1 Earnings Beat Estimates, Gross Margin Down",https://www.zacks.com/stock/news/2220500/hologics-holx-q1-earnings-beat-estimates-gross-margin-down,2024-02-02 17:52:00,"Hologic's (HOLX) Breast Health segment registered strong growth in Q1, primarily owing to higher capital equipment revenues.",HOLX,0.316337,0.204465,Somewhat-Bullish
"Amazon To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday - Deckers Outdoor  ( NYSE:DECK ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/24/02/36907476/amazon-to-rally-over-41-here-are-10-top-analyst-forecasts-for-friday,2024-02-02 12:33:38,"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. JP Morgan cut the price target for WEC Energy Group, Inc. WEC from $90 to $84.",HOLX,0.234307,0.075314,Neutral
Hologic Reports Better-Than-Expected Q1 Results - Hologic  ( NASDAQ:HOLX ) ,https://www.benzinga.com/news/earnings/24/02/36900207/hologic-reports-better-than-expected-q1-results,2024-02-01 21:52:21,"Hologic, Inc. HOLX reported better-than-expected first-quarter financial results after the bell Thursday. Here's a look at the highlights.",HOLX,0.943189,0.572653,Bullish
Here's Why You Should Retain Hologic  ( HOLX )  Stock for Now,https://www.zacks.com/stock/news/2218881/heres-why-you-should-retain-hologic-holx-stock-for-now,2024-01-31 16:17:00,Investors are optimistic about Hologic (HOLX) owing to its strength in the Breast Health and GYN Surgical segments.,HOLX,0.326129,0.215534,Somewhat-Bullish
BD  ( BDX )  Gears Up for Q1 Earnings: What's in the Offing?,https://www.zacks.com/stock/news/2217270/bd-bdx-gears-up-for-q1-earnings-whats-in-the-offing,2024-01-29 15:49:00,Continued strength in BD's (BDX) Life Sciences segment's base business is expected to have benefited fiscal first-quarter sales.,HOLX,0.118452,0.069659,Neutral
"Big Tech stocks look 'exhausted,' analyst warns. But these 100 'next-gen' Nasdaq names appear poised to take off.",https://www.marketwatch.com/story/big-tech-stocks-look-exhausted-analyst-warns-but-these-100-next-gen-nasdaq-names-appear-poised-to-take-off-99e0c050,2024-01-29 14:55:00,"A group of 100 next-generation Nasdaq-traded names, including sports-betting company DraftKings, appears poised to move higher, according to one Wall Street analyst.",HOLX,0.193465,0.113017,Neutral
What Analyst Projections for Key Metrics Reveal About Hologic  ( HOLX )  Q1 Earnings,https://www.zacks.com/stock/news/2217027/what-analyst-projections-for-key-metrics-reveal-about-hologic-holx-q1-earnings,2024-01-29 14:16:08,"Evaluate the expected performance of Hologic (HOLX) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",HOLX,0.387674,0.150088,Somewhat-Bullish
